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Abstract 
Transcriptional and histone modification profiles were analysed in detail across 
several regions of the mouse genome in order to examine how tissue-specificity is 
determined at early stages of development and how it is maintained during cell 
commitment. The analysis was mainly focused on a 2 Mb gene-dense region containing 
68 known closely situated genes, having very diverse expression patterns. 
Transcriptional profiling of this region showed that clustered tissue-restricted and 
housekeeping genes are associated with clearly defined monovalent or bivalent 
epigenetic domains. In ES cells, the actively transcribed housekeeping genes were 
enriched for histone H3K4me1, H3K4me2, H3K4me3, H3K9ac and binding of Pol II. 
Most of the silent tissue-restricted genes were marked by bivalent domains and had 
background levels of Pol II.  In few cases, substantial levels of Pol II were found at 
inactive genes situated close to housekeeping genes, suggesting that transcriptional 
read-through could be occurring at these genes in ES cells. Epigenetic profiling of the 
gene-dense region in LPS-activated B cells showed that B cells have a very similar 
histone modification profile to ES cells. Specifically, the analysis showed that bivalent 
domains which were thought to be a defining characteristic of pluripotent stem cells are 
equally prevalent in B cells, suggesting that the epigenetic marking of silent genes is 
quite similar in these two very different cell types. Analysis of a large gene-poor region 
containing four genes encoding GABAA neurotransmitter receptor subunits showed that 
the this locus acquires a large bivalent domain of approximately 1.3 Mb following 
differentiation of ES cells into NS cells and astrocytes. The results obtained in this study 
demonstrate the complex and diverse nature of histone modifications at tissue-restricted 
genes and suggest that trans-acting factors are responsible for generating highly specific 
combinations of histone modifications at each individual gene at different stages of cell 
differentiation.  
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1 Introduction 
1.1 Epigenetic Regulation 
The identity of each cell in a multicellular organism is determined by a unique 
gene-expression pattern specific to that cell type. This characteristic of each cell is 
remembered and passed through subsequent cell divisions to daughter cells by 
epigenetic mechanisms.  Epigenetic modifications refer to heritable changes, such as 
post-translational histone modification and DNA methylation, which affect chromatin 
structure but do not alter the DNA sequence itself (see Table 1.1 and Table 1.2). These 
modifications play an important role during cell differentiation, permitting cells to 
activate specific tissue-specific genes and repress genes whose expression is 
unnecessary in that specific lineage. Histone modifications are thought to act primarily 
by altering the ability of non-histone proteins to interact with chromatin and 
subsequently modify surrounding nucleosomes  
 
1.1.1 Chromatin Organization 
The pattern of expression of each individual gene is regulated by the interaction 
of transcription factors with a set of cis-acting sequences, which combine to form a 
genetic functional unit. The functional unit contains the sequence elements that are 
necessary for gene regulation, such as enhancers and promoters (Dillon and Festenstein, 
2000). However, the genome is also subject to an additional level of regulation, 
influenced by epigenetic modifications, which play an important role in gene regulation. 
It is now known that specific combinations of epigenetic modifications establish 
domains of active and inactive chromatin leading to either gene expression or silencing 
(Litt et al., 2001; Schubeler et al., 2000). Establishment and maintenance of these 
modifications is the result of a complex interplay between many different components, 
including transcription factors (TFs), histone modifying enzymes and noncoding RNAs 
(ncRNAs). 
The most studied epigenetic modifications are the histone modifications and 
DNA methylation. The nucleosome, which is a fundamental subunit of chromatin, 
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consists of 147 base pairs of DNA wrapped around a histone octamer. The histone 
octamer contains two of each of the core histones H2A, H2B, H3 and H4 (Kornberg and 
Lorch, 1999).  Histones are among the most highly conserved eukaryotic proteins 
known, suggesting that the fundamental structure of chromatin has evolved in a 
common ancestor of eukaryotes (Felsenfeld and Groudine, 2003). The DNA wound 
around the surface of the histone octamers is partially accessible to regulatory proteins, 
but specific sequences can become more available if the nucleosomes slide away 
(Boeger et al., 2003) or if the DNA partly unwinds from the octamer. Changes in the 
chromatin structure can be caused by covalent modification of the conserved N-terminal 
histone ‘tails’, central histone-fold domains and C-terminal regions (Figure 1.1) 
(reviewed in (Latham and Dent, 2007)).  
 
 
Figure 1.1 Modifications that are known to occur on the histones that form the nucleosome core 
particle. (Adapted from (Turner, 2005)). 
 
Modification of specific amino acid residues can have profound effects on the 
interaction of the histones with the DNA and the communication between non-histone 
proteins with chromatin. A large number of modifications are known, including 
acetylation, methylation, phosphorylation, ubiquitination, SUMOylation, ADP 
ribosylation, deimination and proline isomerization (Kouzarides, 2007) (summarized in 
Table 1.1). 
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Table 1.1 Different classes of modifications identified on the core histones are involved in distinct 
biological pathways (adapted from (Kouzarides, 2007)). 
 
The most studied modifications are lysine acetylation and methylation. 
Acetylation of lysines is broadly linked with transcriptional activation, whereas lysine 
methylation can be associated with either transcriptionally active or repressed sites. 
Specific modifications, such as histone H3 lysine 9 di-methylation and H3 lysine 27 tri-
methylation are associated with the presence of more compact and less accessible 
chromatin structure, whereas methylation of lysine 4, 36 and 79 on histone H3, are 
linked to more open chromatin and transcriptionally active regions. The general 
characteristics of different chromatin structures are summarized in Table 1.2. 
 
 
Table 1.2 General characteristics of euchromatin, constitutive and facultative heterochromatin. 
(Adapted with changes from (Arney and Fisher, 2004)). 
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1.1.2 Heterochromatin 
Heterochromatin was firstly described in 1928 by E. Heitz as chromatin that 
stained darkly during all phases of the cell cycle (Heitz, 1928). Many studies have been 
carried out in order to understand the structure of this chromatin state. It is now known 
that the heterochromatin is a condensed chromatin structure, which is devoid of protein 
coding sequences and has reduced recombination frequency. It also has a tendency to 
localise to specific nuclear departments, such as the nuclear periphery and in general 
replicates late in the cell cycle. Sequence analysis of heterochromatic regions has 
revealed that it is highly enriched for repetitive elements, such as long- and short- 
interspersed noncoding elements (LINEs and SINEs, respectively) and transposable 
elements.  
Two types of heterochromatic structure have been described; constitutive and 
facultative. Constitutive heterochromatin is associated with centromeres and yeast 
telomeres, but can also be found in large blocks on the long arms of chromosomes 
(reviewed in (Buhler and Moazed, 2007)). Facultative heterochromatin is a structure 
that forms as a result of a developmentally regulated condensation of gene-rich 
euchromatic regions. These regions become decondensed and transcriptionally active at 
specific points during development. A well-studied example of facultative 
heterochromatin is formed during X chromosome inactivation in female mammals. 
During X inactivation, the transcriptionally inert heterochromatin of the inactive X 
chromosome is visible as the condensed Barr body located close to the nuclear 
periphery in female somatic cells (Barr and Bertram, 1949). 
  
1.1.3 Euchromatin 
Euchromatic regions of the genome are observed cytologically as more 
decondensed structures and are located near the centre of the interphase nucleus. 
Euchromatin normally contains a high density of functional genes and often replicates 
earlier in S-phase than heterochromatic DNA (Dimitri et al., 2005). Several histone 
modifications are associated with this chromatin structure, such as hyperacetylation of 
histones H3 and H4, methylation of K4, K36 and K79 on histone H3, and many others 
(summarized in Table 1.2). Besides the modifications of histones at specific residues, 
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CpG dinucleotides in the associated DNA are often unmethylated, in association with 
expressing genes (Eden et al., 1998).  
Numerous studies have demonstrated that histone modifications associated with 
euchromatic structure are associated with actively transcribing genes. It has been shown 
that acetylation of histones is enriched at promoters and at 5’ends of the transcribed 
regions, together with methylation of H3K4. These modifications are recognized by 
either chromo- or bromodomain containing proteins, which subsequently interact with 
additional chromatin-modifying enzymes and further reinforce the formation of a more 
open chromatin structure. Additionally, some of these active histone modifications are 
involved in recruiting chromatin-remodelling proteins, which regulate chromatin 
compaction following gene transcription. Different mechanisms that are involved in 
changes in chromatin structure and gene regulation will be described in the following 
sections. 
 The idea that modifications on histone tails could be recognized by a specific 
binding protein, which in turn can influence gene expression was suggested a number of 
years ago (Turner, 1993) and is now being reinforced by experimental data. However, 
what still remains controversial is the existence of a histone code and heritability. While 
cells replicate, they maintain their identity and one of the questions still to be answered 
is if cellular memory could actually operate through patterns of histone modifications. 
 
1.1.4 Histone Methylation 
Methylation of histones H3 and H4 occurs on both arginine and lysine residues 
and can be associated with either gene activation or repression, depending on the 
particular lysine/arginine residue that is methylated (Kouzarides, 2002). Even within the 
same lysine residue, the biological consequences of methylation can differ depending 
on whether the lysine residue has acquired single, double or triple methylation mark 
(Santos-Rosa et al., 2002) (Wang et al., 2003). At least five lysine positions can be 
methylated at the N-termini of histone H3 (K4, K9, K27, K36 and K20) and histone H4.  
Methylation of histones has variable effects, depending on the location and 
context of the methylated residues. For example, tri-methylation of H3K4 occurs at the 
5’ ends of the transcribed regions of active genes, whereas H3K9me3 is associated with 
pericentromeric heterochromatin, which is transcriptionally inert.  
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Histone methyltransferases display remarkable specificity for the type of 
methylation that they catalyse (Zhang and Reinberg, 2001). There are three defined 
types of S-adenosylmethionine (AdoMet)-dependent methyltransferases. The largest 
class (Class I), which includes the PRMT (protein arginine N-methyltransferase) family, 
has a common seven-stranded β-sheet structure. Class II includes the SET domain-
containing methyltransferases (named after D. melanogaster, Su(var)3-9, Enhancer of 
zest and Trithorax). The MLL (mixed-lineage leukemia) and ASH1 (absent, small, or 
homeotic-1) subfamilies belong to class II histone methyltransferases.  The membrane-
associated methyltransferases belong to class III (Bedford, 2007). In recent years, the 
search for new histone modifying enzymes has led to the discovery of a large number of 
new enzymes. However, this has resulted in a sometimes noncoherent nomenclature 
which was not always consistent between species. For this reason, a new nomenclature 
was recently agreed for chromatin-modifying enzymes. The new nomenclature for 
lysine (K) methyltransferases (KMTs) is shown in Table 1.3 (in the following chapters, 
both old and new nomenclatures will be shown for each enzyme): 
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Table 1.3 Schematic representation of known K-methyltransferases and their target residues. 
(Adapted from (Allis et al., 2007)). 
 
Distinctive domains at the C- and N-terminal ends of the KMTases flank the 
catalytic SET domains. The narrow channel that is formed by the C- and N-terminal 
regions provides an entry site for the lysine residue to be modified. Transfer of the 
methyl group, which derives from AdoMet occurs after a process of deprotonation, 
where the positive charge of a lysine residue is removed (Guo and Guo, 2007). There 
are also KMTases that lack the SET domain. An example is Dot1/KMT4, which is 
responsible for the methylation of H3K79 and telomeric silencing (Feng et al., 2002). 
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Heterochromatin formation: histone H3 arginine 2 methylation  
Histone H3 arginine (H3R) methylation occurs in the mono- and di-methylated 
forms and can either lead to symmetric or asymmetric methylation (Torres-Padilla et al., 
2007). Members of PRMT family have been shown to catalyse H3R methylation. 
Mammalian CARM1 (PRMT4) catalyzes the asymmetric di-methylation of H3 arginine 
2 (H3R2me2a) (Torres-Padilla et al., 2007). H3R2me2a has been shown to be 
associated with heterochromatic loci and euchromatic repressed genes, in S. cerevisiae 
(Kirmizis et al., 2007). It has also been demonstrated that H3R2me2a and H3K4me3 are 
mutually exclusive and that the presence of di-methylated H3R2 inhibits methylation of 
K4 by Set1/KMT2 methylase. Mutation of arginine 2 to alanine 2 resulted in loss of 
silencing and increased levels of H3K4me3, but did not affect the methylation of other 
resides such as K36 and K79.   
A recent study showed that TFIID, which is involved in the formation of the pre-
initiation complex (PIC) binds directly to histone H3K4me3 through a PHD domain of 
its TATA box binding protein (TBP)-associated factor 3 (TAF3) subunit (Vermeulen et 
al., 2007). The presence of H3R2me2a has been shown to inhibit this interaction, which 
suggests that because of their close physical proximity, R2 and K4 modifications act 
antagonistically during recruitment of the transcriptional machinery in S. Cerevisiae 
(Figure 1.2). Indeed, Kirmizis and colleagues have demonstrated that H3R2 methylation 
regulates the activity of Set1/KMT2 (the KMTase involved in methylation of K4). 
H3R2me2a is also involved in controlling H3K4 trimethylation in humans, indicating 
that this mechanism is likely to be conserved amongst all eukaryotes (Guccione et al., 
2007). Together, these data suggest that H3R2me2a is a negative regulator of H3K4 tri-
methylation.  
It is believed that methylated arginine (and lysine) residues serve as docking 
sites for methyl-binding proteins and influence the deposition of other post-translational 
marks on the surrounding nucleosomes (reviewed in (Bedford, 2007)). CARM1/PRMT4 
is found in a complex of at least ten proteins called the nucleosomal methylation 
activator complex (NUMAC) (Xu et al., 2004). This complex is comprised of eight 
components of the SWI/SNF nucleosome remodelling complex, which are involved in 
displacement of the SAGA complex and formation of transcriptionally active 
chromatin. It has been proposed that gene repression by histone H3R2me2a is reversed 
by recruitment of KMTases responsible for methylation of H3K4 (Kirmizis et al., 
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2007). However, it is still not clear if SWI/SNF complexes are involved in this 
exchange process between inactive and active states (reviewed in (Bedford, 2007)).  
 
 
Figure 1.2 Methylation of histone H3R2 blocks the binding of SET1/KMT2 and methylation of 
H3K4. In the repressive state (OFF), R2 is methylated by CARM1, which in return prevents methylation 
of K4 by SET1/KMT2. Upon gene activation (ON), arginine demethylase removes methyl groups from 
H3R2 while H3K4 is subsequently methylated by SET1/KMT2. H3K4me3 is then recognized and bound 
by TAF3, a subunit of the TFIID complex. 
 
Transcriptional activation: histone H3 lysine 4 methylation  
Modification of lysine 4 of histone H3 is known to be an important epigenetic 
marker for active transcriptional states.  The KMTase, which is responsible for mono-, 
di- and tri-methylation of H3K4 is Set1/KMT2 which associates with other proteins to 
form the COMPASS complex. The COMPASS/MLL complex contains a WD40-repeat 
protein called WDR5, which binds to H3K4me1 and H3K4me2 and contributes to the 
addition of another methyl group and formation of H3K4me3 (Wysocka et al., 2005). 
Many genome-wide studies from yeast to human have shown that H3K4me3 and 
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H3K4me2 are associated with the 5’ ends of active genes (Bernstein et al., 2005), 
whereas H3K4me1 was linked to enhancer regions in humans (Heintzman et al., 2007). 
The identification of several methyl-interacting proteins has highlighted the role played 
by these proteins in targeting KMTases onto chromatin and recruiting proteins that are 
involved in stepwise activation or repression (reviewed in (Kouzarides, 2007)). 
 
Methylated histone H3K4 is recognized by a variety of proteins 
Methylated lysine residues provide binding sites for a variety of proteins, which 
are able to further remodel surrounding nucleosomes.  Histone H3K4 is bound by a 
group of chromo- and PHD domain-containing proteins, such as CHD1 and BPFT, 
ING2 and TAF3, respectively (Figure 1.3). CHD1 (chromo-ATPase/helicase-DNA-
binding protein1), a member of SNF2-like family of proteins, and BPFT (bromo-
domain PHD transcription factor), a component of the NURF (nucleosome remodelling 
factor) complex, bind to methylated H3K4 (Flanagan et al., 2005) and contribute to 
chromatin opening by further modifying surrounding nucleosomes. Recognition of 
H3K4me3 by the TAF3 subunit of the TFIID complex, which plays a crucial role in the 
formation of PIC, is a good demonstration of how histone modifications and the 
transcriptional machinery jointly contribute to transcriptional regulation  (see section 
1.3.1) (Vermeulen et al., 2007). The interaction between components of the PIC and 
H3K4me3 is specifically inhibited by H3R2me2a and enhanced by other active histone 
marks, such as acetylated H3K9 and H3K14. 
ING2 (inhibitor of growth) is a subunit of the repressive mSin3a-HDAC 
complex and is a first effector molecule, which links K4me3 to gene repression (Shi et 
al., 2006)(see section 1.1.7). Shi and colleagues suggested that by recruiting histone 
deacetylase (HDAC) via ING2 to H3K4me3 modified promoters, the nucleosomes 
become rapidly deacetylated, which results in chromatin compaction and gene 
silencing. It was proposed that cells use this mechanism in order to rapidly repress gene 
expression in response to cellular stress caused by DNA damage. 
Together, these data imply that the above-mentioned complexes compete for 
binding to H3K4me3 and can lead to either chromatin-remodelling (via BPTF/NURF 
binding) and gene activation (via TFIID/TAF3 binding) or gene repression (via the 
ING2/Sin3A pathway). These studies demonstrate the complexity of interactions 
between euchromatic modifications, different members of the transcriptional machinery 
and chromatin-remodelling proteins. 
 22 
 
Figure 1.3 Schematic representation of the different protein complexes that interact with H3K4. 
The Wdr5 subunit of the COMPASS KMTase is involved in converting of H3K4me2 to H3K4me3. 
BPFT and CHD1 are involved in the recruitment of chromatin-remodelling complexes (orange dashed 
lines), thereby promoting formation of the active chromatin structure. Binding of TAF3 to H3K4me3 
leads to the recruitment of the PIC, which is necessary for the transcriptional initiation to occur. Binding 
of the ING2 component of the HDAC complex, leads to rapid histone deacetylation and gene repression 
in response to cellular stress (black line). 
 
Transcriptional activation: histone H3 lysine 36 methylation  
Another modification, which is associated with transcriptionally active 
chromatin, is methylation of histone H3K36. It occurs as H3K36me2 and H3K36me3 
and it is predominantly located within genes and at the 3’ end (Li et al., 2007a). The 
KMTases that are responsible for the transfer of a methyl group onto this lysine residue 
are ASH1/KMT3, which belongs to the trithorax (trx) group of proteins (Gregory et al., 
2007) and Set2/KMT3. Trx proteins were initially discovered as major regulators of 
Hox gene clusters. It was believed that Drosophila Ash1/KMT3 is involved in di-
methylation of histone H3K36 and also methylation of H3K9 and H4K20. However a 
recent study reported that Drosophila Ash1/KMT3 specifically mono- and dimethylates 
only H3K36 and is not involved in the methylation of H3K9 and K20, as previously 
published (Tanaka et al., 2007). The specificity of Ash1/KMT3 was demonstrated by 
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mutation of the lysine at position 36 to arginine, which abolished the activity of 
Ash1/KMT3 and prevented methylation at this position. 
Tri-methylation of H3K36, which is catalysed by Set2/KMT3 is linked to 
transcriptional elongation (Krogan et al., 2003b). Set2/KMT3 interacts directly with 
RNA Polymerase II (Pol II) through the phosphorylated Serine 2 residue, which is 
located at the C-terminal repeat domain (CTD) of the large subunit of the polymerase 
(CTDS2ph). Phosphorylation of CTD2, which is a characteristic mark of elongating Pol 
II (Li et al., 2002) is catalysed by Ctk1 kinase (Cho et al., 2001)(for a more detailed 
description of the role of H3K36 methylation during different steps of transcription, see 
section 1.3.4) and is a prerequisite for Set2-dependent H3K36 methylation (reviewed in 
(Lee and Shilatifard, 2007)).  
Acetylation and deacetylation of lysine residues on histones are associated with 
transcriptional activation and repression, respectively. Rpd3 is a HDAC in S. Cerevisiae 
that functions as a transcriptional repressor of many genes and is a member of a 
multisubunit protein complex. Two forms of the Rpd3 complex have been identified, 
Rpd3S and Rpd3L (Carrozza et al., 2005) and it has been shown that the Eaf3 and Rco1 
subunits of Rpd3S are essential for correct functioning of the HDAC complex. 
Additionally, Carrozza and colleagues have shown that when Rco1 and Eaf3 were 
mutated, an increase in acetylation was observed across the coding regions of analysed 
genes, which led to the appearance of incorrect transcripts within the body of a gene. 
Moreover, the same affect was observed in mutants lacking a functional Set2/KMT3 
(Carrozza et al., 2005) and subsequent studies demonstrated that methylated H3K36 is 
bound by Rpd3S (Li et al., 2007b). These studies showed the link between K36 
methylation associated with transcriptional elongation and the subsequent requirement 
for chromatin compaction by Rpd3 deacetylation. 
Besides being a part of deacetylase complex, chromodomain-containing Eaf3 is 
also a subunit of NuA4, a histone acetyltransferase complex that is essential for the 
acetylation of the 5’ ends of active genes (Reid et al., 2004). The dual role of Eaf3 can 
be explained by the fact that it recruits NuA4 at the 5’ end of the genes and promotes an 
open chromatin structure, whereas it recruits HDAC in the body of genes at their 3’ end, 
following the passage of Pol II (reviewed in (Lee and Shilatifard, 2007)). These results 
highlight the importance of different levels of specific modifications, such as H3K36 
methylation across specific intergenic sites and how they can affect the synthesis of 
correctly initiated transcripts.  
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Heterochromatin formation: histone H3 lysine 9 methylation  
Heterochromatin formation has been connected to methylation of lysine 9 thanks 
to studies of position effect variegation (PEV) in Drosophila. PEV was first observed in 
Drosophila mutants generated by X-irradiation. The mutant flies exhibited mosaic 
(variegated) expression of the white gene. This was the result of a translocation, which 
placed a white gene close to pericentromeric heterochromatin (Muller and Altenburg, 
1930). The identification of Su(var)39 as a suppressor of variegation and its subsequent 
identification as a KMTase, established the importance of this gene in chromatin 
modification (Tschiersch et al., 1994). The mammalian homologues SUV39H1/KMT1 
and Suv39h1 were later discovered to have methyltransferase activity, which is specific 
for histone H3K9 (Rea et al., 2000). More specifically, methylation of H3K9 by 
Suv39h/KMT1 is now known to be linked to constitutive heterochromatin together with 
high levels of DNA methylation (Rice et al., 2003). 
Recently, there have been many studies describing histone modifications that are 
associated with different types of heterochromatin. Several KMTases catalyse 
methylation of H3K9 and promote gene silencing in the context of euchromatic 
chromatin. Among these are G9a/KMT1C, G9a-related protein (GLP)/KMT1D (Rice et 
al., 2003) and ESET/KMT1E (Dodge et al., 2004). G9a/KMT1C and GLP/KMT1D 
have also been found to be responsible for the vast majority of H3K9 methylation in 
mouse embryonic stem cells. Absence of G9a gene resulted in a global increase in 
active histone modifications associated with transcription, as well as resulting in early 
embryonic lethality due to severe defects in cell differentiation (Tachibana et al., 2002). 
These results imply that methylation of H3K9 plays an important role in the early stages 
of cell differentiation as well as the establishment and maintenance of developmentally 
regulated gene silencing.  
 
Methylated K9 is bound by heterochromatin protein 1 (HP1) 
An important function of methylated H3K9 is to act as a recognition site for 
heterochromatin protein 1 (HP1), which binds to H3K9 via its chromodomain region. 
HP1 was originally identified as a modifier of PEV (Weiler and Wakimoto, 1995) and 
belongs to a group of proteins, which are highly conserved amongst eukaryotes. In 
mammals, three different isoforms of HP1 are linked to different degrees of H3K9 
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methylation. Initially, binding of HP1 was associated with pericentric heterochromatin, 
whereas recently, its association with gene repression and activation has also been 
described. HP1α is found predominantly in foci of pericentric heterochromatin, HP1β is 
present both on constitutive heterochromatin and euchromatin, whereas the HP1γ 
isoform is dispersed through the genome (reviewed in Dialynas et al. 2007). Binding of 
HP1 to differentially methylated H3K9 residues leads to very diverse biological 
processes. In constitutive heterochromatin, HP1 binds to H3K9me3 and recruits 
Su(var)39/KMT1, thereby promoting further H3K9 methylation and 
heterochromatinisation. Binding of HP1γ to methylated H3K9 has also been described 
for several transcriptionally active genes within mammalian genome (Vakoc et al., 
2005).  
HP1 also has the ability to bind to non-histone proteins and thereby promote 
heterochromatinisation. It can bind to the automethylated form of G9a/KMT1c (Chin et 
al., 2007; Sampath et al., 2007) and also to DNA methyltransferase (DNMT1) (Agarwal 
et al., 2007; Esteve et al., 2006; Smallwood et al., 2007). Binding of HP1 to G9a results 
in increased H3K9 methylation whereas the interaction between DNMT1 and HP1 leads 
to augmented DNA methylation. Moreover, HP1 can recruit histone deacetylases, 
cohesin and the CAF1 chromatin assembly complexes, demonstrating its role in 
chromatin-remodelling and chromosome segregation (reviewed in (Hediger and Gasser, 
2006)). 
 
Gene silencing: histone H3 lysine 27 methylation   
Methylation of histone H3K27 has been associated with several silencing 
phenomena including X chromosome inactivation, HOX gene regulation and genomic 
imprinting during mammalian development. It is now known that H3K27 methylation is 
mediated by the polycomb protein complexes (PcG). The PcG proteins were first 
described in Drosophila and are known to play an important role in the epigenetic 
inheritance of cellular identity (Orlando, 2003; Ringrose and Paro, 2004). Polycomb 
proteins form two major complexes, polycomb repressive complex 1 (PRC1) and 2 
(PRC2). PRC1 is composed of five subunits, HPC1-3, Ring1A, HPH1-3, SCMH1-2 and 
Bmi1 (reviewed in (Schuettengruber et al., 2007)). HPC1-3 recognizes methylated 
histone H3K27 and subsequent binding of other components of PRC1 complex 
reinforces the process of gene repression, through a mechanism that involves 
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ubiquitination of H2A by Ring1A (see section 1.1.9). The PRC2 complex includes Eed, 
Ezh2, Suz12 and RbAp46/48. The Ezh2/KMT6 (enhancer of Zeste 2) subunit possesses 
a SET-containing domain and is involved in the transfer of a methyl group onto H3K27, 
whereas Eed and Suz12 contribute to the enzymatic activity of Ezh2/KMT6. 
RbAp46/48 contribute to gene silencing by interacting with histone deacetylases 
(HDACs) (see section 1.1.7) (reviewed in (Grimaud et al., 2006)). A summary of 
different PcG complexes and their components is shown in the following table. 
 
 
Table 1.4 A summary of the PcG complexes in D. melanogaster and their human homologues 
(Adapted from (Schuettengruber et al., 2007)).  
 
Polycomb recruitment 
PcGs act on their chromatin targets by binding to cis-regulatory sequences 
known as polycomb response elements (PREs). They are defined as genomic elements, 
which are capable of maintaining targeted genes in a repressed state. The role of PREs 
in gene repression has been demonstrated by analysis using a reporter assay, where 
silencing of Drosophila mini-white gene (necessary for red pigmentation) was observed 
when flanked by PREs (Chan et al., 1994). To date, PREs have only been characterized 
in Drosophila and it remains unclear how polycomb proteins are recruited in other 
organisms, including human.  
The situation is further complicated by the fact that neither neither PRC1 nor 
PRC2 contain DNA binding proteins. Nevertheless, it has been reported that in 
Drosophila, the sequence specific DNA binding protein Pleiohomeotic (Pho), enables 
the core complex of PRC1 to bind specifically to PREs without the need for PRC2 
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(Mohd-Sarip et al., 2005). Pho is a subunit of a third polycomb complex, PhoRc 
(Klymenko et al., 2006), which besides this DNA binding subunit includes the dSfmbt 
protein (Scm-related gene containing four malignant brain tumour (MBT) domains). 
dSfmbt subunit binds specifically to repressive marks such as histone H3K9me1, 
H3K9me2 and H4K20 (reviewed in (Schuettengruber et al., 2007)). However, 
mammalian homologues of PhoRc have still not been identified and the mechanisms 
behind the PRC1 and PRC2 recruitment to their targets are the subjects of a high level 
of research interest.  
Recently, small interfering RNAs (siRNAs) and the protein components of the 
RNA interference (RNAi) machinery have been reported to be involved in the 
recruitment of PcGs to their target genes. A recent study has shown that argonaute-1, a 
major effector component of the siRNA machinery, directs siRNA-mediated 
transcriptional genes silencing (TGS) in human cells by associating with target 
promoters and possibly by recruiting EZH2 (Kim et al., 2006). It has been purposed that 
the siRNA mechanism mediates gene silencing by targeting gene promoters and 
promoting the formation of facultative heterochromatin (reviewed in (Buhler and 
Moazed, 2007)).  
 
Polycomb proteins during early development 
Recent genome-wide studies have described PcG targets in human and mouse 
ES cells, as well as in more committed cell types (Boyer et al., 2006; Lee et al., 2006; 
Mikkelsen et al., 2007). Methylation of histone H3K27 by EZH2/KMT6 occurs at 
several levels, and lead to mono-, di- and trimethylation. Genome-wide analysis of 
H3K27me3 and H3K27me2 has demonstrated that these marks often localise to the 
promoters of transcriptionally inactive genes, even in the presence of active histone 
modifications (Azuara et al., 2006; Bernstein et al., 2006). On the other hand, 
H3K27me1 has been predominantly found within the coding regions of transcribed 
genes (Barski et al., 2007).  The association of H3K27me1 with active chromatin 
structures contradicts the model according to which H3K27 methylation is exclusively 
linked with gene silencing, and suggests a possible involvment of H3K27me1 in the 
recruiting specific activators, leading to transcriptional activation and chromatin 
opening.  
Coexistence of H3K27me3 and active histone modifications has been described 
as bivalent chromatin structure (Bernstein et al., 2006). As described above, methylation 
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of H3K4 by Set1/KMT1 promotes the formation of active chromatin structure by 
recruiting a variety of chromatin-remodelling proteins. It is interesting to speculate 
which are the molecular events that occur upon the formation of bivalent domains and 
how PRC2 and Set1/KMT1 can co-function. The role of bivalent chromatin 
modifications during early development and cell differentiation will be described in 
section 1.7.3. 
 
1.1.5 Histone Acetylation 
Lysine acetylation has been reported on all four of the core histones where it has 
the effect of neutralizing the positive charge of lysine residues. Histones H3, H4, H2A 
and H2B are all associated with acetylation of specific residues (reviewed in 
(Kouzarides, 2007)). The residues on histone H3 that are usually associated with this 
modification are K9, K14, K18, K23, K27, K36 and K56. Acetylation of histone H4 is 
observed at residues K5, K8, K12 and K16. Acetylation of lysine residues is catalyzed 
by histone acetyltransferases (KATs, previously known as HATs). The acetyl residue 
derives from acetyl-coenzyme A and is transferred to the ε-amine molecule of the target 
lysine residue. There is evidence that the presence of the acetyl group alters histone-
DNA interaction and makes the chromatin structure more open and accessible to 
binding of TFs.  
KATs can be organised into five major families, which display different 
mechanisms of histone substrate binding and catalysis (Roth et al., 2001). Some of them 
are components of basal transcription factor complexes such as TFIID while others act 
as nuclear receptor co-activators. The well-studied yeast KAT Gcn5/KAT2, belongs to a 
Gcn5/PCAF (Gcn5-related N-acetyltransferase) family. Gcn5/KAT2 specifically 
modifies histone H3K9 and H3K14 (amongst others), and has been implicated in 
displacement of promoter nucleosomes upon transcriptional activation (Barbaric et al., 
2001). It has been shown that Gcn5/KAT2 mediated histone acetylation facilitates TBP 
binding and Pol II recruitment to promoters, a step which is additionally stimulated by 
the presence of Swi/Snf remodelling complex. Recruitment of Pol II and general 
transcription factors (GTFs) such as TBP are crucial events in the formation of the PIC 
and gene activation (see section 1.3.2).  
 29 
 
Figure 1.4 Classification of known lysine acetyltransferases (KATs) previously known as HATs 
(Adapted from (Allis et al., 2007)). 
 
The enzymatic activities of KATs are regulated in many different ways. It has 
been reported that KATs are subject to covalent modifications, ubiquitin-dependent 
proteasome degradation and interaction with specific TFs and that the formation of 
multisubunit complexes affects their specific activities and substrate recognition (Yang, 
2004). Two models have been put forward to explain how KATs recognize their 
substrates; ‘hit and run’ and ‘attract and hit’ models. In the first model, the interaction 
between the enzyme and substrate is transient and is terminated once the reaction is 
completed, while in the ‘attract and hit’ model, the substrate is brought to physical 
proximity of the enzyme through the help of an adaptor protein.  
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Acetylation and chromatin remodelling 
Acetylation of a lysine residue neutralizes the positive charge of a lysine side 
chain and this modification may affect its interaction with DNA, RNA and proteins. It is 
believed that acetylated histones affect overall nucleosomal structure and impair 
chromatin condensation. Furthermore, the acetylation of lysine residues could inhibit 
the deposition of other molecules such as methyl and ubiquitin groups, which would 
otherwise lead to the formation of different chromatin structures. One interesting 
example is K9 of histone H3, where acetylation and methylation of this residue have 
contrasting functions. While acetylation of H3K9 is associated with the formation of an 
active chromatin structure, methylation of same residue is linked to repressed 
chromatin.  
Similar to histone methylation, attachment of an acetyl group onto a lysine 
residue results in formation of a new binding surface for proteins containing specific 
binding domains. While methylated lysine residues are recognized by chromodomain 
containing proteins, acetylated residues are bound by bromodomain containing proteins. 
An example is Gcn5/KAT2, which is a catalytic subunit of the Spt-Ada-Gcn5 (SAGA) 
complex. SAGA is a large histone acetyltransferase complex, which besides 
Gcn5/KAT2 contains TBP and several TAF proteins. In yeast, this complex is recruited 
by activators to the upstream activation sequences (UAS) in the promoter regions, 
where it is involved in chromatin opening. Moreover, Gcn5/KAT2 also interacts with 
the SWI/SNF chromatin-remodelling complex. Binding of SWI/SNF to acetylated 
lysines occurs through a Brg1 (Brahma-related gene 1) subunit of the complex (Singh et 
al., 2007) (see Figure 1.5), where the SWI/SNF uses the energy of ATP hydrolysis to 
mobilize nucleosomes, leading to gene activation (Pollard and Peterson, 1997) (Roberts 
and Winston, 1997).  
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Figure 1.5 Model representing how SWI/SNF complex participates in the displacement of the KAT 
complex SAGA and subsequent nucleosome remodelling. Recruitment of the SAGA complex results 
in acetylation of promoter-proximal nucleosomes, where it is stabilized via interactions of the Gcn5 
subunit of the complex. The SWI/SNF complex also contains a bromodomain in its Swi/Snf2 subunit and 
competes for binding to acetylated nucleosomes with the SAGA complex. Binding of the SWI/SNF 
complex results in nucleosome displacement and gene activation (Adapted from (Hassan et al., 2006)). 
 
Spilianakis and colleagues have analysed the temporal order of recruitment of 
transcription factors and histone modifying complexes upon activation of the major 
histocompatibility class II (MHCII) DRA gene following IFN-γ stimulation (Spilianakis 
et al., 2003). They have suggested that the gene is “poised” for activation prior to IFN-γ 
stimulation since activators and the basal transcriptional machinery are both pre-
assembled at the enhancer and the promoter of MHCII gene. Upon stimulation, 
additional factors including CIITA (class II transactivator), CBP (CREB-binding 
protein) and Gcn5/KAT2 were recruited and replaced by the SWI/SNF complex. They 
have also demonstrated that the CIITA protein recruits kinases that are involved in 
phosphorylation of Pol II at serine 5, the modification that is associated with the 
elongating Pol II activity (Komarnitsky et al., 2000) (see section 1.3.4).  
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Taken together, these observations imply that acetylation of lysine residues on 
histone proteins, mediated by different KAT complexes has a major impact on 
subsequent chromatin-remodelling steps with accompanying effect on transcriptional 
regulation.  
 
1.1.6 Histone Demethylases 
Epigenetic memory is essential for the development of a complex multicellular 
organism and is involved in transmission of the heritable changes in gene function onto 
subsequent generations. Until recently, it was believed that histone methylation is a 
stable modification, which was considered to play an essential role in the epigenetic 
gene regulation. It was believed that the only way of turning over the methylated 
histones was through the exchange of unmethylated histones or by proteolytic cleavage 
of the methylated histone tails (Agger et al., 2008). However, this view has been 
radically altered with the recent identification of a members of histone demethylases, 
suggesting that the methylation mark is much more dynamic than was previously 
anticipated and is involved in fine-tuning transcription.  
Lysine demethylases (KDMs) are classified into two groups based on their 
distinct catalytic activities. The LSD1 (BHC110) (KDM1) class demethylates 
H3K4me1/H3K4me2 and H3K9me1/H3K9me2 whereas the Jumonji class removes 
methyl groups from H3K4me2/H3K4me3, H3K9me2/H3K9me3 and 
H3K36me2/H3K26me3 (reviewed in (Berger, 2007)) (Table 1.5). 
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Table 1.5 Known K-demethylases (KDMs), previously known as histone lysine demethylases 
(Adapted from (Allis et al., 2007)). 
 
The precise function of histone demethylases is still not entirely clear but it is evident 
that these enzymes antagonize methylation by recruiting and binding other chromatin-
modifying complexes. Several recent studies have reported the interactions between 
KDMs and KMTs during molecular switching from transcriptionally inactive to active 
chromatin states. 
 
Histone H3K27 demethylation 
Two demethylases have been described that are responsible for removal of 
methyl groups from histone H3K27. They are UTX/KDM6A, a gene member of 
Jumonji C family (ubiquitously transcribed tetratricopeptide repeat, X chromosome) 
and JMJD3/KDM6B (Agger et al., 2007). It has been shown that human UTX/KDM6a 
specifically demethylates di- and trimethyl H3K27, but has no involvement in 
demethylation of H3K27me1 (Lee et al., 2007b).  
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Hox genes remain silent in pluripotent cells and are covered by the repressive 
histone H3K27me3 mark. During embryogenesis, the Hox gene clusters are activated in 
a temporal and spatial collinear manner, with the most anterior genes activated first and 
the most posterior activated later during development (Kondo et al., 1998). During the 
transcriptional activation, these gene clusters undergo a series of chromatin 
modifications, which are tightly regulated and result in the controlled expression of the 
locus. Until very recently, it was not clear how the H3K27me3 mark is regulated across 
these loci, during cell differentiation and gene activation. The collinear expression of 
the HOX gene clusters is preserved during retinoic acid (RA) differentiation of mouse 
ES cells or human embryonic carcinoma cells into cells forming neural lineages. Lee 
and colleagues have demonstrated that the histone demethylase UTX/KDM6A is 
recruited to the promoters of the HOXA and HOXB loci following RA treatment and 
that this coincides with the disappearance of H3K27me3, loss of PRC2 binding and 
with gene activation (Lee et al., 2007c).  
In addition, the occupancy of UTX/KDM6A and MLL containing-complexes 
across HOX clusters was investigated following treatment with RA. It has been shown 
that Wdr5, which is the methyltransferase component of MLL-containing complexes 
(Wysocka et al., 2005) specifically associates with UTX/KDM6A, and that tri-
methylation of H3K4 occurred within a shorter time after RA induction compared with 
demethylation of H3K27. Knockdown the UTX/KDM6A gene using siRNA led to the 
continuous presence of H3K27me3 at the target promoters and resulted in gene 
repression (Agger et al., 2007; Lee et al., 2007b), suggesting that UTX/KDM6A activity 
is required for gene activation to occur following Wdr5-mediated H3K4 methylation. 
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Figure 1.6 Methylation and demethylation of lysine 27 on histone H3 (adapted from (Swigut and 
Wysocka, 2007)). A) Methyl group is deposited on H3K27 by EZH2 (PRC2) and is removed by the 
UTX/KDM6A (or JMJD3) demethylase. B) During ES cell differentiation, UTX/KDM6A demethylase is 
recruited to a Hox gene promoter. Together with the action of MLL, this leads to chromatin decompaction 
and gene activation. 
 
Demethylation of histone H3K4  
The histone demethylase that reverses di- and trimethylation of histone H3K4 is 
JARID1d/KDM5, which belongs to the jumonji class of histone demethylases 
(Eissenberg et al., 2007). An interesting feature of this enzyme is that it interacts with 
the polycomb-like protein Ring6a (Lee et al., 2007a). Lee and colleagues have 
demonstrated that absence of functional JARID1d leads to increased H3K4me2 and 
K4me3 levels and recruitment of chromatin-remodeling complexes such as NURF and 
basal transcriptional machinery, which result in increased gene expression. 
Monomethylation of H3K4 is reversed by LSD1/KDM1 (also known as BHC110) 
demethylase, which is a member of the CoREST repressor complex (see section 1.4.2), 
which also contains HDAC1 and HDAC2 (Lee et al., 2005). It has been shown that 
LSD1 is most active toward hypoacetylated histone H3, indicating that deacetylation 
probably occurs prior to demethylation of H3K4. 
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1.1.7 Histone Deacetylases (HDACs) 
The enzymes responsible for removing acetyl groups from histone tails are 
known as histone deacetylases (HDACs). HDACs participate in large regulatory 
complexes that are involved in both the suppression and enhancement of transcription. 
Mammalian deacetylase can be grouped into four classes. Class I HDACs, which 
encompass HDAC 1, 2, 3, and 8, share homology in their catalytic sites and are 
homologous to yeast Rpd3. Class II deacetylases include HDAC 4, 5, 6, 7, 9 and 10.  
HDACs 4, 5, 7 and 9 share a C-terminal catalytic domain as well as a regulatory N-
terminal domain. These HDACs are homologous to yeast Hda1. HDACs 6 and 10 share 
homology with other HDACs from class II, only within the catalytic subunit (de Ruijter 
et al., 2003). A third class of HDACs is the sirtuin (SIR) deacetylases, which are 
homologous to the yeast silent information regulator 2 (Sir2) protein. Several 
mammalian homologues are known including SIRT1, 2, 3, 4, 5, 6 and 7.  Class IV 
HDACs includes proteins that are related to the human HDAC11 gene (Gregoretti et al., 
2004). 
The catalytic domains of HDACs belonging to class I and II are composed of 
390 highly conserved amino acids, which deacetylate their substrates by zinc-catalyzed 
hydrolysis of the acetyl-lysine amide bond (reviewed in (Gallinari et al., 2007). Sirtuin 
deacetylases (SIRT) contain a conserved 275 amino acid catalytic domain, which is 
unrelated to that of other HDACs and operates by a different mechanism that utilises 
nicotinamide adenine dinucleotide (NAD) as a cofactor. However, recent studies have 
reported that some mammalian SIRT homologues (SIRT6 and 7) seem to lack NAD 
dependent protein deacetylase activity and therefore might function using different 
cofactors (Mahlknecht et al., 2006; Voelter-Mahlknecht et al., 2006). 
HDACs do not bind directly to DNA but are instead recruited by the proteins 
with which they are associated in different complexes. HDACs 1 and 2 are found in 
three ubiquitously expressed repressive complexes; Sin3, NuRD (nucleosome 
remodelling and deacetylation) and CoREST (co-repressor for element-1-silencing 
transcription factor). All three repressive complexes consist of HDACs 1 and 2, and 
histone binding proteins RbAp46 and 48, which form “core complex subunits”.  The 
different repressve complexes are shown in Figure 1.7. 
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Figure 1.7 A schematic representation of the Sin3, NuRD and CoREST HDAC complexes. 
 
The Sin3 complex 
The Sin3 complex is composed of core complex subunits together with two 
additional Sin associated proteins, SAP18 and SAP30 (Figure 1.7). The role of the 
Sin3A subunit in the Sin3 complex is to serve as a scaffold for the assembly of the 
entire HDAC complex and for its interaction with other DNA binding proteins. Another 
group of proteins that are implicated in the HDAC-DNA interplay are the ING proteins. 
These proteins are involved in regulating chromatin remodelling, by binding and 
affecting the activity of KATs and HDACs. Recently, it has been reported that ING2, 
which is a subunit of the repressive mSin3a-HDAC1 complex, binds with high affinity 
to histone H3K4me3 through its PHD domains in mammalian cells (Shi et al., 2006) 
(see section 1.1.4). Shi and colleagues have also shown that the association of the ING2 
PHD domain with histone H3 was increased by hypermethylation of bulk histones with 
H3K4 methyltransferase SET7/KMT7. In the reverse experiment, knockdown of Wdr5 
methyltransferase was used to decrease H3K4me3 levels leading to a reduction of ING2 
binding to histone H3. These results indicate that H3K4 methylation is a prerequisite for 
ING2 binding to histone H3, which leads to HDAC1 recruitment and chromatin 
compaction. It has been suggested that the cells use this mechanism to repress gene 
expression in response to cellular stress (Shi et al., 2006).  
  
The NuRD complex 
The NuRD complex, besides the core complex subunits, includes three 
additional proteins, Mi2, MTA2 and MBD3. Mi-2 possesses the same DNA 
helicase/ATPase domain that is found in the SWI/SNF family of chromatin-remodelling 
proteins (Knoepfler and Eisenman, 1999), whereas MTA2 (metastasis associated 
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protein 2) is involved in the formation of an enzymatically functional NuRD complex 
by promoting the assembly of all of its remaining subunits (Zhang et al., 1999).  
The Mbd3 subunit was originally identified in mice and humans as a protein 
containing a region with high homology to the methyl-CpG-binding domain (MBD) of 
MeCP2 (methyl-CpG-binding protein 2). However, it has been demonstrated that 
MBD3 cannot bind DNA and that it is present in a complex together with HDACs 1 and 
2 and other subunits of NuRD complex (Zhang et al., 1999). Recently, an important 
function of the MBD3 subunit has been described during the earliest stages of mouse 
development. By generating Mbd3-/- deficient mice by gene targeting, it was shown that 
ES cells derived from these embryos were viable and maintained the expression of 
pluripotent markers, such as Oct4 and Nanog, but were not able to differentiate upon 
withdrawal of leukaemia inhibitory factor (LIF) from culture medium. Further analysis 
demonstrated that NuRD complexes were not formed in Mbd3 deficient ES cells and 
that this mutation resulted in compromised differentiation (Kaji et al., 2007).  These 
data imply that the NuRD complex is required for the initial steps of pluripotent cell 
differentiation but is not essential for self-renewal.  
 
The CoREST complex 
Unlike the Sin3 and NuRD complexes, the CoREST complex contains HDAC1 
and HDAC2 but does not appear to have the RbAp46/48 subunits (see Figure 1.7). A 
characteristic feature of this HDAC complex is that it is associated with the 
LSD1/KDM1 demethylase along with BRG1, MeCP2 and the G9a/KMT1c 
methyltransferase (reviewed in (Ooi and Wood, 2007)). Binding of the CoREST 
complex to target DNA sequences is accomplished by the sequence-specific 
transcription factor REST (repressor element 1-silencing transcription factor).  
REST is a transcriptional repressor that is involved in regulating gene 
expression. REST-mediated gene repression is triggered by binding of REST to 
repressor element 1 sites, which are situated in the promoters of target genes. This 
interaction is further reinforced and stabilized by the ATP-dependent chromatin-
remodelling protein, BRG1, which recognizes acetylated histone tails. The recruitment 
of CoREST complex to target sequences occurs via C-terminal part of the REST 
protein. Subsequent chromatin compaction leads to gene repression, which is 
furthermore stimulated by different subunits of CoREST, including G9a which 
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promotes H3K9 di-methylation, LSD1/KMD1 which demethylates H3K4 and HDACs 
which deacetylate surrounding histones (Ooi and Wood, 2007).  
Different HDACs play important and unique roles in distinct biological 
processes. HDAC1 knock-out mice die during embryonic development and the ES cells 
derived from them show decreased growth and enhanced expression of the cyclin-
dependent kinase inhibitors p21 and p27 (Lagger et al., 2002). Compensatory 
upregulation of the expression of other class I HDACs was not sufficient to 
counterbalance the loss of HDAC1, which suggested its functional uniqueness 
(Zupkovitz et al., 2006). As mentioned earlier, HDAC1 is an important subunit of the 
Sin3, NuRD and CoREST complexes, which are involved in a complex interplay with 
methyltransferases, demethylases and chromatin-remodelling complexes. The absence 
of HDAC1 would therefore be expected to affect correct functioning of several protein 
complexes, which would lead to aberrant transcriptional regulation and therefore 
abnormal cell development.  
 
Sirtuin deacetylases  
Sirtuin deacetylases belong to the HDAC class III of NAD-dependent HDACs. 
Yeast Sir2 (Silent information regulator 2) protein was the first characterized sirtuin 
and members of the Sir2 family exist in species that range from prokaryotes to higher 
eukaryotes. In S. cerevisae, Sir2 is involved in epigenetic silencing of mating type loci, 
telomeric and nucleolar rDNA tandem repeats. Recently, several mammalian 
homologues have been described (SIRT1, 2, 3, 4, 5, 6 and 7). SIRT1, 2 and 3 seem to be 
the only sirtuin members that posses HDAC activity and show similar specificity for 
histone H4K16 and H3K9 (Vaquero et al., 2007b).  
A recent report has shown that Suv39h1/KMT1 is a direct target of SIRT1 
(Vaquero et al., 2007a). It has been shown that human SIRT1 regulates the activity of 
SUV39H1/KMT1 by controlling the acetylation levels of lysine residue within the SET 
domain, which is the catalytic subunit of the methyltransferase. By controlling the 
activity of SUV39H1/KMT1, SIRT1 indirectly controls the level of H3K9me3 and the 
formation of heterochromatin. Vaquero and colleagues have also demonstrated that loss 
of SIRT1 greatly affects Suv39h1/KMT1-dependent methylation and impair 
localization of HP1, which would otherwise bind to methylated H3K9 residues and 
participate in the formation heterochromatin. These results imply that the establishment 
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of specific chromatin structures is the result of an interplay between HDACs and 
KMTases. 
 
1.1.8 Histone Phosphorylation 
Phosphorylation of all four core histones, histone variants and histone H1 occurs 
at specific serine and threonine residues. The overall charge of the histone is altered by 
phosphorylation and this can disrupt the electrostatic interactions between histones and 
DNA. Similar to acetylation and methylation, histone phosphorylation is a reversible 
mark that plays an important role during transcriptional regulation. Additionally, this 
histone modification is implicated in the condensation and decondensation of sister 
chromatids during DNA replication.  
The link between phosphorylation of histone H3 and transcriptional activation 
was first suggested in 1991, when Mahadevan and colleagues observed a rapid 
phosphorylation of histone H3 molecules concomitant with the activation of the 
immediate-early genes such as c-jun and c-fos. This effect was dependent on stimulation 
of the cells with growth factors, phorbol esters, protein synthesis and protein 
phosphatese inhibitors (Mahadevan et al., 1991). Moreover, a genome wide ChIP-on-
chip analysis in S.cerevisiae has shown that MAPK (mitogen-activated protein kinase) 
and PKA (protein kinase A) are associated with promoter regions of their target genes 
upon kinase stimulation (Pokholok et al., 2006). The authors suggested that the protein 
kinases become recruited to specific sites in the genome by association with chromatin 
regulators and possibly with the transcriptional machinery.  
 
Phosphorylation of histone H3S10 by aurora B 
Phosphorylation of histone H3 on serine 10 (H3S10ph) has a major role in 
chromosome condensation and segregation during mitosis (Gurley et al., 1978) (Wei et 
al., 1998) and has been linked to both acetylation and methylation of other residues on 
the same histone tail. Phosphorylation of histone H3S10 together with H3K9 and K14 
acetylation (H3K9ac and H3K14ac, respectively) are associated with transcriptional 
activation (Cheung et al., 2000), while co-existence of H3S10ph with H3K9me3 is 
linked with heterochromatin and gene repression (Hirota et al., 2005). The kinases 
responsible for the H3S10 phosphorylation are Aurora B and MSK kinase.  
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Aurora B is a component of the chromosomal passenger complex, which 
modulates chromosome structure and segregation during mitosis. This complex 
participates in chromosome alignment and attachment to the microtubules of the mitotic 
spindles, which is crucial for correct mitosis and chromosome separation (Vader et al., 
2006).  
The interplay between H3S10ph and H3K9me3 during mitosis has been 
demonstrated by several groups. Hendzel and colleagues showed that inhibition of 
Aurora B-mediated phosphorylation of H3S10 interfered with chromosome 
condensation during mitosis (Hendzel etg al., 1997) and resulted in continuous binding 
of HP1β to H3K9me3, leading to chromatin condensation and gene repression (Hirota 
et al., 2005). In addition, mouse embryonic fibroblasts had increased levels of H3S10 
phosphorylation when Suv39h1/KMT1, which is responsible for generating H3K9me3 
was knocked out (Rea et al., 2000). Together these results imply that H3S10ph and 
H3K9me3 are interdependent and contribute to the displacement of HP1β during 
mitosis (Hirota et al., 2005).  
 A role for Aurora B in the formation of the double modification 
H3S10ph/K9me3 has recently been identified (Sabbattini et al., 2007). It has been 
shown that H3S10ph/K9me3 is associated with repressed genes in differentiated cell 
types and it was suggested that the double modification creates new docking sites for 
the binding of proteins that could participate in the formation of a permanent repressive 
chromatin structure. These results imply that Aurora B kinase may interact with a 
different set of proteins in the post-mitotic state than in dividing cells and the 
identification of its interacting partners would be necessary for understanding of gene 
repression processes in more committed cell types.  
 
Phosphorylation of histone H3S10 by MSK 
While Aurora B mediated phosphorylation of H3S10 is involved in gene 
repression, MSK (mitogen and stress activating kinase) mediated phosphorylation of 
H3S10 is implicated in gene activation. The involvement of histone phosphorylation in 
gene activation was supported by several studies, one of which is the regulation of 
HDAC1 gene, where co-operative phosphorylation and acetylation of histone H3 
(H3S10ph/K14ac) were observed, upon transcriptional induction (Hauser et al., 2002).  
Similarly to bromo- and chromodomain proteins which bind to either acetylated 
or methylated histone residues, the phosphorylated histone tails create new binding sites 
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for proteins that are known as phosphor-binding proteins. Recently, the 14-3-3 protein 
family has been identified as a group of proteins that specifically bind to H3S10ph 
during gene activation and it has been shown that acetylation of H3K14 further 
promotes this binding (Macdonald et al., 2005; Walter et al., 2008; Winter et al., 2007) 
(see Figure 1.8).  Winter and colleagues have analysed the regulation of the HDAC1 
gene in resting and anisomycin/TSA stimulated mouse fibroblasts. At the promoter of 
silent HDAC1 gene, H3K9me2 was co-localized with HP1γ and H3S10ph/K14ac was 
absent. Upon stimulation with anisomycin/TSA, MAP-kinase was activated and two 
members of 14-3-3 family (14-3-3ε and 14-3-3ζ) were recruited to the phosphorylated 
histones, leading to displacement of the HP1γ.  It was suggested that histone 
phosphoacetylation and 14-3-3 protein recruitment are required for the transition from 
the transcriptionally inactive to active state. Additionally, during HDAC1 induction, the 
H3K9me2 mark was detected across the coding region, which was consistent with 
another study where H3K9 methylation was found to be associated with active genes 
(Vakoc et al., 2005).  
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Figure 1.8 Model to explain the role of histone H3 modification in the regulation of HP1 and 14-3-3 
binding during transcriptional induction of HDAC1 gene. In the silent state, H3K9me2 and HP1γ 
occupy the HDAC1 promoter. Activation of MAP kinase signalling leads to formation of 
H3K9me2/S10ph/K14ac modified histones and binding of 14-3-3 and transcriptional activation of 
HDAC1. Removal of the phosphorylation and acetylation marks via phosphatases and deacetylases, 
respectively, can regenerate H3K9 di-methylation and allow recruitment of HP1 molecules and chromatin 
compaction. 
 
1.1.9 Histone Ubiquitination 
For many years it was believed that ubiquitination was exclusively involved in 
proteasome-dependent protein degradation. Nowadays, it is known that ubiquitination 
of different histone residues plays an important role in transcriptional regulation and in 
the cross-talk with other histone modifications. Histone ubiquitination occurs on 
histones H3, H2A and H2B and usually affects the lysine residues of the histone tails. In 
higher eukaryotes, histone H2A is mostly monoubiquitinated at K119 (H2AK119ub) 
although polyubiquitination has also been reported. It is believed that polyubiquitination 
of H2A is a signal for the protein to be degraded by the proteasome, whereas 
monoubiquitination modifies H2A function (Pickart, 2001). In contrast, histone H2B is 
found only in the monoubiquitinated form, with the monoubiquitination occurring at 
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K120 in humans (yeast K123) (H2BK120ub). The exact ubiquitination sites on histone 
H3 are still unknown.  
Histone ubiquitination occurs through the formation of an isopeptide bond 
between the carboxy-terminal glycine of ubiquitin (ub), a 76 amino acid protein and the 
ε-group of a lysine residue (reviewed in (Bhaumik et al., 2007)). This bond is formed 
through stepwise catalytic actions of Ub-activating enzyme (E1), Ub-conjugating 
enzyme (E2) and a ligase enzyme (E3). Whereas the same E1 enzyme is involved in the 
ubiquitination of all target proteins, different E2 enzymes are involved in the 
ubiquitination of different substrates and the E3 ligase provides protein target 
specificity.  
 
Ubiquitination of H2B and transcriptional regulation 
The enzyme responsible for ubiquitination of H2B (H2Bub) is Rad6 in yeast 
(Robzyk et al., 2000) and RNF20/40 in humans (Zhu et al., 2005). The involvement of 
H2Bub in transcriptional regulation was established by studies that showed that H2Bub 
is required for recruitment of histone modifying enzymes such as DOT1 and 
COMPASS, which mediate methylation of H3K79 and K4, respectively (Sun et al., 
2002; Ng et al., 2002). Because H3K4me3 is known to be associated with the promoter 
region of actively transcribed genes, it was suggested that H2Bub might also play role at 
the early stages of transcriptional regulation. Indeed, further analysis of the molecular 
mechanisms used by Rad6 demonstrated that it mediates H2B ubiquitination through an 
interaction with a Ring finger protein, Bre1 (Wood et al., 2003a). It was shown that 
Bre1 is involved in recruiting of Rad6 to the promoters of target genes and that mutation 
in the Bre1 gene lead to transcriptional repression and loss of H3K4 and K79 
methylation (Hwang et al., 2003). 
During transcriptional initiation and elongation, several histone-modifying 
enzymes are recruited to target promoters and regulatory elements, contributing to the 
chromatin opening and exposure of DNA to binding of PIC complexes (see section 
1.3.1). Efficient elongation also requires removal of the physical barrier imposed by the 
nucleosomes on the transcribing Pol II (see Figure 1.9). It has been suggested that 
removal of the H2A/H2B dimer and subsequent formation of a hexamer are essential for 
the passage of Pol II along the coding regions (reviewed in (Laribee et al., 2007)). 
FACT (facilitates chromatin transcription) and PAF (transcription elongation complex) 
are two protein complexes involved in this process that are closely linked with the 
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ubiquitination of H2B. The PAF complex recruits the Rad6/Bre1 ubiquitination 
machinery, leading to H2Bub (Pavri et al., 2006; Wood et al., 2003b) (reviewed in 
(Reinberg and Sims, 2006)), whereas FACT subsequently binds and displaces the 
H2A/H2B dimer from the core nucleosomes (Belotserkovskaya et al., 2003) (see Figure 
1.10).  
 
 
Figure 1.9 FACT-mediated transcription through the nucleosome results in hexasome formation. 1) 
The removal of one H2A/H2B dimer by FACT facilitates transcriptional elongation. 2) The chaperone 
activities of FACT (through its two subunits Spt16 and SSRP1) and CHD1 facilitate re-assembly of 
nucleosomes following termination of transcriptional elongation (Adapted from (Reinberg and Sims, 
2006)).   
 
The interactions between the transcriptional regulators and ubiquitinated 
histones are conserved amongst eukaryotes. An example is the human HOX locus 
whose transcriptional regulation has been extensively studied. It was shown that the 
RNF20/40 ligase directly interacts with human PAF and that its overexpression leads to 
an increase in H2Bub. Concomitantly, higher methylation levels of H3K4 and K79 were 
detected, resulting in HOX overexpression (Zhu et al., 2005).  
The removal of ubiquitin from histone H2B is performed by the Ubp8 
deubiquitinase (Wyce et al., 2007) (Figure 1.10). Ubp8 is recruited to genes in 
association with the Gcn5-containing complex. Additionally, its activity is required for 
recruitment of the Ctk1 kinase-containing complex and subsequent phosphorylation of 
Pol II (see section 1.3.4). Wyce and colleagues have also shown that when Ubp8 is 
deleted, recruitment of Set2/KMT3 is perturbed, which leads to a decrease in H3K36 
methylation levels and inhibition of elongation (Daniel et al., 2004; Henry et al., 2003; 
Wyce et al., 2007).  
Taken together, these results suggest that ubiquitination of H2B is required for 
recruitment of chromatin-remodelling complexes, which lead to histone displacement 
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prior to gene activation. In addition, H2B deubiquitination is essential for Ctk1 
mediated phosphorylation of Pol II and methylation of H3K36, which are required for 
the transcriptional elongation.  
 
 
Figure 1.10 H2B ubiquitination regulates transcription. Ubiquitin is transferred to histone H2B by 
Rad6/Bre1 and is thereby recruited to Pol II via the PAF transcription elongation complex. H2Bub 
recruits the 19S proteasome to transcribed genes and facilitates the functioning of other complexes such 
as COMPASS and SET1 on chromatin. During transcriptional elongation, H2Bub stimulates H2A/H2B 
dimer removal by FACT. Ubiquitin molecules are removed from H2B by SAGA-associated Ubp8, which 
promotes Ctk1-mediated phosphorylation of Pol II and recruitment of Set2/KMT3. The question mark 
represent the H2A/H2B dimer, which is removed by FACT and possibly, degraded by the proteasome 
(Adapted from (Laribee et al., 2007) with minor changes). 
 
Ubiquitination of H2A and transcriptional regulation 
Ubiquitination of H2A (H2Aub) is mediated by the Ring1B E3-ubiquitin ligase, 
a subunit of the PRC1 complex (Wang et al., 2004) (Figure 1.11a). In contrast to 
H2Bub, H2Aub is found at the promoter regions of target genes and is associated with 
transcriptional repression (Cao et al., 2005; Wang et al., 2004). Besides its role in 
transcriptional regulation, Ring1B-mediated H2A ubiquitination has also been described 
during the initiating stage of X chromosome inactivation (Fang et al., 2004) and Hox 
gene silencing (Cao et al., 2005)  
H2A ubiquitination is closely linked to the activity of EZH2, which is another 
polycomb protein and a component of the PRC2 complex. EZH2 is a histone 
methyltransferase, which catalyses H3K27 trimethylation (Figure 1.11b), a modification 
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that is reversed by the UTX demethylase. An interaction between UTX and H2Aub 
during transcriptional regulation of the HOXA and HOXC gene clusters was recently 
investigated (Lee et al., 2007). Knockdown of the UTX demethylase using siRNA led to 
retention of H3K27me3 across the intergenic regions and to increased levels of H2Aub, 
which led to the gene repression (Figure 1.11c). These results suggested that the 
mechanisms that are involved in removal of the repressive marks H3K27me3 and 
H2Aub are linked, and are equally required for transcriptional regulation. 
The interplay between ubiquitinated H2A and different forms of Pol II (see 
sections 1.3.3 and 1.3.4) has recently been examined. As previously described, genome-
wide studies in mouse and humans have demonstrated that an important subset of 
developmental genes are enriched for both PRC2-mediated H3K27 methylation and trx-
mediated H3K4 methylation (Bernstein et al., 2006; Boyer et al., 2006). It was shown 
that the initiating form of Pol II is present at the promoters of bivalent genes in mouse 
ES cells (Stock et al., 2007) and Drosophila (Muse et al., 2007; Zeitlinger et al., 2007). 
Stock and colleagues have shown that in the absence of Ring1B, an increase in the 
elongating form of Pol II is observed across the body of the analyzed genes, correlating 
with increased expression. The authors suggested that H2Aub is a novel histone mark, 
necessary for keeping initiating Pol II poised at the promoters of bivalent and repressed 
genes.  
H2A ubiquitination is reversed by Ubp-M deubiquitinase (also known as 
USP16) (Joo et al., 2007)(Figure 1.11d). By knocking-down Ubp-M and analysing the 
expression levels of Hox genes, Joo and colleagues have shown that absence of 
functional deubiquitinase leads to a decrease in Hox genes transcription.  
Taken together, these results suggest that removal of repressive H3K27me3 by 
UTX, deubiquitination of H2A and displacement of H2A/H2B dimers is followed by 
recruitment of actively transcribing Pol II, leading to gene activation. These results shed 
new light onto the function of histone ubiquitination during gene activation and 
demonstrate the complex interplay between different histone tail modifications, 
chromatin-modifying enzymes and the components of the transcriptional machinery.  
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Figure 1.11 The mechanisms involved in gene regulation by H2A ubiquitination. During gene 
repression, H2A is ubiquitinated by Ring1B (a) and H3K27 is methylated by Ezh2 (b), subunits of PRC1 
and PRC2 complexes, respectively. These histone modifications are associated with initiating form of Pol 
II (CTDS5ph). Following transcriptional induction, H3K27 is demethylated by UTX, which interacts with 
elongating Pol II (CTDS2ph) (Smith et al., 2007) (c). Deubiquitination of H2A by Ubp-M (d) is required 
for FACT recruitment and subsequent chromatin opening. Upon gene activation H3K4 and K79 
methylation recruit additional factors such as TAF3 and participate in the formation of the PIC (see 
following section). 
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1.2 Gene organization 
 
The size of the genome, the proportion of coding (exonic) and non-coding 
(intronic) sequences and the number of repetitive elements, are the features that affect 
gene organization within an organism. These characteristics differ widely between the 
species. Two such contrasting examples are yeast and human. The yeast genome is 
much smaller than the genome of humans, contains smaller genes and has a higher 
proportion of coding sequences (68% versus 1% of total genomic sequence in yeast and 
human, respectively) (Taft et al., 2007), suggesting that there could be significant 
differences in the mechanisms that control gene regulation in different species (Table 
1.6).  
 
 
Table 1.6 Genomic feature comparison across eight species. Sequence analysis was accomplished 
using the featureBit program of the UCSC genome browser for each species and the corresponding gene 
annotation track (CDS, coding sequences; UTR, untranslated regions) (Adapted from (Taft et al., 2007)). 
 
In higher eukaryotes, correctly regulated expression of a gene in vivo is not 
simply a function of a single sequence element but more often of multiple sequences 
that act co-operatively and can be distributed over large distances. These sequence 
elements define the complete expression domain that correctly regulates a gene locus. 
The concept of gene expression domains arose from transgenic experiments, which 
have shown that the insertion of sufficiently large amount of sequences flanking a target 
gene leads to copy-dependent and position independent expression of the transgene 
(Grosveld et al., 1987a; Sabbattini et al., 1999). The regulatory sequence elements, 
which are components of these expression domains, are promoters, enhancers and locus 
control regions (LCRs). Promoters and distal regulatory elements are both bound by 
sequence-specific TFs and general transcription factors (GTFs), leading to the assembly 
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of the PIC (section 1.3.2). It is now also known that direct contact between promoters 
and enhancers occurs during gene activation. The mechanisms that have been proposed 
for this interaction will be described in section 1.4.1.  
In addition, gene loci with quite different expression patterns are often located in 
close proximity to one another on the same chromosome. A number of different models 
has been put forward that aim to explain how neighbouring loci are independently 
regulated (Dillon and Sabbattini, 2000). Early models for chromosomal domain 
organization arose from light and electron microscopy studies of the interior of the 
nucleus where genomic DNA appeared to be anchored to a nuclear matrix, thereby 
creating loops (Manuelidis, 1990). The anchored DNA sites were postulated to act as 
functional boundaries, creating isolated transcriptional units. The concept of a structural 
domain physically separated from neighbouring domains by boundaries was considered 
to represent a functional compartmentalisation of active versus silent gene loci. 
However, functional analysis has demonstrated that these matrix attachment regions 
(MARs) do not generally constitute borders between active or inactive chromatin 
(Wang et al., 1996). 
 A different model proposed that transcriptionally active units are located within 
domains that undergo local chromatin reorganization and lead to “open” chromatin 
domains. Neighbouring silent domains would instead have a closed, compacted 
chromatin structure. The borders between the active and inactive domains would be 
defined by discrete boundary or insulator elements, which would have the specific 
function of preventing the effects from surrounding chromatin domains. This type of 
model has been termed the ‘strong’ domain model (Dillon and Sabbattini, 2000). 
The strong domain model has been based mainly on studies of two loci, the 
Drosophila 87A7 heat-shock locus and the chicken β-globin locus. The 87A7 heat-
shock locus, containing a pair of divergently transcribed hsp70 genes, is the site of a 
heat-inducible chromatin puff on polytene chromosomes, which undergoes generalized 
chromatin decondensation upon gene activation (Udvardy et al., 1985). It was shown 
that a set of specialised chromatin sequences (scs and scs') located at each side of the 
puff could establish a domain of independent gene activity in vivo and insulate against 
chromosomal position effects (Figure 1.12) (Kellum et al., 1991).  
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Figure 1.12 Insulator and enhancer blocking effects identified in different eukaryotic systems. (A) 
Insulator effects of ‘specialised chromatin sequences’ (SCS) at the Drosophila 87A7 heat-shock locus. 
The SCS and SCS' insulators (indicated by vertical arrows) exist as a pair of strong DNase I 
hypersensitive sites flanking the Drosophila 87A7 heat-shock locus. SCS' is also the Aurora gene 
promoter. These elements act as insulators and were identified on the basis of their ability to give 
position-insensitive expression when placed either side of a transgene (Kellum and Schedl, 1991) 
(adapted from (Dillon and Sabbattini, 2000)). 
 
An important question mark about the functional role of insulators was raised by 
the observation that they are frequently associated with sequences that have other 
functions (Dillon and Sabbattini, 2000). One such example is the SCS' insulator for 
which it has been shown to be the promoter of the nearby Aurora gene (Glover et al., 
1995). Another study demonstrated the inability of the SCS and SCS’ elements to form 
boundaries within different chromatin domains (Kuhn et al., 2004). The authors tested 
the mechanisms by which SCS and SCS’ elements act to constrain regulatory 
interactions, by constructing a hsp70-lacZ gene and examining the structure of a heat 
shock puff in the presence and absence of insulators. It was shown that the SCS and 
SCS’ elements did not prevent the spread of decondensation resulting from hsp70-lacZ 
transcription, demonstrating that these sequences are not boundary elements that block 
the spreading of an altered chromatin state associated with gene activation.  
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1.3 Transcriptional unit 
Correct expression of an individual gene requires tight control and progression 
through a number of biological processes, including nuclear reorganization, chromatin 
remodelling, transcription, mRNA processing, nuclear export, translation and 
degradation. The mechanisms involved in the formation and maintenance of different 
chromatin structures have been widely studied and contributed to our understanding of 
how genes are regulated during the early stages of development and cell differentiation.  
As mentioned in previous sections, the interplay between chromatin-remodelling 
proteins and TFs plays an essential role in gene regulation. The acquisition of distinct 
histone modifications results in nucleosome remodelling and subsequently leads to 
exposure of target sequences for binding of TFs. Binding of different TFs to these 
sequences can either activate or repress the transcription of target genes by promoting or 
preventing recruitment of Pol II and other components of the transcriptional machinery. 
The processes that lead to regulated activation of transcription will be discussed in the 
following sections. 
 
1.3.1 Promoter sequences 
Gene promoters are DNA sequences that are essential for initiation of 
transcription and are targets for regulatory proteins. They can be divided into two 
groups: 1) promoters that have a single transcription start site (TSS) (known as focused 
promoters) and 2) promoters that have multiple TSS spread over a 50-100 bp long 
sequence (dispersed promoters) (reviewed in (Sandelin et al., 2007)). The TATA box, 
located near position -30 to -25 of the TSS, the initiator (INR) sequence located at the 
start site of transcription and the motif ten element (MTE) are all components of the 
conserved core promoter. These sequences participate in the interaction of sequence-
specific TF and GTFs with the promoter, and play a major role in the assembly of the 
PIC at the focused promoters.   
Dispersed promoters are more common in vertebrates, are typically associated 
with CpG rich sequences and lack the TATA-box and other sequences associated with 
core promoters (Carninci et al., 2006). This suggests that different mechanisms of 
transcriptional initiation could operate at different promoters. Indeed, in Drosophila, it 
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was shown that dispersed promoters are regulated by the downstream promoter element 
(DPE), situated 28-32 bp downstream of TSS and that these sequences participate in 
assembly of the PIC at TATA-less promoters.  
 
1.3.2 Assembly of the pre-initiation complex 
 In eukaryotes, transcription is regulated by three nuclear RNA polymerases (Pol 
I, Pol II and Pol III). Pol I and III transcribe the genes for ribosomal RNA and transfer 
RNA respectively. Pol II is responsible for transcribing all protein-encoding genes and 
consists of 12 subunits, which are remarkably conserved throughout eukaryotes (Young, 
1991).  
A series of GTFs, assist Pol II in binding to the promoter sequences (Orphanides 
et al., 1996). The binding of Pol II to the TATA-box and INR of focused promoters is 
assisted by the TATA-box binding protein (TBP), which is part of the TFIID complex. 
TFIID is composed of fourteen TAFs and TBP, which are implicated in sequence 
specific binding  (reviewed in (Muller and Tora, 2004)). For many years, it was 
considered that the same GTFs are involved in the formation of the PIC at the promoters 
of protein-coding genes. It is now known that transcriptional initiation is also regulated 
at the level of PIC formation and that distinct promoters are recognized by distinct TFs 
(Sandelin et al., 2007). As mentioned above, the mechanisms involved in the assembly 
of PICs in the context of dispersed promoters are still not entirely clear. However, it has 
been reported that in Drosophila, recruitment of TAF1 and TAF4 to DPE sequences is 
important for transcriptional initiation and PIC assembly (Wright et al., 2006).  
Even though only 10-20% of mammalian promoters contain a TATA-box, most 
of our knowledge regarding the mechanisms involved in PIC assembly, derives from 
focused promoters.  Prior to transcriptional initiation of TATA-box containing 
promoters, TBP binds in a sequence-specific manner to the promoter region to establish 
a nucleoprotein recognition site for Pol II (Burley and Roeder, 1996). In the second 
step, TFIIB, which is essential for promoter recognition and selection of the TSS, binds 
to the DNA and is in direct contact with TFIID (Deng and Roberts, 2007)  (Figure 
1.13). TFIIB is one of several general initiation factors (TFIIA, TFIIB, TFIID, TFIIE, 
TFIIF and TFIIH), which are required for PIC assembly. Assembly of TFIIB is an 
absolute requirement for recruitment of Pol II, which enters the PIC when it is pre-
bound to TFIIF and Mediator (reviewed in (Deng et al., 2007)).  
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A major function of TFIIF is to prevent non-specific binding of Pol II to DNA. 
TFIIS, which is known to be an important elongation factor, seems to also play an 
important role in determining the rate of PIC formation and its stability (Kim et al., 
2007). Besides its role during the formation of the stable PIC, TFIIS also interacts with 
the SAGA complex, which further stimulates the formation of a transcriptionally active 
chromatin structure by acetylating surrounding histones (see section 1.1.5). Once the 
PIC is fully assembled, an ATP-dependent process, which requires the action of the 
helicase TFIIH, causes opening of the double stranded DNA at the TSS by unwinding 
10-15 bp of DNA. The process of promoter “opening” is required in order to position 
the single-stranded template in the Pol II cleft, which will initiate RNA synthesis 
(reviewed in (Li et al., 2007a)).   
 
 
Figure 1.13 The mechanisms involved in the assembly of the PIC. TFIID binds to promoter regions 
through its TBP subunit, which subsequently recruits TFIIB, TFIIE, TFIIF, TFIIH and TFIIS. The 
holopolymerase complex (composed of Pol II and Mediator) binds to GTFs, which form the PIC complex 
at the gene promoter.   
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Chromatin-remodelling during PIC formation 
Formation of the above-described promoter-bound complex is sufficient for a 
basal level of transcription. However, obtaining the correct expression level of a gene 
requires the involvement of a number of additional co-activators, which are recruited to 
regulatory elements such as enhancers and UAS. These co-activators contribute to gene 
transcription by using several distinct mechanisms, which involve altering the 
chromatin structure and reinforcing the interaction between Pol II, GTFs and promoters. 
Co-activators facilitate stronger binding of activators to target DNA sequences while 
also making nucleosomal DNA more accessible to GTFs.  
In order for GTFs and co-activators to access promoter and enhancer regions, 
chromatin organization around these genomic sites needs to be remodelled and rendered 
more accessible. Whether GTFs and co-activators cause the recruitment of nucleosome 
remodelling and chromatin-modifying proteins, or whether histone-modifying enzymes 
first remodel chromatin, in order for GTFs to bind, remains unclear. As described in the 
previous section, some of the subunits involved in PIC assembly, such as TFIIS, interact 
with chromatin-modifying complexes, demonstrating that a very close interplay exists 
between GTFs and chromatin-remodelling proteins.  
Another event, which plays an important role in regulating transcriptional 
inititation, is histone displacement, a process that is regulated by ATP-dependent 
chromatin-remodelling complexes (reviewed in (Li et al., 2007a)). It leads to transient 
unwrapping of the DNA from core histone octamers and nucleosome sliding, which in 
turn makes target sequences more accessible for Pol II and other components involved 
in transcription.  
Genome-wide studies in yeast have shown that nucleosome density at promoter 
regions is generally lower than in coding regions (Bernstein et al., 2004) and these 
regions have been defined as nucleosome-free regions (NFRs). However, the 
association of most active promoter regions with general hyperacetylation of histones 
H3 and H4 and other histone modifications suggests that these genomic sites are not 
completely devoid of histones (Pokholok et al., 2005). Nevertheless, during 
transcriptional initiation and elongation, histone eviction (displacement) is required in 
order to remove the physical barrier, which is imposed by the nucleosomes (reviewed in 
(Li et al., 2007a)). FACT is one of the histone chaperons that binds and evicts the 
H2A/H2B dimer from the nucleosomal octamer and leads to the formation of a 
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hexasome, which subsequently allows Pol II to progress through the coding region of a 
target gene (Belotserkovskaya et al., 2003).  
 
1.3.3 Transcriptional Initiation 
Transcriptional initiation occurs after partial disassembly of the PIC complex 
and promoter clearance. A subset of GTFs remains at the promoter where they 
constitute a scaffold for the formation of the next transcription initiation complex 
(Zawel et al., 1995) (Yudkovsky et al., 2000), while Pol II is being modified by a 
subunit of TFIIH. The Kin28/Cdk7 kinase is a subunit of TFIIH protein complex 
(Feaver et al., 1994), which is responsible for phosphorylation of the serine 5 residue 
that is situated at the CTD of the large subunit of Pol II (CTDS5ph).  
It has been demonstrated that CTDS5ph is associated with transcriptional 
initiation and is found at the promoters of active genes (Xiao et al., 2007). It has also 
been suggested that CTDS5ph causes the disassociation of Mediator protein from 
holopolymerase complex and that this leads to promoter clearance and transcriptional 
initiation (see Figure 1.13). As described above, the subunits of the TFIID complex bind 
to the TATA-box, but also contribute to transcriptional initiation through recognition of 
the H3K4me3 mark by the TAF3 subunit (Vermeulen et al., 2007) (see Figure 1.3). 
Nevertheless, it still remains unclear whether the interaction between TAF3 and 
H3K4me3 serves as a primary recruitment signal for TFIID to promoters or whether the 
interaction occurs subsequently, after TFIID binding. 
 
1.3.4 Transcriptional Elongation 
In order for mRNA to be produced, transcription of the entire coding region 
needs to be accomplished. Transcriptional elongation is triggered upon Pol II release 
from the PIC. This event is accompanied by the recruitment of the elongation 
machinery including chromatin-remodelling factors as well as proteins implicated in 
mRNA processing and exports. Factors belonging to the elongation machinery have 
been identified as TFIIF, TFIIS, Spt4-5, FACT, PAF1, the Elongins, DSIF, CSB and the 
ELL family of proteins. They participate in controlling the rate and efficiency of  the 
elongating Pol II, facilitating transcription through nucleosome remodelling (reviewed 
in (Li et al., 2007a) and (Sims et al., 2004)). 
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Ctk1 kinase 
Transcriptional elongation is associated with CTD phosphorylation at serine 2  
(CTDS2ph), which is catalysed by the Ctk1/CDK9 kinase (Cho et al. 2000; 
Komarnitsky et al., 2000). Ctk1 phosphorylated Pol II is predominantly localised across 
the body of actively transcribing genes and a direct interaction has been reported 
between CTDS2ph and the KMTases that are involved in chromatin-remodelling during 
transcription (Figure 1.14) (Li et al. 2003; Xiao et al., 2007). An example is 
Set2/KMT3, which catalyzes methylation of histone H3K36 and associates directly with 
CTDS2ph (Li et al., 2003). Ctk1 also affects the enzymatic function of Set1/KMT2, 
which is responsible for methylation of H3K4. It has been shown that in yeast, absence 
of Ctk1 leads to increased levels of H3K4me2 and H3K4me3 and spreading of these 
marks across the coding regions of genes (Xiao et al., 2007). Xiao and colleagues 
suggested that Ctk1-catalyzed CTD phosphorylation is required for the restriction of 
H3K4me3/H3K4me2 mark to the 5’ end of target genes. These results demonstrated the 
multiple roles of Ctk1, such as reinforcement of transcriptional elongation by 
interacting with Set2/KMT3 and preventing the spreading of H3K4me3/H3K4me2 from 
the promoter regions. The different roles of Ctk1 are illustrated in the following figure. 
 
 
Figure 1.14 Role of Ctk1 in the control of chromatin structure. Ctk1 directs the interaction of Set2 
and Pol II (RNAPII), leading to H3K36 methylation and deacetylation within the body of gene. 
Simultaneously, Ctk1 prevents spreading of H3K4me3 from the gene promoter region (Adapted from 
(Xiao et al., 2007)). 
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Chromatin remodelling during transcriptional elongation 
Because nucleosomes are one of the most stable DNA-protein complexes under 
physiological conditions, they represent a physical obstacle for access of the 
transcriptional machinery to the DNA. Nevertheless, this protein complex also 
possesses dynamic properties, which allows it to undergo a series of reversible changes, 
carried out by nucleosome remodelling proteins such as FACT, and PAF1. The PAF1 
complex functions at both the initiation and elongation stages of transcription (Pokholok 
et al., 2002). It has been demonstrated to be physically associated with elongating Pol II 
and functions as a platform for recruitment of the histone modifying machinery (e.g. 
COMPASS and DOT1) to the transcribing polymerase (Krogan et al., 2003a) (Krogan 
et al., 2003b). As described in section 1.1.9, FACT interacts with PAF1 and together 
they contribute to transcriptional elongation through recruitment of the ubiquitination 
machinery involved in H2B ubiquitination. Ubiquitination of H2B leads to removal of 
the H2A/H2B dimer from the core nucleosomes and allows Pol II to continue to 
transcribe through the coding region of a gene (Belotserkovskaya et al., 2003; Pavri et 
al., 2006) (see Figure 1.10).  
 
1.3.5 Transcriptional Termination 
Transcriptional termination is defined as cessation of RNA synthesis followed 
by disassociation of Pol II from the DNA. During this process, the nascent transcripts 
and Pol II are released from the DNA template. Pol II is recycled back to the promoter 
for subsequent rounds of transcription. Transcriptional termination is dependent on 
poly(A) signals, downstream termination sequences and multiple trans-acting proteins. 
Transcripts of all protein-encoding genes, with exception of histone genes, contain 
poly(A) stretches positioned 10-30 nucleotides upstream of the cleavage site (reviewed 
in (Rosonina et al., 2006)).  
These “termination-specific” elements are recognized by cleavage-
polyadenylation specificity factor (CPSF), cleavage stimulatory factor (CstF), cleavage 
factors I and II (CFI/CFII) and poly(A)polymerase (PAP). Cleavage and 
polyadenylation of the nascent transcript occur co-transcriptionally and are essential for 
accurate termination of transcription, ultimately releasing the pre-mRNA from the 
transcription site (West and Proudfoot, 2007). 
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Two models have been proposed for the mechanisms involved in the 
transcriptional termination; the allosteric model and the torpedo model. The allosteric 
model proposes that transcription of the poly(A) signal triggers conformational changes 
in the Pol II elongating complex (PolIIEC) by recruiting factors that have a negative 
effect on the elongation machinery. These changes subsequently lead to destabilisation 
of PolIIEC and transcriptional termination. The torpedo model purposes that during 
endonucleolytic cleavage of the nascent pre-mRNA at the poly(A) site, a 5’ to 3’ 
exonuclease degrades the downstream cleavage product while still linked to Pol II. The 
exonuclease continues to degrade the transcript until it reaches and destabilizes the 
PolIIEC (Rosonina et al., 2006). However, a very recent study has shown that the 
combination of the mechanisms described in these two models is involved in 
transcriptional termination (West et al., 2008). The authors of this paper have shown 
that during transcription of the human β-globin gene, transcription of the poly(A) signal 
renders Pol II termination competent. Additionally, they have shown that co-
transcriptionally cleaved terminator transcript leads to an unprotected 5’ end, leading to 
degradation of the Pol II-associated nascent transcript (pre-mRNA) and ultimately DNA 
template release. 
The pre-mRNA needs to go through several processing stages, which will lead 
to functional messenger RNA. Among these steps are the addition of a 7-methyl 
guanosine (m7G) cap at the 5’ end and splicing of introns (reviewed in (de Almeida and 
Carmo-Fonseca, 2008)). Initially, it was believed that these events occur once the pre-
mRNA is released from the target DNA and Pol II, but it is now known that these 
processes take place in conjunction with transcription. This was demonstrated by in vivo 
studies that showed that truncation of the CTD domain of Pol II causes defects in 
splicing (Rosonina and Blencowe, 2004) and also that the components of the splicing 
machinery are co-transcriptionally recruited to active genes (Gornemann et al., 2005; 
Ujvari and Luse, 2004). 
 
1.4 Cis-acting regulatory sequences 
1.4.1 Enhancers and LCRs  
Besides the promoter regions, additional regulatory elements such as enhancers 
and LCRs are required for correct transcriptional regulation. Enhancers are DNA 
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sequences that can activate a promoter and control its efficiency and rate of 
transcription independently of orientation. These regulatory sequences can be located at 
varying distances from the target promoter, which can extend to hundreds of kilobases 
(Nobrega et al., 2003; Qin et al., 2004). Enhancers are composed of multiple binding 
sites for transcription factors such as GTFs, Pol II and chromatin-remodelling proteins 
such as Brg1 and TRRAP (transformation/transcription domain-associated protein) 
(reviewed in (Szutorisz et al., 2005b)). The assembled TFs form complexes known as 
“enhanceosomes”, which lead to chromatin decondensation and formation of active 
chromatin structures. Several recent studies have shown that the GTFs and Pol II are 
first recruited to the enhancer elements, and subsequently to the promoters of target 
genes (Louie et al., 2003) (Rastegar et al., 2004; Szutorisz et al., 2005a). 
One such example is the mouse HoxD4 gene, which is expressed in mesodermal 
tissues and the central nervous system (CNS). Transgenic studies have identified an 
enhancer situated downstream from the 3’ end of the gene, which is essential for HoxD4 
activation in neurons (Figure 1.15 A). It has been shown that during gene induction, Pol 
II and CBP are first recruited to this enhancer and subsequently to the promoter 
(Rastegar et al., 2004).  
 
Figure 1.15 GTFs and Pol II bind to the enhancers of developmentally regulated genes. A) The 
HoxD4 gene is activated from the P1 promoter during neuronal development by an enhancer located 
downstream from the gene. Binding of Pol II to the enhancer is observed prior to HoxD4 transcript 
detection. (B) The human β-globin locus. The five genes in the locus are activated during development in 
the same order as their position in the locus in a 5’ to 3’ direction. TFIIB, TBP and Pol II bind to the 
upstream promoter prior located in the LCR prior to detection of β-globin transcripts. The red arrows 
indicate the direction of intergenic transcription (adapted from (Szutorisz et al., 2005b)). 
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The human β-globin gene cluster consists of five erythroid specific genes 
arranged along the chromosome in the same order as they are expressed during 
development (Figure 1.15 B). Binding of TBP, Pol II and TFIIB to the DNase I 
hypersensitive site (HS) 2 has been reported to occur prior to erythroid differentiation 
and expression of the genes (Vieira et al., 2004). HS2 is one of the six HS, which form 
part of the LCR that is required for correct expression of the β-globin genes (Grosveld 
et al., 1987b).  
LCRs are defined as sequences that have the ability to drive expression of a 
transgene in a position-independent and copy number-dependent fashion (Grosveld et 
al., 1987b). These regulatory elements are composed of DNase I HS that are rich in 
binding sites for transcription factors. Several studies have shown that transcriptional 
activation of genes by long-range action of regulatory sequences involves direct 
interaction between these elements and promoters. The looping model is the most 
widely accepted model to explain the long distance interaction between regulatory 
sequences (reviewed in (Li et al., 2006)). According to this model, enhancer elements 
communicate with promoters through direct interaction between proteins bound to both 
elements, with the intervening DNA looping out and not participating in enhancer 
function.  
Studies on several genomic loci have contributed extensively to our 
understanding these mechanisms and communication between distal elements and 
promoters. Analysis of the distribution of histone acetylation across the human β-globin 
locus during different stages of development has shown that the active chromatin state 
correlates well with activation of the LCR and transcription of the genes (Forsberg et 
al., 2000). The chromosome conformation capture (3C) technique was used to directly 
investigate looping in the locus. The 3C technique involves fixation of cells, followed 
by PCR-based analysis to analyse the frequency with which specific genomic regions 
interact with each other. Using this method it was possible to show that upon activation 
of the locus in erythroid cells, the HS of the LCR situated 40-60kb away from the β-
globin gene, come into close spatial proximity with the active gene (Tolhuis et al., 
2002). 
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1.5 Chromosomal organization 
Apart from transcriptional factors that bind directly to DNA and lead to changes 
in the local chromatin environment, the nuclear organization of chromatin also affects 
the gene regulation. Chromatin organization in the cell nucleus influences gene 
expression, DNA replication, damage, and repair. When the interphase nucleus forms, 
chromosomes partially decondense and occupy distinct chromosomal territories (CT) 
(Cremer and Cremer, 2001), where it was thought that interchromosomal interactions 
would occur only rarely (Kosak and Groudine, 2004) (Chambeyron and Bickmore, 
2004b). However, recent data has provided evidence that there is a significant amount  
of physical interaction between different chromosomes, which leads to genes from 
different chromosome to come into contact with one another (Branco and Pombo, 
2006). Branco and colleagues have demonstrated that chromosomes intermingle 
extensively in interphase nuclei of human cells, and that the extent to which particular 
pairs of CTs intermingle correlates with the frequency of chromosome translocations in 
the same cell type.  
Condensed heterochromatin folds into chromatin aggregates and is associated 
with densely stained chromatin (Heitz, 1928). Additionally, it has been shown that 
heterochromatic and gene-poor regions preferentially localise to the nuclear periphery 
(Bolzer et al., 2005; Boyle et al., 2001). Gene-dense regions and euchromatic chromatin 
associated with actively transcribed genes is usually found in the interior of nucleus. 
Additionally, genes with quite distinct biological functions can be situated very close to 
each other and the enhancer of one tissue-restricted gene can be situated within another 
gene. One such example is the tissue-specific enhancer of mouse thrombospodin3 
(Thbs3) gene, which is situated within an intron of the adjacent ubiquitous Mtx1 gene 
(Collins et al., 1998). In spite of their close proximity, each of these genes have quite 
different expression patterns and tissue-specificities. This has important implications for 
models that propose that location of a gene within a CT influences regulation, since 
movement of one gene to a specific location will pull it’s closely linked neighbour 
along with it. 
Movement of specific genomic regions that is accompanied by changes in the 
transcriptional state of genes located within the affected loci has also been 
demonstrated. Analysis of the Hoxb gene cluster upon RA induction of ES cells has 
 63 
shown that Hoxb1 gene, which is the first of the genes to be activated, was associated 
with general acetylation and decondensation of the locus (Chambeyron and Bickmore, 
2004a). Additionally, it was shown that a specific region encompassing the Hoxb1 gene 
looped out from the chromosome territory whereas the inactive Hoxb9 gene remained 
within the territory.  Looping out of the Hoxb1 gene was accompanied by movement of 
the locus towards the centre of the nucleus. Other studies have shown that large-scale 
looping out of CTs is not always required for gene expression to occur. Analysis of 1 
Mb encompassing human WAGR region showed that the locus remains localised within 
the CT even upon activation of some of the genes (Mahy et al., 2002). 
 
1.5.1 Interactions between chromatin and nuclear membrane proteins 
In eukaryotic cells, chromatin is tightly packed in a highly organized fashion 
within a nucleus, that is composed of the nucleoplasm and the nuclear envelope (NE). 
Additionally, it has been proposed that there are subcompartments within the nucleus, 
containing factors that are involved in DNA replication, transcription and RNA splicing 
(Zirbel et al., 1993). The NE separates the nucleus from the cytoplasm and there is 
evidence that its inner surface provides docking sites for chromatin. The main 
components of the NE are the inner nuclear membrane (INM), the outer nuclear 
membrane (ONM), the nuclear pore complexes (NPC) and the nuclear lamina (reviewed 
in (Dechat et al., 2008)). 
Several studies have suggested that the lamina and other INM proteins interact 
with or sequester, proteins that regulate transcription. There is evidence that mutations 
in NE proteins cause changes in nuclear envelope structure and stability, which could 
predispose cells to damage and/or alter transcriptional regulation and gene expression. 
Two major lamina isoforms are A-type (lamins A and C) and B-type (lamins B1 and 
B2/B3). A mutation of human nuclear lamin A has been implicated in reduced amounts 
of constitutive and facultative heterochromatin and accompanying histone H3K9 and 
K27 methylation (Shumaker et al., 2006; Lammerding et al., 2005). 
The DmaID method was used to demonstrate that lamin B interacts with specific 
genomic regions in Drosophila and human cells (Guelen et al., 2008; Pickersgill et al., 
2006). The method involves fusing the protein of interest (in this case lamin B) to the 
E.coli DNA methyltransferase. The fusion protein was then expressed in Drosophila and 
human cells and adenine methylation was analysed using microarray technology. In 
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both Drosophila and human cells, lamin B was preferentially associated with large 
gene-poor regions.. Additionally, in humans, lamin-interacting regions were enriched 
for H3K9 and H3K27 methylation and were very often flanked by chromatin insulator 
CTCF’s binding sites, promoters or CpG islands.  
 Finlan and colleagues investigated whether proximity to the nuclear periphery 
can directly facilitate transcriptional suppression in mammalian cells by tagging two 
different human chromosomes with arrays of the E.coli lac operator (lacO). Expression 
of a fusion protein generated by fusing the lac repressor (lacI) to the integral INM 
protein Lap2beta was used to relocate the chromosomes to the nuclear periphery in a 
human fibrosarcoma line (Finlan et al., 2008). The authors showed that this resulted in a 
reduction in the expression of a small number of endogenous genes located close to the 
lacO sites but left most genes unaffected. These results suggest that the majority  of 
mammalian gene are resistant to the repressive effects of peripheral location in the 
nucleus but also indicate that localization relative to the nuclear membrane could be 
involved in the regulation of a subset of genes. 
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1.6 Noncoding RNAs (ncRNAs) 
The ratio of noncoding to protein coding DNA rises with the complexity of the 
organism.  Current estimates suggest that the proportion of the DNA that does not code 
for proteins in prokaryotic, yeast, chicken and human genomes is approximately 10%, 
32%, 98% and 99% respectively (Taft et al., 2007). A growing body of evidence 
suggests that non-coding RNAs (ncRNAs) play an important role in the biology of 
complex organisms. Genome-wide expression analysis of short and long ncRNAs has 
shown that a large proportion of non-coding sequences are transcribed in humans 
(Bertone et al., 2004; Kapranov et al., 2007; Rinn et al., 2003). Kapranov and 
colleagues have shown that the majority of transcribed ncRNAs is located at the 
promoter regions of protein coding transcripts. The authors suggested that these short 
ncRNAs could represent “transcriptional noise” or by-products of abortive transcription 
or that they could be involved in transcriptional regulation of nearby genes by 
regulating chromatin remodelling..  
It has been shown that ncRNAs are involved in mechanisms such as 
transcriptional and post-transcriptional gene silencing (TGS and PTGS, respectively) 
(reviewed in (Costa, 2007)). In mammalian female cells, one X chromosome is 
inactivated in order to equalise gene expression levels between the sexes. X-
chromosome inactivation is directed by a 19 kb long ncRNA known as Xist, which coats 
the inactive chromosome and plays an important role in the epigenetic silencing of this 
X chromosome (Heard and Disteche, 2006). It has also been shown that ncRNAs 
negatively regulate early stages of transcription, such as PIC formation. Studies carried 
out on the human DHFR (dihydrofolate reductase) gene, showed that short non-coding 
transcripts accumulate in quiescent cells after serum starvation, thereby repressing 
DHFR (Martianov et al., 2007). The short transcripts were transcribed from a minor 
promoter and besides forming the triple-helix complex with target DNA, they also 
bound TFIIB. As described in section 1.3.1, TFIIB plays en essential role in the 
formation of the PIC, by recognizing target DNA sequences and interacting with the 
TFIID complex. Martianov and colleagues suggested that binding of short transcripts to 
TFIIB disrupts this interaction and lead to disassociation of the PIC.  
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1.6.1 Regulation of Hox loci by ncRNA 
The homeotic gene clusters (HoxA, HoxB, HoxC and HoxD) show a characteristic 
genomic organization in which the arrangement of transcription units is correlated with 
their temporal and spatial pattern of expression. Activation of the Hox clusters during 
development is a multistage process, involving the collinear chromatin opening and the 
activation of the individual loci (Kondo et al., 1998). The process of chromatin 
decondensation involves removal of repressive complexes, and recruitment of histone 
acetyltransferases and co-activators. Retinoic acid (RA) is a well-characterised 
morphogen that is involved in regulating these events. Changes in higher-order 
chromatin structures, such as chromatin looping are also involved in the triggering of 
Hox gene expression (Chambeyron and Bickmore, 2004a). Ultimately, all of these 
events lead to the collinear activation of the genes located within Hox clusters 
(Gronemeyer and Miturski, 2001).  
 The involvement of intergenic, ncRNAs in transcriptional silencing of Hox gene 
clusters has recently been described (Rinn et al., 2007; Sessa et al., 2007). These studies 
detected ncRNAs from regions close to Hox genes that were transcribed from the 
opposite strand from the gene transcripts (Sessa et al., 2007). Moreover, 90% of these 
transcripts were expressed co-ordinately with the adjacent 3’ Hox gene (Rinn et al., 
2007). Rinn and colleagues investigated the mechanisms used by ncRNA to 
transcriptionally regulate Hox genes. Because the Hox genes showed coordinate 
expression with their neighbouring ncRNAs, it was suggested that common chromatin 
domains could be responsible for the transcriptional co-regulation. ChIP-on-chip data 
reinforced this idea, by demonstrating that the transcribed HOX genes and ncRNAs 
belonged to a broad Pol II and histone H3K4me2 domain, whereas silenced regions 
were covered by repressive H3K27me3 and Suz12.  
Another interesting observation was the identification of a ncRNA which 
regulated the transcription of a Hox gene in trans. Rinn and colleagues identified a 2.2 
kb long ncRNA called HOTAIR (HOX Antisense Intergenic RNA) situated within the 
HOXC locus on chromosome 12,Knockdown of HOTAIR using RNAi led to 
derepression of HOXD but did not have any effect on the nearby HOXC gene. Further 
analysis demonstrated that in the absence of HOTAIR, H3K27me3 was decreased 
across the HOXD gene, which suggested that HOTAIR might regulate a 
methyltransferase involved in H3K27 methylation. Indeed, co-immunoprecipitation 
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experiments demonstrated that ncRNA interacts with the Suz12 and Ezh2 subunits of 
the PRC2 complex (Figure 1.16). A similar interaction has been reported in Drosophila, 
where a ncRNA transcribed from the Hox homologue, Ubx, bound to and recruited a 
histone methyltransferase ASH1, resulting in spreading of an active chromatin state and 
activation of Hox gene expression (Sanchez-Elsner et al., 2006). 
Taken together, these results suggest a novel role for ncRNAs in regulating 
transcription in trans. As previously mentioned, the polycomb protein complexes PRC1 
and PRC2 do not have DNA binding components and it has been suggested that 
ncRNAs could act as a link between polycomb proteins and their target DNA 
sequences.  
 
Figure 1.16 Model of a transcriptional gene silencing and activation by ncRNA. Transcription of a 
ncRNA in cis may be involved in the recruitment of Ash1/KMT3, leading to H3K4 methylation and gene 
activation of the downstream Hox gene (Sanchez-Elsner et al., 2006). In contrast, recruitment of PRC2 by 
ncRNA, produced in trans would be responsible for spreading of the repressive H3K27me3 mark and 
silencing of the Hox genes  (adapted from (Rinn et al., 2007)).  
 
1.6.2 RNAi and heterochromatin formation 
A number of studies have implicated ncRNAs in gene silencing and formation 
of heterochromatin (Moazed et al., 2006; Volpe et al., 2002; Rinn et al., 2007). 
Transcription of ncRNAs from heterochromatic repeats has been observed in several 
organisms. RNAi-mediated gene silencing occurs via short, double stranded RNAs 
known as small interfering RNAs (siRNAs). siRNAs are involved in the recruitment of 
Argonaute-1 (Ago1) and other members of the RNAi machinery (reviewed by (Buhler 
and Moazed, 2007)). Volpe and colleagues have shown that deletion of components of 
RNAi machinery in the fission yeast Schizosaccharomyces pombe, leads to a decrease 
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in H3K9me2 across centromeric repeats and derepression of transgenes that were 
integrated into centromeric heterochromatin  (Volpe et al., 2002).  
Targeting of siRNAs to promoters in human cells can also lead to transcriptional 
gene silencing (TGS) through the formation of facultative heterochromatin (Kim et al., 
2006; Morris et al., 2004). By introducing siRNA against the promoter of the human 
CCR5 gene into human cell lines, Kim and colleagues demonstrated that siRNA-
mediated (TGS) induces the appearance of H3K9 and H3K27 methylation at the 
promoter. Moreover, mutations in the subunits of the RNAi machinery led to 
derepression of target genes. Together these results imply that the RNAi machinery is 
able to mediate TGS possibly through recruitment of the EZH2/KMT6 
methyltransferase (Kim et al., 2006). 
 
1.7 Embryonic stem cells 
The pre-implantation mouse embryo at the blastocyst stage is composed of three 
distinct cell types: the trophectoderm, the primitive endoderm, and the inner cell mass 
(ICM). The trophectoderm gives rise to the placenta and the primitive endoderm forms 
the visceral and parietal endoderm that lines the yolk sac cavity. The ICM gives rise to 
all of the somatic cell types in the embryo (Gardner and Beddington, 1988). ES cells are 
derived from the inner cell mass (ICM). They have the unique capability of indefinitely 
propagating in culture in an undifferentiated state (self-renewal), while maintaining the 
capacity to generate any cell type in the body (pluripotency). The mechanisms 
responsible for ES cell pluripotency have been extensively studied in recent years. A 
number of ES cell-specific proteins have been identified that are involved in 
establishing and maintaining pluripotency, which are then switched off during cell 
commitment (see section 1.7.2). In addition, the process of ES cell differentiation 
towards more committed cell types requires the activation and/or silencing of tissue-
specific genes. 
Self-renewal requires that the ES cell genome is able to maintain the epigenetic 
features that specify its pluripotent capacity through multiple cell divisions. At the same 
time, the genome in pluripotent ES cells has to be highly plastic in order to be able to 
enter multiple differentiation pathways. Once differentiation is initiated, lineage 
commitment is accomplished by activation of gene expression programmes, which are 
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specific for each cell type. The molecular mechanisms behind the self-renewal capacity 
and pluripotency of ES cells will be discussed in section 1.7.3. 
 
1.7.1 Chromatin structure in ES cells 
Chromatin structure can influence gene function by affecting the ability of 
regulatory proteins to access their target sites and by modulating the affinity of 
transcriptional regulators for their targets. Initial studies indicated that ES cells were 
rich in euchromatin and that upon differentiation they accumulated highly condensed, 
transcriptionally inactive heterochromatic regions (Francastel et al., 2000; Meshorer and 
Misteli, 2006). This was consistent with the spatial rearrangement of the 
heterochromatic loci and an increase in the number of heterochromatic foci that have 
been observed after differentiation of mouse ES cells into neural progenitor cells 
(NPCs) (Meshorer and Misteli, 2006). This led to the “global accessibility model” 
which suggests that globally open chromatin structure is the feature that is responsible 
for stemness and plasticity of ES cells, which allows them to rapidly activate or repress 
lineage-specific genes, upon differentiation into more committed cells (Kimura et al., 
2004; Lee et al., 2004; Meshorer and Misteli, 2006). 
More recent studies have shown that histone modifications associated with 
euchromatin and heterochromatin can co-exist at the same genomic loci in ES cells as 
the term  “bivalency” has been used to describe this phenomenon (Azuara et al., 2006; 
Bernstein et al., 2006). Bernstein and colleagues demonstrated that upon differentiation 
of ES cells into NPCs, most of the bivalent marks resolved to either active or repressive 
marks. These initial studies suggested that bivalent domains are an exclusive mark of 
stem cells and could be responsible for their “plasticity”. However, others have reported 
the presence of bivalent histone modifications in more committed cell types, which 
raised new questions about the role of bivalent domains in different cell types (Roh et 
al. 2006; Mikkelsen et al., 2007).  
The global accessibility model has been supported by a study that has shown 
that most of genes in mouse embryonic stem cells are active (Guenther et al., 2007). 
However, only half of these transcripts proceeded through elongation, producing mature 
transcripts, suggesting that many genes are regulated at the post-initiation level. 
Together, these recent findings contribute to the understanding of the chromatin state of 
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the stem cells, but equally demonstrate that the ES cell genome is a subject to a complex 
regulation (Guenther et al., 2007).   
Recent observations indicated that some DNA-binding proteins undergo 
remarkably transient interactions with native chromatin in pluripotent ES cells. 
Dynamic measurements and biochemical analysis showed that residence times range 
from a few minutes for linker histones to a few seconds for most transcription factors, 
remodellers and structural proteins, including heterochromatin protein HP1 (Meshorer 
and Misteli, 2006). The dynamic nature of chromatin-associated proteins could make it 
easier for regulatory factors to gain access to regulatory sequences, and to rapidly 
activate complex lineage-specific gene expression programmes (Meshorer and Misteli, 
2006). 
 
1.7.2 Embryonic stem cell regulators 
Self-renewal of mouse ES cell in culture depends upon extrinsic signals from 
LIF and bone morphogenetic proteins (BMP). The key event, which occurs upon LIF 
stimulation of ES cells is tyrosine phosphorylation, dimerization and translocation to the 
cell nucleus of the signal transducer and activator of transcription-3 (STAT3) (Matsuda 
et al., 1999) (Niwa et al., 1998). In the absence of LIF signalling, induced either by LIF 
withdrawal or by the expression of a dominant interfering form of STAT3, ES cells 
differentiate into a morphologically mixed cell population expressing genes 
characteristic of endoderm and mesoderm (Niwa et al., 1998) (Niwa et al., 2000).  
BMP is not generally added to ES cell cultures as a recombinant factor but is 
present in fetal calf serum. The BMP requirement for ES cell self-renewal is strictly 
dependent upon continued LIF stimulation, since in the absence of LIF, BMP directs 
differentiation into cells that are morphologically similar to those formed upon LIF 
withdrawal. In contrast, upon withdrawal of BMPs, ES cells differentiate toward neural 
lineages (Harland, 2000). The target genes responsible for maintenance of pluripotency 
by BMPs are the inhibition of differentiation (ID) genes (Ying et al., 2003), whose 
transcription is further induced by another crucial ES cell factor, Nanog (Chambers et 
al., 2003). ID-proteins block neural differentiation of ES cells by preventing 
transcription factors needed to initiate commitment to this lineage (reviewed in 
(Wagner, 2007)). 
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In the past decade, several intrinsic regulators essential for ES cell pluripotency 
have been identified. The best characterized is the homeodomain protein Oct-4 (Oct-
3/4, pou5f1), a member of the POU class of transcription factors. Oct-4 is involved in 
the formation of the ICM and its precise levels are required for maintenance of ES cells. 
The overexpression of Oct-4 results in differentiation of ES cells into extraembryonic 
tissues (Niwa et al., 2000), while the repression of Oct-4 leads to blastocysts in which 
cells fail to adopt a pluripotent identity and differentiate instead into the 
trophectodermal lineage (Nichols et al., 1998). Recently, it has been demonstrated that 
Oct-4 co-operates with Stat3 and together regulate embryonic ectoderm development 
(Eed) component of PRC2, responsible for H3K27me3 (Ura et al., 2008). This study 
showed that Stat3 and Oct-4 directly bound the promoter region of the polycomb 
protein Eed and regulated its transcription. Absence of any of these factors led to the de-
repression of differentiation-associated genes and resulted in ES cell differentiation.  
As mentioned above, Nanog, which is another homeodomain protein, has been 
shown to be important for ES cell pluripotency. Genetic deletion of Nanog showed that 
the protein is required for the maintenance of pluripotency, since cells from the interior 
of the blastocyst did not maintain their pluripotency but rather differentiated into 
primitive endoderm cells (Mitsui et al., 2003). Moreover, when overexpressed in ES 
cells, Nanog maintains self-renewal in the absence of LIF-Stat3 pathway, which are the 
conditions under which ES cells would normally differentiate (Chambers et al., 2003; 
Mitsui et al., 2003). Compared to Oct-4 mutants, the ability of Nanog mutant embryos 
to produce the temporally more mature primitive endoderm indicates that Nanog‘s 
function is critical at a later time during development than Oct-4. As in the case for Oct-
4, a recent study reported a cooperative interaction between Nanog and Stat3, 
suggesting that they synergistically activate Stat3-dependent promoters and thereby 
promote ES cell self-renewal (Torres and Watt, 2008).   
A genome-wide ChIP-on-chip analysis of human and mouse ES cells showed 
the presence of a complex network of interactions between Oct-4, Nanog and Sox2, a 
HMG factor, at specific promoter regions (Boyer et al., 2005; Loh et al., 2006). The 
most surprising result of the study carried out by Boyer and colleagues was the high 
frequency of co-occupancy of same genomic regions, implying that these TFs form a 
transcriptional circuit, whereby besides regulating themselves, they regulate each other 
as well.   
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To summarize, two regulatory network models have been proposed to account 
for these new findings. One model (feed forward loop) suggests that OCT-4 and SOX2 
converge on the regulation of Nanog, which, in turn, acts with these proteins to control 
a vast array of downstream targets. The other model, consistent with the co-occupancy 
of the promoters of the genes that produce the factors, proposes that OCT-4, SOX2, and 
NANOG are each forming an auto-regulatory loop, whereby they promote their own 
expression and the expression of other pluripotency/self-renewal genes, while 
simultaneously preventing expression of differentiation-promoting genes. 
 
1.7.3 Models for ES cell pluripotency 
In recent years, a large number of studies have been carried out in order to 
understand the chromatin state of ES cells and how genes are regulated within this 
unique enviroment. Models that have been put forward to explain the epigenetic control 
of gene plasticity in ES cells include the hierarchical activation (HA) model, the ETCM 
model and the bivalent doman model (Figure 1.17).  
The hierarchical activation (HA) model proposes that in addition to 
housekeeping genes, ES cells express a subset of genes that are responsible for self-
renewal and maintenance of pluripotency (reviewed in (Szutorisz and Dillon, 2005)). 
During differentiation, external and internal signalling would result in repression of 
these genes and expression of lineage-specific TFs, which would activate transcription 
of lineage-specific genes.  
The ETCM model proposes that tissue specific genes, which are inactive in ES 
cells, are epigenetically marked for expression at a later stage. According to this model, 
the transcriptional competence of lineage-specific genes is determined by localized 
marks of histone modifications established by binding of sequence-specific transcription 
factors to discrete genomic sites at the ES cell stage. These early transcription 
competence marks would help to maintain pluripotency by preventing the spread of 
repressive chromatin modifications and would act as recruitment centres for 
transcriptional activators as ES cells commit to different lineages (reviewed in 
(Szutorisz and Dillon, 2005)). This model is based on the observation that several 
lineage-specific genes, which are repressed in ES cells, contain localised active 
chromatin marks which appear to spread across larger genomic regions following gene 
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activation (Chambeyron and Bickmore, 2004a; Szutorisz et al., 2005a; Vieira et al., 
2004).  
The bivalent domain model proposes that genes encoding crucial TFs and 
developmental genes, which are silent in ES cells, are enriched for marks associated 
with both active and inactive histone modifications (Azuara et al., 2006) (Bernstein et 
al., 2006). Co-existence of H3K27me3 with active histone modifications would poise 
these genes for activation or silencing during cell differentiation. Upon cell 
commitment, the bivalent marks would resolve to either active or repressive marks only, 
which would lead to gene activation or long-term silencing.  
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Figure 1.17 Models to explain ES cell pluripotency. A) The hierarchical activation (HA) model 
purposes that ES cell specific transcription factor (X) activate genes that encode factors required for 
differentiation into more committed progenitors (Y). B) The ETCM model suggests that the 
transcriptional competence of lineage-specific genes is determined by localized marks (underlined in 
orange) established by binding of sequence-specific TFs (for simplicity, histone modifications are omitted 
in this figure). C) The bivalent model purposes that tissue-specific genes are marked with active and 
repressive histone modifications in ES cells. Upon cell commitment, only one of the marks will remain 
leading to either gene activation or repression.  
 75 
 
1.8 Development of the nervous system 
The principal functional property of nerve cells is their ability to receive, 
conduct and store information.  The structure of neurons is divided in three 
compartments; a cell soma, an axon and dendrites. The soma contains the nucleus, 
ribosomes, endoplasmatic reticulum, Golgi apparatus and mitochondria. The axon 
contains the molecular and subcellular components that are required for propagation of 
action potentials. Dendrites, which extend from the cell body and are involved in 
enlarging the soma for signal reception.  
 
1.8.1 Early neural development 
Developing a nervous system involves the formation of a variety of neuronal and 
glial cell types that must be produced in the correct numbers, at appropriate positions 
and at defined times. The early CNS begins to develop when the simple neural plate 
folds, fuses and forms a neural tube (Figure 1.18). Upon the formation of the neural 
tube, the neural crest cells are released and migrate toward different locations within the 
body, where they further differentiate and give rise to a wide variety of cell types. The 
neural crest cells have the capability of differentiating into skeletal, pigment cells and 
peripheral neurons (reviewed in (Morest and Silver, 2003)). Neuroepithelial cells 
remain within the inner walls of the neural tube and give rise to neural precursors. The 
differentiation of NPCs into more committed progenitors occurs during the 
development of the CNS and leads to the formation of neurons and neuroglia (astrocytes 
and oligodendrocytes) (Figure 1.19).  
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Figure 1.18 Formation of neural tube. The simple neural plate folds and form a groove, which during 
development fuses to form a neural tube. The process of neural plate folding relies on the inhibition of 
BMP signalling. The neural tube will give rise to the brain and the spinal cord. The neural crest cells 
migrate towards different locations and differentiate into a variety of cell types, while the remaining cells 
within the interior of neural tube give rise to neural stem cell and more differentiated neurons (adapted 
from (Liu and Niswander, 2005)).    
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Figure 1.19 Schematic view of the early CNS lineage specification. Immature progenitors, such as 
neural stem cells (NSCs), neuroblasts (NB), glioblasts (GB), astrocytes and oligodendrocyte progenitors 
(APC and OPC, respectively) are capable of self-renewal (green arrow) (adapted from (Nguyen et al., 
2001) 
 
What distinguish the neurons from neuroglia are the axons and dendrites. These parts of 
neurons can propagate action potentials, make synaptic junctions with other neurons 
and form release and reception sites for neurotransmitters. Neuroglia, which lack axons 
and dendrites are defined by their tendency to support other cells, either neurons or 
other cell types, including other neuroglia, ependymal cells and vascular endothelium 
(reviewed in (Morest and Silver, 2003)). 
 
1.8.2 Neurotransmitters 
Neurotransmitters are the chemical messengers, which participate in the synaptic 
communication between neurons. Upon their release by neurons, neurotransmitters 
induce postsynaptic effects on their target cells, a process that is mediated by specific 
neurotransmitter receptors (NTRs). The major excitatory and inhibitory 
neurotransmitters are γ-aminobutyric acid (GABA), serotonin, dopamine, gluatamate, 
glycine and nicotin acetylcholine (Nguyen et al., 2001). There is increasing evidence 
that neurotransmitters, such as GABA, can act as trophic factors in the immature 
nervous system, and influence early developmental events such as cell proliferation, 
differentiation and migration (Varju et al., 2001; Nguyen et al., 2001). 
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GABA receptors 
GABA receptors are bound by γ-aminobutyric acid, which is the most 
ubiquitous inhibitory neurotransmitter in the brain and CNS. GABA mediates neuronal 
inhibition by opening a chloride channel within the receptor. GABA-mediated signaling 
is thought to be involved in the regulation of nearly all key developmental stages during 
neural development (Owens et al., 2002) and both type B (GABAB) and type A 
(GABAA) receptors have been reported to be involved in developmental regulation 
(Wang et al., 2003; Jelitai et al., 2004). 
There are nighteen GABAA receptor subunit isoforms in mammals and they are 
often clustered within the same genomic regions (Figure 1.20). They differ in their 
affinity to bind neurotransmitters, desensitization rate and channel conductance 
(reviewed in (Joyce, 2007)). The most common model of the GABAA receptor consists 
of a pentameric structure which forms an ion pore and is selective for chloride ions 
(Figure 1.20). A wide variety of GABAA receptors are obtained by different pentameric 
combinations. However, most are believed to be composed of two α-, two β- and one γ-
subunit (Backus et al., 1993).   
 
 
Figure 1.20 GABAA receptor structure and GABAA gene clusters. A) Two α, two β and one γ 
subunits surround a central channel, with a GABA binding site located at each α-β interface, B) 
Schematic representation of the organisation of three GABAA receptor gene clusters in the mouse. 
(Adapted from (Joyce, 2007)). 
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In situ hybridization and immunohistochemical studies have revealed that 
individual GABAA receptor subunits exhibit different patterns of temporal and spatial 
expression, and are expressed in different brain regions. The α2, α3 and β3 subunits are 
predominantly expressed in prenatal brain regions, while α1 and β2 are most prominent 
during postnatal development (Laurie et al., 1992). In adult brain, the α1β2γ2 
combination is widely expressed and represents the largest population of GABAA 
receptors (Laurie et al., 1992). In contrast, most other subunits are rarely expressed 
and/or have a unique distribution. One such example is α6, which is exclusively 
expressed in cerebellar granule cells (Wisden et al., 1992). Interestingly, the genes that 
encode the α1,β2 and γ2 receptors form part of a gene cluster that also contains the α6 
gene. This suggests that the GABAA receptor genes are subject to a combination of 
coordinate and individual regulation. 
 
Glutamate receptors 
Glutamate is the most common excitatory transmitter in the adult CNS 
(reviewed in (Nguyen et al., 2001)). It is bound by glutamate receptors, which are the 
predominant excitatory NTRs in the mammalian brain and are activated in a variety of 
normal processes such as neural differentiation and proliferation. Glutamate receptors 
are expressed by neurons and neuroglia cells and they are tetrameric proteins composed 
of a various combinations of five subunits, GluR5, GluR6, GluR7, KA1 and KA2. 
 
Serotonin receptors 
There are seven types of serotonin (5-hydroxytryptamine) receptors (5-HT1-7) 
(reviewed in (Nguyen et al., 2001)), which are expressed in several different areas of the 
brain and are involved in the release of neurotransmitters such as dopamine and GABA. 
Although two receptor subunits have been identified, 5-HT3A and 5-HT3B, homomeric 
5-HT3A receptors are thought to be the dominant functional form in the CNS. Lower 
transcript levels of 5-HT3A are detected in peripheral neurons where this subunit is co-
expressed with 5-HT3B (Morales and Wang, 2002). The activation of the 5-HT3 receptor 
occurs upon binding of serotonin but also of another neurotransmitter, dopamine (Solt et 
al., 2007). 
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Dopamine receptors 
Dopamine (DA), which is released by dopaminergic neurons, regulates a 
number of physiological and behavioural functions, alterations of which can lead to 
severe human disorders such as Parkinson’s and Huntington’s disease. DA regulates 
several neuronal processes such as differentiation, maturation and axon guidance 
(Jassen et al., 2006). Five dopamine receptors (D1-D5) have been identified, encoded 
by the Drd1a, Drd2, Drd3, Drd4 and Drd5 genes. They are widely expressed across the 
brain (Vallone et al., 2000). DA binding to dopamine receptors leads to activation or 
inhibition of the cAMP pathways, transactivation of receptor tyrosine kinases and 
modulation of Ca2+ signalling (Vallone et al., 2000). 
 
1.9  B cell development 
Hematopoietic stem cells (HSCs) are multipotent cells that have the potential to 
self-renew and differentiate into all cells of the erythromyeloid and lymphoid lineages 
(Figure 1.21). Differentiation of HSCs into lymphoid precursors and B cells initially 
occurs in the foetal liver and after birth, in the bone marrow. B lymphocytes are 
responsible for humoral immunity, which allows the immune system to respond to 
almost any antigen to which it is exposed, because of the diversity of the antibody 
repertoire. B cell development can be divided in a series of discrete developmental 
stages (summarized in Figure 1.22) (Nutt and Kee, 2007). Each stage is defined by the 
expression of specific cell surface markers and/or gene expression patterns, as well as 
the rearrangement status of the immunoglobulin (Ig) genes. The first functional B cells 
are known as immature B cells and are defined by expression of IgM at the cell surface. 
Immature B cells exit the bone marrow and migrate to secondary lymphoid organs such 
as the spleen, lymph nodes and Peyer’s patches, where they further differentiate through 
several transitional stages and eventually become mature follicular or marginal-zone B 
cells. These cells can undergo terminal differentiation and become antibody producing 
plasma cells or they can differentiate into long-term memory B cells (Sabbattini and 
Dillon, 2005).  
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Figure 1.21 Differentiation pathway for hematopoietic precursors (HPCs)/hematopoietic stem cells 
(HSCs). HPCs can differentiate towards multipotent lymphoid progenitors, which will give rise to B and 
T lymphocytes, or multipotent erythromyeloid precursors, which will differentiate into erythrocytes and 
myocytes.  
 
The earliest differentiated progeny of HSCs are multipotent progenitors 
(MPPs), which have lost the capacity for extensive self-renewal but retain multilineage 
differentiation potential (Figure 1.22). A subset of MPPs express high amounts of the 
tyrosine kinase receptor Flt3, leading to differentiation into lymphoid-primed MPPs 
(LMPPs). In these cells, expression of Flt3 is regulated by PU.1 and Ikaros, two 
transcription factors that are essential for B cell development. Among the LMPPs are 
early lymphoid progenitors (ELPs), which can give rise to B and T lymphocytes, natural 
killer (NK) cells and dendritic cells (DC). The ELPs express the interleukin-7 receptor 
(IL-7R) (Borge et al., 1999), which is also regulated by PU.1 and Ikaros. It has been 
shown that mice lacking IL-7R and Flt3 receptors fail to develop any B cells, 
demonstrating that both of these receptors are essential for B cell development (Sitnicka 
et al., 2003). 
Further specification of ELPs towards the B cell lineage occurs upon induction 
of early B cell factor-1 (Ebf1). Expression of EBF1 persists right through B cell 
development until the plasma cell stage and is regulated different sets of TFs at different 
stages. At the early pre-pro B cell stage, EBF1 is regulated by E2A and by STAT5 
(Roessler et al., 2007), while in mature B cells, a combinatorial regulatory effect of 
PU.1, ETS1 and PAX5 is involved in its regulation reviewed in (Nutt and Kee, 2007)). 
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EBF1 together with E2A contributes to early B cell commitment by activating many B 
cell-specific genes (such as CD19). A summary of TFs implicated in B cell 
development is shown in Table 1.7. 
 
 
Figure 1.22 Stages of B cell commitment. ELPs (early lymphoid progenitors), pre-pro B cells and 
committed pro- and pre-B cells are shown. Developmental capacities of different stages are indicated, 
together with the most important TFs, growth-factor receptors and cell-surface markers. The most 
essential interactions are highlighted by blue arrows, while ⊥ indicates gene repression. Rag1 expression 
is initiated at the ELP stage (adapted from (Nutt et al., 2007).  
 
Besides the effect that TFs exert on gene expression and the subsequent lineage choice 
of HSCs, some of the TFs described above, recruit and interact with distinct chromatin 
remodelling proteins. Two such proteins are Ikaros and Aiolos, which associate with 
Mi2β, HDAC1 and 2 components of the NuRD complex and are involved in gene 
silencing (Koipally et al., 1999) (Kim et al., 1999). Ikaros associates with 
heterochromatic loci and also exerts its repressive activity through direct binding to the 
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promoter of its target genes (Brown et al., 1999) (Sabbattini et al., 2001). 
 
Table 1.7 Proteins involved in transcriptional networking during B cell development (adapted from 
(Nutt and Kee, 2007)).  
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Aim of the project  
The aim of this project was to investigate the histone modifcation profile of 
gene-dense and gene-poor regions in ES cells and more differentiated cells and to use 
this information to gain insights into the mechanisms that allow differential regulation 
of gene expression at early stages of development and during cell commitment. By 
focusing the analysis on a relatively small region (2 Mb) containing a large number of 
tissue-specific and housekeeping genes, it was possible to correlate the epigenetic 
profiles with detailed transcriptional analysis and to provide insights into the 
mechanisms that are involved in regulation of these genes. 
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2 Material and Methods 
 
2.1 Standard stock solutions 
10 x TBE  890mM Tris, 890mM Boric Acid, 20mM EDTA, pH 8.0 
20 x SSC  3M NaCl, 0.3M Tri-sodium Citrate, pH 7.0 
TE buffer  10mM Tris-HCl, pH 7.4, 1mM EDTA   
PBS-A   137mM NaCl, 2.68mM KCl, 4mM Na2HPO4, 1.76mM 
                                    KH2PO4  
10 % SDS  10 % weight/volume (w/v) Sodium Dodecyl Sulphate 
 
2.2 Solutions for bacterial culture 
LB-broth with chloramphenicol: 
10g/l Bacto-tryptone (Merck), 5g/l Bacto-yeast extract  (GIBCO BRL), 1g/l NaCl, 
25µg/ml chloramphenicol 
LB-agar with chloramphenicol: 
1.5 % Bacto-agar (Merck) in LB-broth, 25µg/ml chloramphenicol 
 
Unless otherwise stated all chemicals were obtained from Sigma (Sigma-Aldrich.com). 
 
2.3 Deoxyribonucleic acids (DNA) 
 
2.3.1 Mini-prep of BAC DNA 
A single colony of transformed bacteria was used to inoculate 3ml of LB-broth 
(containing chloramphenicol 25µg/ml) and incubated overnight in 37°C C shaker. All 
BAC clones where purchased from “BACPAC Resources” and the following protocol 
was used for the isolation of BAC DNA: using a sterile pipette tip, a single bacterial 
colony was inoculated into 2ml LB media (supplemented with 25µg/ml 
chloramphenicol) and was grown under constant shaking overnight at 37°C. The 
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following day, 2ml of media was transferred to an Eppendorf tube and spun down at 
3500 rpm for 10 minutes. The pellet was resuspended in 300µl of a solution containing 
50mM Tris pH 8, 10mM EDTA and 100µg/ml RNase A. Additional 300µl of 0.2N 
NaOH and 1% SDS were added and the content of the tube was gently mixed. Followed 
by 5 minutes incubation at room temperature, 300µl of 3M KOAc pH 5.5 was added 
and the samples were left on ice for 5 minutes. Samples were pelleted at 10000 rpm for 
10 minutes at 4°C and the supernatant was precipitated with 800µl cold isopropanol at -
20°C for 15 minutes. The samples were pelleted at 10000 rpm for 15 minutes at 4°C, 
washed with 70% ethanol, air-dried and resuspended in 50µl TE. 
 
2.3.2 Isolation of mouse genomic DNA from ES cells 
Approximately 106 cells were collected and washed twice with ice cold PBS. Cells 
were then pelletted in 15ml falcon tubes. Thereafter, 0.7ml DNA isolation buffer  
(0.05M Tris-HCl, pH 8.0, 0.1M EDTA, 0.1 M NaCl, 1% (w/v) SDS) and 10µl 
proteinase K (10mg/ml) were added. The sample was incubated at 55°C overnight with 
rotation. The day after, a volume of 0.7ml 1:1 phenol-chloroform was added and the 
sample was extracted by vigorous shaking for 15 minutes at room temperature and 
recovered after spinning at 13000 rpm for 10 minutes. After addition of ethanol the 
DNA became visible as a white cotton-like precipitate, which could be spooled with a 
plastic rod. The DNA was placed into 100µl of TE buffer and the DNA was allowed to 
fully dissolve overnight at 4 °C. 
 
2.3.3 Quantification of nucleic acids 
The concentration of genomic and BAC DNA was determined using a Nanodrop 
(ND-1000 Spectrophotometer). The concentration of DNA was measured in 1µl of 
loaded sample. Concentration of DNA obtained from ChIP experiments was determined 
by PicoGreen Quant-IT Kit (Invitrogen, cat. nr. P7581) using a standard 
spectrofluorometer at the fluorescent excitation and emission wavelengths of 480nm 
and 520nm, respectively. 
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2.4 Isolation of ribonucleic acids (RNA) 
When working with RNA samples, samples were kept on ice during all 
procedures and work in sterile enviroment. 
 
2.4.1 Isolation of mouse RNA from ES cells and B cells 
Total RNA was isolated from 5 x106 ES cells and B cells using Trizol 
(Invitrogen cat. nr. 15596-018). Cells were pelleted and resuspended in 1ml of Trizol. 
After 5 minutes of incubation at room temperature, 200µl chloroform was added, 
samples were shaken vigourously and incubated for 3 minutes at room temperature. 
Samples were centrifuged at 2-8°C at the speed of 12000 rpm for 15 minutes. Following 
centrifugation, the mixture separated into a lower red, phenol-chloroform phase, an 
interphase and an upper aqueous phase where RNA remained. The aqueous phase was 
precipitated with 500µl isopropanol, left at 15°C - 30°C  for 10 minutes and centrifuged 
at 12000 rpm for 10 minutes, at the temperature of 2-8°C. The pellet containing RNA 
was washed with 75% ethanol, air-dryed and resuspended in water. The RNA samples 
that were immediately used were stored at -20°C and the remaining aliquots were kept 
at -80°C. 
 
2.4.2 Isolation of mouse RNA from several mouse adult tissues 
Total RNA was isolated from six adult mouse tissues: brain, spleen, liver, lung, 
muscle and kidney. The tissues were homogenized using a dounce homogenizer. The 
RNA was extracted with Trizol (as described above), using 1ml of Trizol per 50-100mg 
of tissue.  
 
2.4.3 Quantification of ribonucleic acids 
Purified RNA samples were measured with Nanodrop (ND-1000 
Spectrophotometer) and the integrity of the RNA was verified by loading the samples 
on 1% Agarose gels and visualizing the 18 and 28S ribosomal RNA bands.  
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2.4.4 DNase treatment of RNA samples 
1µg of total RNA was treated with 1U DNase (DNase I Amplification Grade, 
Invitrogen, cat. nr. 18068-015 1U) in the presence of 1µl 10x buffer in total volume of 
10µl. The DNase treatment was performed for 10 minutes at room temperature and the 
reaction was stopped by adding 1µl 25mM EDTA and incubating samples for 10 
minutes at 65°C.  
 
2.4.5 cDNA synthesis 
cDNA synthesis was performed using oligo dT. DNase-treated RNA (720ng)  
was primed with 1µl oligo dT (Invitrogen, 50 µM) and 1µl NTP mix (10mM) for 10 
minutes at 65°C. Samples were briefly cooled on ice and the following mix was added: 
4µl First Strand buffer 5x, 2µl DTT 0.1M, 0.5µl SuperScript II Reverse Transcriptase 
(200U/µl) (Invitrogen cat. nr. 18064-014) in a final volume of 20µl. A negative control 
(RT-) was also prepared, in which SuperScript II Reverse Transcriptase was omitted. 
Reverse transcription was performed at 42°C for 90 minutes. The reaction was stopped 
by incubating samples at 70°C for 10 minutes and the remaining RNA was denaturated 
with 1µl 1M NaOH. cDNA samples were diluted 19 fold and RT- samples 8 fold and 
used as the template for the Quantitative Real-Time PCRs.  
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2.5 Cell culture 
 
2.5.1 Culture of Embryonic Stem cells 
E14 ES cells were cultured in 0.1% gelatin coated flasks on an γ-irradiated ST2 
stromal feeder layer provided kindely by Andrew Georgiou. Culture medium was 
Dulbecco minimal essential medium (DMEM) supplemented with 15% foetal calf 
serum, 2mM glutamine (Gibco), 50µgM β-mercaptoethanol (Sigma), 2mM non-
essential amminoacids (Sigma), 2mM sodium pyruvate (Sigma), 1.8U/µl LIF 
(Leukemia Inhibitory Factor from Chemicon). The presence of two pluripotent ES cells 
markers, Oct4 and SSEA was verified by FACS analysis (carried out by A. Georgiou). 
Cells were found to be >90% positive (Figure 2.1). 
 
Figure 2.1 FACS analysis of ES cells. a) Percentage of cells positive for Oct4 (90%) and b) SSEA 
(93%) pluripotent markers. 
 
2.5.2 Activation and culturing of primary mature B cells 
Activated B cells were generated from spleens dissected from wild type adult 
mice. The spleens (3-5 per experiment) were homogenised by passing through a fine 
metal mesh and re-suspended in 20ml of RPMI media (supplemented with 2mM 
glutamine (Gibco), 15% foetal calf serum, 50µM β-mercaptoethanol (Sigma) and 
100U/(100µg/ml) penicillin/streptamicin (Sigma cat. nr. P0781). Cells were purified on 
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Ficoll and then re-suspended in RPMI 15% foetal calf serum supplemented with 
10µg/ml LPS at a final concentration of 0.5 x 106 cells/ml. After Ficoll purification, the 
cell population consisted mainly of B lymphocytes (60%) and T cells (35%). After 
activation for three days with LPS, FACS analysis has shown that the cells were found 
to be 98% positive for the B cell specific surface marker B220 and negative for the T 
cell specific Thy1 marker. They were also ~ 93% positive for surface expression Ig 
expression as measured by staining for the κ light-chain (Approximately 5% of mouse 
B cells express λ light-chains, bringing the total percentage of of Ig expressing cells to 
98%) (Figure 2.2). 
Thy1-FITC kappa-FITC
(A) (B)
 
Figure 2.2 FACS analysis of mature B cell cultures. A) Percentage of cells positive for B220 (98%) 
and B) kappa surface marker (93%) 
 
2.6 Chromatin immunoprecipitation (ChIP) 
 
2.6.1 Fixed chromatin preparation 
ChIP of formaldehyde-cross-linked chromatin was carried out essentially as 
described by (Soutoglou and Talianidis, 2002). The following solutions were used (all 
solution were supplemented with inhibitor cocktail tablets from Roche (Protease 
Inhibitor Cocktail Tablets Complete REF11836153001 and EDTA-free 
REF11836170001): 
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Before use, protein G-Sepharose beads (GE Healthcare cat. nr. 17-0618-02) were pre-
cleared as follows: A100µl aliquot beads stock/IP sample was washed twice with 
sonication buffer and then incubated with 1ml sonication buffer containing 1mg/ml 
BSA and 1mg/ml salmon sperm DNA for 1 hour with rotation. After incubation, the 
beads were spun down at 1200 rpm for 5 minutes and resuspended in 200µl of 
sonication buffer.  
1x108-3x108 cells were harvested and crosslinked by addition of formaldehyde 
to the medium to a final concentration of 1%. After 10 minutes incubation at 37°C, the 
reaction was stopped by adding glycine to a final concentration of 0.125M. Cells were 
incubated at room temperature for 5 minutes and then washed 3 times with ice-cold 
PBS containing protease inhibitors. Cells were resuspended in 10ml of swelling buffer, 
chilled on ice for 10 minutes and homogenized in a glass homogenizer (tight pestle) 
with nuclei extrusion. The nuclei were centrifuged at 5000 rpm for 5 minutes at 4°C and 
resuspended in sonication buffer to a final concentration of 2x107cells/ml. Chromatin 
was sonicated to give DNA fragments of approximately 150-500 bp in size (verified by 
agarose gel electrophoresis) (Appendix, Figure A1). After sonication the chromatin 
sample was spun down at 14000 rpm for 15 minutes at 4°C, the supernatant was 
recovered and the spin was repeated. The chromatin was then used for 
immunoprecipitations. 
 
Immunoprecipitation of fixed chromatin  
The total amount of chromatin needed for several immunoprecipitations (500µg 
for each sample) was pre-cleared with 100µl of pre-cleared protein-G-Sepharose beads. 
Chromatin was spun down at 1400 rpm for 5 minutes, the supernatant was collected and 
the concentration adjusted to 500µg/ml. Immunoprecipitations were carried out in the 
volume of 1ml, overnight with rotation at 4°C. 100µl-200µl of the chromatin that was 
not immunoprecipitated with any antibody was kept aside as control (input). The 
antibodies used are listed in Table 2.1: 
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Table 2.1 List of antibodies used in fixed chromatin immunoprecipitation. The amount of antibodies 
that were used for the IP with 500µg of chromatin are shown in last column. * Antibodies provided by Dr 
.Laszlo Tora. 
 
After overnight incubation, 200µl of pre-cleared protein G Sepharose beads were added 
to the samples. Samples were left on the rotating platform for 3 hours, and then 
centrifuged for 5 minutes at 1200 rpm. Samples were washed twice with sonication 
buffer, twice with wash buffer A, twice with wash buffer B and twice with TE. 
Immunocomplexes were eluted twice with 250µl of elution buffer at 65°C for 10 
minutes and then left on a rotating platform, at room temperature for 15 minutes. After 
the elution, the cross linking was reversed by adding 16µl 5M NaCl and 1µl 10mg/ml 
DNase-free RNase A to the eluates and the input sample, and incubated overnight at 
65°C. On the following day, 5µl of 10mg/ml proteinase K were added and samples 
were incubated for 2 hours at 45°C before phenol/chloroform extraction and ethanol 
precipitation. Glycogen (0.1µg) was added to each sample before precipitation to 
facilitate visualization of the pellet. DNA concentration was determined by Pico green 
as described in section 2.3.3. 
 
2.6.2 Unfixed chromatin preparation 
Preparation of unfixed chromatin and ChIP were carried out as previously 
described (Crane-Robinson et al., 1997; O'Neill and Turner, 1995) with some 
modifications. The following solutions were used (all of the solutions were 
supplemented with protease inhibitor cocktail tablets from Roche): 
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1x108-3x108 cells for each chromatin preparation were harvested and washed 3 
times with ice cold PBS plus 5mM Sodium Butyrate. Cell pellets were resuspended in 1 
X TBS to a final concentration of 2 x 107 cells/ml. An equal volume of 1% NP40 
solution containing protease inhibitor was then added and the cells suspension was left 
for 40-60 minutes to equilibrate on ice while stirring. After stirring on ice, cell 
suspensions were homogenized in a glass homogenizer (tight pestle) with nuclei 
extrusion. Homogenates were centrifuged at 3500 rpm for 20 minutes at 4ºC. The pellet 
was resuspended in 25% sucrose in TBS (20ml) and underlayed with 2ml of 50% 
sucrose. After centrifugation at 4000 rpm for 20 minutes at 4ºC, the nuclear pellet was 
washed once in 25% sucrose in TBS and resuspended in digestion buffer to a 
concentration of 0.5mg of DNA/ml. Chromatin was released from the nuclei by 
digestion with micrococcal nuclease (MNase) (15U/ml) for 5 minutes at 37 ºC. 
Digestion was stopped by adding EDTA to a final concentration of 5mM and by 
cooling on ice. Samples were centrifuged at 13000 rpm for 10 minutes and the 
supernatant (S1) was recovered. The pellet was resuspended in lysis buffer (1-2ml), left 
for 30 minutes at 0 ºC and then frozen overnight at -20 ºC to complete nuclei lysis. S1 
was kept overnight at 4 ºC after. The following day, the samples in the lysis buffer were 
centrifuged at 4000 rpm and the second supernatant (S2) was collected. The chromatin 
concentration of S1 and S2 was determined by Nanodrop measurements. MNase 
digestion was assessed on a 1% agarose gel and samples S1 and S2 were mixed together 
prior to the immunoprecipitation (see Appendix, Figure A1). 
 
Immunoprecipitation of unfixed chromatin 
 The following solutions were prepared (all the solution were supplemented with 
inhibitor cocktail tablets from Roche): 
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Protein G-Sepharose beads were pre-cleared before use as follows; 100µl beads for each 
IP sample were washed twice with ChIP buffer 1 and then incubated with 1ml ChIP 
buffer 1 containing 1mg/ml BSA and 1mg/ml salmon sperm DNA for 1 hour with 
rotation at 4°C. After incubation beads were spun down at 1200 rpm for 5 minutes and 
resuspended in 200µl of ChIP buffer 1.  
150µg of unfixed chromatin was used for each immunoprecipitation. Samples 
were pre-cleared with 100µl of Protein G-Sepharose beads in 1ml of ChIP buffer 1. The 
samples were left for 1 hour on a rotating platform at 4ºC. Then, they were centrifuged 
at 1400 rpm for 5 minutes. 100µl of pre-cleared chromatin was saved as input material. 
Immunoprecipitations were carried out overnight with rotation at 4°C using 25µg of 
H3H3K4me2 and IgG antibodies. After overnight incubation, 100µl of pre-cleared 
beads was added to the samples. They were then left on the rotating platform for 3 
hours, followed by centrifugation for 5minutes at 1400 rpm. The supernatant was 
discarded and the pellet was washed once with 1.5ml ChIP buffer 1, once with 1.5ml of 
ChIP buffer 2 and twice with 1.5ml of ChIP buffer 3. The bound fraction was eluted 
twice with 250µl of ChIP Buffer 1 with 1% SDS for 15 minutes on rotating wheel at 
room temperature. DNA was extracted two times with phenol/chloroform, ethanol 
precipitated and resuspended in 50µl water. DNA concentration was determined by 
PicoGreen. 
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2.7 Real-Time PCR 
All real-time PCR (RT-PCR) amplifications were performed on DNA Engine 
Opticon system (MJ research, Inc.). Reactions were set up in 25µl using SYBR Green 
Jumpstart Mix (Sigma cat. nr. 037K6812). The following amounts and sources of DNA 
were used as a template (in duplicates): 
• For the expression profiling, 10ng of cDNA was used 
• For the analysis of ChIP DNA and validation of chip on chip data, 0.25ng-2.5ng 
of DNA was used. 
 
2.7.1 Primers for Real-time PCR 
All primers were designed using Primer3 software. The thermal cycling 
conditions were as follows: initial denaturation at 95°C for 10 minutes followed by 40 
cycles at 95°C for 15 s, annealing at 61°C for 15 s, and extension at 72°C for 15s. For 
each experiment, the threshold was set to cross a point at which RT-PCR amplification 
was linear (0.02 to 0.05 for the majority of the experiments).   
 
2.7.2 Primer efficiency and data analysis 
To test the efficiency of different primer pairs in real-time amplification, it was 
necessary to carry out the reactions with known concentrations of a BAC clones 
containing the appropriate target regions. Standard curves were generated by plotting 
the cycle number at which the PCR signal rose above background (Ct value) against the 
number of molecules. The slope of the standard curve was used to determine the 
efficiency of each primer pair, using the following formula: 
 
Efficiency = 1 - (10 (-1/slope))  
 
The efficiencies of all primers used during this project are summarized in Table 2.2 and 
Table 2.3. 
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Table 2.2 List of primer pairs used for the qRT-PCR analysis of 68 genes. Sequences for the forward 
and reverse primers are shown alongside with the efficiencies.  
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Table 2.3 List of primer pairs used for the ChIP DNA analysis and validation of the ChIP-on-chip 
data.  
Real-time PCR reactions were performed with the same amount of DNA (0.25-
2.5ng) for the immunoprecipitated and for the input sample. The amount of DNA 
produced in any PCR reaction can be described by the formula X=X0 2Ct where X and 
X0 are respectively the final and the initial DNA concentration of a target sequence and 
Ct is the number of cycles. If data are collected at a fixed threshold value of 
concentration the final concentration X became a constant. The number of cycles 
required to reach this value is inversely related to the initial target sequence 
concentration X0. 
Therefore, for the same target sequence X0(IP) 2Ct (IP)  = X0(Input) 2Ct (Input) from which: 
 
Fold Difference (enrichment) = X0(IP) / X0(Input) = 2 (Ct Input-Ct IP)  
 
A different approach was used for histone modifications, which are widely 
spread across genome, such as histone H3K9 di- and trimethylation. This method, 
known as “volume method”, allows detection of modifications that are widespread 
across the genome, more efficiently than when equal amounts of DNA are used. When a 
modification is widely present in the genome, the target sequence of the IP sample will 
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be similar to that of the input material and, therefore if equal quantities of DNA are 
analysed by PCR, the enrichment will be not detectable. ChIP samples analysed by the 
volume method were dissolved in a fixed volume, following ethanol precipitation. The 
DNA was not quantified and PCRs were performed with 5µl of each sample. The 
percentage of the DNA immunoprecipitated with the specific antibody was calculated 
with an equation similar to the one described previously. However, one correction term 
was added to take into account the volumes in which input (VInput) and 
immunoprecipitated (VIP) samples were dissolved and the fact that only 1/10 of the total 
volume used for the specific immunoprecipitation was taken as input material. The 
values obtained represent, for each target sequence, the percentage of the 
immunoprecipitated DNA relative to input. 
 
X0IP/ X0Input (%) = {[2(Ct (input) – Ct (IP)] x [VIP/10 x VInput] }x 100  
 
 
2.7.3 Analysis of mRNA levels 
To quantify mRNA 5µl of diluted cDNA sample (see 2.4.5) and RT- was used 
as a template. It has been previously shown that housekeeping gene, Mln51 is 
ubiquitously expressed (Szutorisz et al., 2005). This was verified by examining Mln51 
transcript levels in several mouse tissues and cell types (results chapter 3, Figure 1.3). A 
sample was analysed for Mln51 levels for each RT-PCR reaction set that was performed 
on a particular tissue or cell-type. To calculate the relative expression level of a certain 
gene with respect to Mln51, the following formula was used: 
 
Relative expression level of test gene Y = 2 (Ct value Mln51 – Ct value gene Y) 
 
The normalized expression profiles, which were obtained for all 68 genes are 
summarized in chapter 3 Table 1.1. The error bars in the plots represent the standard 
deviations of the entire set of values obtained for each PCR amplicon, in at least three 
independent experiments. 
 99 
 
2.7.4 Data analysis of chip on chip validation 
Validation of the results ChIP-on-chip experiments was performed by designing 
real-time PCR primers, covering fifteen random genomic sites based on the log2ratio 
values that were obtained from the microarray analysis.. Log2ratio values represented 
the ratio of the signal intensity of input DNA relative to the signal intensity of the 
immunoprecipitated DNA. Probes that gave positive log2ratios were interpreted, as the 
specific genomic sites were a certain histone modification was abundant or transcription 
factor was bound. On the other hand, the probes, which gave negative log2ratios, 
suggested that the genomic regions, which were covered by those probes, were depleted 
for the analysed modification. The purpose of validation was to verify that the genomic 
sites, which gave enrichments/depletion in the ChIP-on-chip experiments, would give 
enrichments/depletion with real-time PCR. RT-PCR analysis was carried out on the 
same immunoprecipitated and input DNA that was hybridised onto the microarrays. An 
example is shown in Figure 2.3, where the log2ratios are shown in upper (A) panel and 
fold enrichments are shown in the panel below (B).  
 
 
Figure 2.3 Validation of ChIP-on-chip data. Validation was carried out by designing a range of 
primers, covering genomic regions, which gave either very high or low log2ratios during the microarray 
analysis. The log2ratios obtained from the microarray analysis (A), were compared with qRT-PCRs 
carried out on immunoprecipitated DNA (B). Probes, which gave high log2ratios, gave in most cases high 
enrichments. Genomic regions that gave low log2ratios gave also low levels of the enrichment.   
 100 
 
2.7.5 Whole Genome Amplification  
Whole genome amplification was carried out using the protocol described by 
(O'Geen et al., 2006). For each reaction 5-10ng of ChIP and Input DNA was amplified 
using whole genome amplification kit (Sigma cat. nr. 037K0445). To each DNA 
sample, 2µl of Library preparation buffer and 1µl of Library Stabilization solution was 
added to total volume of 12µl. Samples were left at 95°C for 2 minutes, briefly chilled 
on ice and 1µl of Library Preparation Enzyme was added. The following reaction was 
carried out in thermal cycler using the following conditions:  
 
16°C for 20 minutes,  
24°C for 20 minutes, 
37°C for 20 minutes,  
75°C for 5 minutes  
and 4°C for 5minutes.  
 
Thereafter, 60µl of a master mix containing 7.5µl of 10x Amplification master mix, 
47.5µl Nuclease-free water and 5µl WGA DNA polymerase, was then added to each 
sample. Reaction conditions for the second thermal cycler reaction were:  
 
95°C for 3 minutes, then 14 cycles of  
94°C for 15 minutes, 
65°C for 5 minutes  
and then 4°C for 5 minutes.  
 
Samples were purified with Qiaquick PCR Purification Kit (Qiagen cat. nr. 28106) 
according to manufacturer’s guidelines, and eluted in 40µl of water. Primers used for 
the PCR analysis of WGA amplified products are shown in Table 2.4. 
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Table 2.4 List of primers used for PCR analysis of WGA amplified products 
 
2.7.6 Labelling of ChIP and Input DNA with Cy5 and Cy3 dyes 
Input and immunoprecipitated DNA were labelled with dCTP-Cy3 (Perkin 
Elmer NEL 57700IEA) and dCTP-Cy5 (Amersham PA53021) respectively. The 
following protocol was used and where possible all steps were performed in the dark: 
2.5µg of DNA was primed with 50µl 2.5x Random primers (BioPrime labelling Kit, 
Invitrogen cat. nr. 18094-011) in a total volume of 130µl at 100°C for 10 minutes After 
chilling samples briefly on ice, the following mix was added: 15µl NTP mix (where the 
final concentration was; 50mM ATP, GTP, TTP and 25mM CTP), 1.5µl dCTP-
Cy3/Cy5 (1mM) and 3µl Klenow (40U/µl). Labelling was performed at 37°C overnight 
in a Thermal Cycler. The following day, the reaction was stopped by adding 15µl stop 
buffer and the DNA was purified using a PCR purification Kit (Qiagen cat.nr. 28106). 
 
2.7.7 Quantification of labelled DNA 
The concentration of purified DNA samples (in ng/µl) and the incorporation 
efficiency (in pmol/µl) were determined by Nanodrop (see Figure 2.4). 
 
 
Figure 2.4 The efficiency of dye incorporation was estimated by measuring number of picomols of 
dye per 1µl of DNA. 
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2.7.8 Design of Agilent Mouse tiling Arrays 
 The genomic tiling arrays were purchased from Agilent Technology 
(www.agilent.com). They consisted of 60mer oligonucleotides spaced at a density of 
approximately one oligonucleotide per 100 bases across non-repetitive sequences. Three 
different mouse tiling arrays were designed, covering the regions of the mouse genome 
shown in Table 2.8:  
 
 
Table 2.5 List of genomic regions covered by the Agilent arrays. *Probes were either spotted as single 
or double probes, depending on the available space on the microarray. 1 and 2 correspond to the 
coordinates inmM7 andmM8 assembly, respectively.  
 
As it can be seen from Table 2.5, besides the main 2 Mb target region on mouse 
chromosome 3, additional chromosomal regions were selected, which contained the 
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following genes: Msx1 (chr5), Msx2 (chr13), Dlx1/2 (chr2), lambda5 (chr16), Htr3a/3b 
(chr9), Gabra (chr11) (3.06 Mb), Sox3 (chrX), Sox4 (chr13), Grik1 (chr16), Grik5 
(chr7) and Drd1a (chr13). The selected genomic regions were repeat-masked (i.e. 
sequences containing LINE, SINE elements were excluded from target regions). 
 
2.7.9 Hybridisation 
Hybridisation of the labelled samples was performed according to 
manufacturer’s protocol (http://www.chem.agilent.com/temp/rad57EC1/00003699.PDF), for 40 
hours at 65°C. Depending on the array design (2x105K or 4x44K), the samples were 
mixed in following way: 
 
 
Samples were heated for 3 minutes at 95°C followed by incubation for 30 
minutes at 37°C in Thermal Cycler. Samples were spun down and loaded onto the 
microarrays as described in the manufacturer’s instructions 
(http://www.chem.agilent.com/temp/rad7186F/00000591.PDF). The hybridisation was allowed to 
proceed for approximately 40 hours at 65°C.  
 
2.7.10 Washing of microarrays 
Washing of the microarrays after hybridisation was performed according to the 
manufacturer’s instructions with minor changes. All washes were performed in a fume 
hood on magnetic stirrers. The microarrays were removed from the hybridisation 
chamber while dipped into Wash Buffer 1 (Agilent cat. nr. 5188-5221). The following 
washes were performed: Wash Buffer 1 for 5 minutes at the room temperature, Wash 
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Buffer 2 (Agilent cat. nr. 5188-5222) for 5 minutes at 31°C, acetonitrile for 1 minute at 
room temperature. The slides were gently removed from the acetonitrile, transferred to 
dark slide racks and scanned within 2 hours.  
 
2.7.11 Slide reuse 
Stripping of Agilent microarray slides for reuse was carried out as previously 
described (Guenther et al., 2007). (All washes were performed in the slide-staining 
dishes on a magnetic stirer). Arrays were washed for 3 minutes in acetonitrile and rinsed 
in stripping buffer (100mM Potassium phosphate, pH6.6) for 1 minute at room 
temperature. Slides were then transferred into a 65°C stripping buffer bath and the 
temperature was increased gradually up to 100°C. After boiling at 100°C for 2-3 
minutes, arrays were transferred to a room temperature stripping buffer bath and 
allowed to cool for 2 minutes. The slides were then transferred to acetonitrile for 1 
minute at room temperature. After this step the arrays were re-scanned (prior to 
hybridization) to verify the efficiency of the stripping process.  
 
2.7.12 Scan of Agilent arrays and Data extraction  
All Agilent microarrays were scanned on Agilent Microarray Scanner. Both 
105K and 44K arrays were scanned under 5µm resolution and 100% of green and red 
PMT values. The microarray data was extracted using Feature Extraction (FE) Software 
(v.9.1) (Detailed information on this software can be found at 
http://www.chem.agilent.com/temp/rad97AEF/00001264.PDF) provided by Agilent. 
The FE software extracted the data from the two-colour tiff images obtained from the 
scanning procedure. After FE analysis was applied to the scanned microarrays, several 
Quality Control reports were obtained and used to evaluate the performance of each 
hybridisation and scanning process. The following QC reports were used; 
 
• Spot finding for four corners (Figure 2.5 a), provided information about the 
features in the four corners of the microarray and whether the spot centroids 
were positioned properly. 
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• Spatial distribution of all outliers, provided information about the non-uniform 
outliers and background population features. Two plots were obtained, one for 
each channel (Figure 2.5 b).  
• Plot of background-corrected signals, which tells whether use of the background 
correction has been done correctly (Figure 2.5 c). 
 
Figure 2.5 QC reports from Feature Extraction. They were used to estimate hybridisation and scan 
quality, a) Spot finding was used to determine the positions of the four corners of the array, b) Spatial 
distribution of green and red outliers, c) shows red and green background corrected signals. The 
intersection of the red lines represents the median signal intensities. 
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2.8  Normalization of ChIP-on-chip data 
Microarray experiments are affected by several sources of technical variation. 
Among these are variation in cell culture preparations that were used as a source of 
DNA for biological replicates, variable labelling efficiencies, variation in 
thehybridisation efficiencies of different probes and dye-bias. Variation between 
biological replicates was addressed by standardising cell culture procedures as much as 
possible. Variation in the hybridisation and analysis of the microarrays was addressed 
by performing several normalization procedures both within each array and between 
arrays. In the following sections, the different normalization steps that were applied will 
be described. 
2.8.1 Data normalization by Feature Extraction 
Feature extraction (FE) software was used to extract the data from the raw signal 
intensities for green and red signals, obtained from the scanned microarrays. The FE 
applied the following normalizations steps: 
 
• Outlier pixels were flagged (i.e. bad features / probes) 
• Statistical analysis was performed on inlier pixels (on good features / probes)  
• Local backgrounds were subtracted from raw signals in each channel  
• The error of each feature was estimated 
• Dye normalization was performed 
 
During this procedure several output text files and QC reports were obtained 
after each scan. The quality control reports were used to assess the array 
(hybridisation/scan) quality (Figure 2.5) and the output text files were used for further 
analysis. 
 
2.8.2 Intra- and Inter-array normalization 
Two additional levels of normalization were applied to FE output files, within-
array and across array normalization. The within-array (also known as intra-array) 
normalization aims at removing intensity measurements that are subject to any 
systematic trends and normalizes the intensity log-ratios so that they average to zero 
within each array. The across array (also known as between arrays) normalization aims 
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at making intensities consistent within each array and normalizes intensities so that the 
log-ratios have similar distributions across the arrays. 
 
Intra-array normalization 
 The intra-array normalization was carried out by applying the 
normalizeWithinArrays LIMMA function (Smyth and Speed, 2003) with the “median” 
method which substracts the weighted median from the M-values (log-ratios) for each 
array. 
 
Inter-array normalization 
 The between-arrays normalization was performed by running the 
normalizeBetweenArrays LIMMA function (Smyth and Speed, 2003) with the 
“Gquantile” method which ensures that the Green channel (Input) has the same 
empirical distribution across arrays, leaving the M-values (log-ratios) unchanged. 
Figure 2.6 shows the box-plots of log-ratios for two biological replicates, before and 
after these two last normalization steps.  
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Figure 2.6  Box-plots representing the log ratios for sample X and Y. (A) Before normalization. Panel 
(B) shows the values after intra-array normalisation and Panel (C) after intra- and inter–array 
normalization.  
 
Correlation between replicates 
After intra- and inter-array normalization, the log ratios from two biological 
replicates were plotted against each other to determine the correlation between these 
two replicates. The plot has a straight line with slope 1 and intercept 0, if two data 
vectors (in our case two biological replicates) have the same distribution (i.e. if they are 
“ideal” replicates). In order to calculate the correlation coefficient for each replicate, a 
straight line was plotted through the majority of spots. The slope of this line was used to 
calculate the correlation coefficient and estimate the quality of biological replicates. An 
example is shown in the Figure 2.7.  
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Figure 2.7 The correlation coefficients (CC). They were calculated for each set of biological replicates, 
before normalization and after the intra-array and inter-array (this step includes also intra-array 
normalization) normalization steps. The values were obtained by plotting a straight line through the 
majority of the probes of both replicates. The slope of the straight line was used to calculate the 
correlation coefficient. 
 
The summary of all correlation coefficients is shown in Table 2.6. The visual 
representation of two log2ratios for two biological replicates, before and after 
normalization is shown in SignalMap in  Figure 2.8. 
 
 
Table 2.6 Summary of the correlation coefficients between biological replicates, before and after 
normalization. 
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Figure 2.8 Visualisation of two biological replicates (A and B), before and after different steps of 
normalization. The upper track (purple) shows gene annotations along the specific genomic sequence 
while the y-axis represents log2ratios. Tracks for not normalized and intra-array normalized data are 
shown in first and second track for each sample. The third track, inter-array normalization (between array 
normalization, also includes intra-array nromalization step). 
 
2.9  Peak detection and grouping 
 
2.9.1 Peak detection 
Peak detection is a procedure that makes it possible to identify significant, peaking 
regions and to distinguish them from background levels. Peak finding was carried out 
by ChIP Analytics software (provided by Agilent), where the peaks were extracted from 
two biological replicates and merged into one text file. The peaks were extracted using 
the Whitehead Per-Array Neighbourhood model, using the following criteria: 
• Maximum distance between two probes that were considered as neighbours was 
1000bp. 
• A probe was considered “bound” if P (Xbar) < 0.001 
(for more details, see http://www.chem.agilent.com/temp/radDC3AB/00001309.PDF). 
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3 Expression profiling of a two megabase gene-dense region 
 
3.1 Introduction 
A major objective of this PhD project was to gain insight on how tissue specific 
genes are regulated and how their tissue specificity is achieved and maintained during 
cell development. A second aim was to investigate whether physical proximity between 
adjacent genes has an effect on their transcriptional regulation. An additional question 
was whether tissue specific/restricted genes are differentially regulated in gene-poor 
versus gene-dense regions. In order to address these questions, a comprehensive 
epigenetic analysis of a region of 2 Mb, located on mouse chromosome 3 was 
performed, using the Chip-on-chip technique. This region was selected because it is 
very gene rich (it contains 68 known genes) and it includes several well-studied tissue-
specific genes, such as nestin and osteocalcin. Nestin is specifically expressed in neural 
stem cells while osteocalcine is a bone specific factor.  
ChIP-on-chip is a method that allows a thorough analysis of the epigenetic 
modifications within the target regions. This powerful technique permits one to map the 
epigenetic modifications across entire genomes and to correlate them with the locations 
of the genes and their regulatory regions and the transcriptional status of specific 
genomic loci. In order to correlate the observed epigenetic modifications with the 
expression patterns and tissue specificities of the target genes, it was necessary to obtain 
detailed expression profiles of those genes. Although information on gene expression 
profiles is available from public databases, the data are often variable and contradictory, 
which makes it difficult to draw quantitative conclusions. Therefore, the decision was 
taken to carry out detailed expression profiling of all target genes in a number of 
different cell types. The expression profiling has been performed using real-time PCR 
analysis of all 68 genes in two different cell types and seven mouse tissues.   
 
3.2 Overview of real time PCR and expression analysis 
Quantitative real-time PCR (qRT-PCR) analysis is a well-established technique, 
used for the quantification of target mRNA molecules in biological samples. The levels 
of specific mRNA transcripts are usually calculated relative to the level of an internal 
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control RNA, encoding a ubiquitously expressed gene. Several different experimental 
factors will affect the quantification of a transcript. These include RNA quality, 
efficient cDNA synthesis, design of PCR primers, choice of a reference gene and the 
final calculation of the expression levels. These different aspects will be discussed in 
more detail in the following sections. 
 
3.2.1 Primer design and efficiency 
Optimal design of PCR primers is essential for accurate and specific 
quantification by real-time PCR. Detection is based on binding of SYBR-Green dye into 
double stranded PCR products, a sequence-independent process. The sensitivity of 
detection using SYBR-Green may be compromised by the formation of primer-dimers, 
by lack of specificity of the primers and by the formation of secondary structures in the 
PCR product. This is avoided by analysing the melting curves after each qRT-PCR and 
loading few of the PCR products onto the agarose gels. The average length of the 
amplicons was between 100bp and 180bp, since longer PCR products are known to 
cause non-linear incorporation of the fluorescent dye, i.e. reducing the accuracy of the 
quantification. Both forward and reverse primers have been selected within the same 
exon in order that their efficiency could be tested using serial dilutions of BAC clones, 
which contained the target sequences. The melting curves were also analysed to exclude 
non-specific amplification and primer-dimer formation in the presence of SYBR-Green. 
The efficiency of each primer pair was determined by plotting Ct (Cycle 
threshold) values (Figure 3.2 y-axis) against the serially diluted (Figure 3.2 x-axis), 
which were used as a template. The values were used to plot a linear regression and the 
“slope value” was used for the calculation of primer efficiency (Figure 3.2). The Ct 
values were calculated from the intersection of the curve of interest with a manually set 
threshold Figure 3.1. 
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Figure 3.1 A typical image observed when testing the efficiency of a primer pair. Each serial dilution 
has been done in triplicate. The Ct values for a specific dilution were read-out from the intersection of the 
curve with a manually set threshold. 
  
By definition, Ct value is the point at which the fluorescence rises above the 
background levels and corresponds to the beginning of the exponential phase of the 
PCR reaction. 
 
 
Figure 3.2 Graph used to estimate the efficiency of primer pairs, used for qRT-PCR. Ct values (y-
axis) were plotted against the serial dilutions (x-axis), which were used as a template. The values were 
used to plot a linear regression. Standard deviations were calculated from data obtained from at least three 
different measurements. 
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The slope of each standard curve was used to calculate the efficiency of each primer 
pair, using the following formula (Peirson et al., 2003);  
 
Efficiency (E) = (10 (-1/slope)) -1 
 
For example, the efficiency of primers for the Gba promoter (GbaPR) (Figure 3.2) was 
calculated: 
 
E = (10 (-1/-3.7032)) - 1   
E = 0.862   
E = 86.2 % 
 
The efficiency of most of the primer pairs was in the range of 70-100%. All primer 
sequences, PCR conditions and efficiencies are summarized in the Material and 
Methods section 2.7.2, Table 1.2  (The additional primer pairs used for the analysis of 
ChIP data are shown in Table 1.3). When the efficiency was found to be lower than 
70%, new sets of PCR primers were designed or different PCR conditions were used 
(increased primer concentration and changed annealing temperature). However there 
were a few exceptions, such as, Msto1 (68.5%), Ash1l (68.7%) and Fdps (62.7%) genes, 
for which it was not possible to obtain primers with higher efficiencies.  
 
3.2.2 Reference gene, Mln51 
The transcript levels for each gene were determined by comparing the levels 
with those obtained for a reference gene. A reference gene, which is ubiquitously 
expressed at similar levels in all tested tissues, was used in order to normalize the data 
and to be able to compare different transcript levels between different tissues. The most 
frequently used reference genes are GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase), albumin, β-actin, HPRT (hypoxanthine phosphoribosyl-transferase) 
and 18S rRNAs. A problem with this approach is that the levels of most housekeeping 
genes vary between different tissues and cells and this variation will influence estimates 
of the expression levels of the target sequences (de Jonge et al., 2007).  
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For our study, we have chosen the Mln51 gene (also known as Cac3, cancer 
susceptibility candidate 3), which was previously shown to be ubiquitously expressed at 
similar levels in a number of mouse tissues (Szutorisz et al., 2005a). qRT-PCRs was 
used to confirm this observation for the tissues and cell types analysed in this project 
(Figure 3.3). These results validated the use of Mln51 as an appropriate control gene for 
normalizing the expression data in this study.  
 
 
Figure 3.3 The Mln51 gene is expressed at similar levels in all tested tissues and cells. Ct values for 
each tissue were plotted as individual bars. 
 
3.2.3 Analysis of expression levels  
The expression levels of target genes were obtained by performing qRT-PCR on 
cDNA preparations from different mouse tissues and cell types. All reactions were 
performed on at least two different cDNA preparations. cDNA samples were diluted 19-
fold and 5µl was used per reaction (as described in Material and Methods, section 
2.4.5). Each data point was run in duplicate. Ct readings for the target gene sequences 
and Ct values specific for the Mln51 reference gene were used to calculate the relative 
levels abundance of the transcripts. The relative expression of a target gene with respect 
to the reference gene can be calculated using one of the two following models: the ΔΔCt 
model (Livak et al., 2001) and the efficiency corrected model (Pfaffl et al., 2001). 
According to the ΔΔCt model, the amount of the specific target is determined by:   
 
2-ΔCt where ΔCt = (Cttarget-Ctreference), which can be written as  
2 -(Ct target-Ct reference)  or   
2 (Ct reference-Ct target) 
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The relative expression ratio (R) of gene Y would in this case be calculated using 
following formula; 
R = 2 (Ct Mln51-Ct gene Y) , which can also be written as  
R = 2 (Ct Mln51)  / 2 (Ct gene Y)     (equation 1) 
 
This formula assumes that the primer efficiency is equal to 100% for both genes and 
this is included within the equation. In reality, equation 1 should be written as: 
 
R = (1+EMln51) (Ct Mln51)  / (1+EY) (Ct gene) 
 
When Mln51 and Y efficiencies are 100%, then E = 1 
 
R = (1+1) (Ct Mln51)  / (1+1) (Ct gene Y)   
R = 2 (Ct Mln51)  / 2 (Ct gene Y) 
 
However, this formula is only valid when the primer pairs for the reference gene and 
gene Y both have an efficiency of 100%, which means that during each new cycle of the 
PCR reaction, the number of the molecules is doubled. In reality, the primer pairs for 
the sixty-eight genes analysed in this project showed varying amplification efficiencies. 
The efficiency corrected (R)e model (Pfaffl et al., 2001) also known as GED (Gene 
Expression’s Ct Difference) (Schefe et al., 2006) corrects for these differences, between 
the primer pairs for the target and reference genes. The expression ratio between the two 
genes is calculated using the following equation:  
 
Re = (1+Mln51efficiency) (Ct Mln51)  / (1+Yefficiency) (Ct gene Y)   (equation 2) 
  
The example shown below illustrates the effect of correcting for primer efficiency. The 
following Ct values were obtained from duplicate measurements of Dap3 and the 
reference Mln51 gene in RNA extracted from spleen.  
 
Dap3;  Ct1 = 23.44   Mln51: Ct1 = 27.45  
Ct2 = 23.08     Ct2  = 27.86  
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Dap3:  Ct average = 23.26 Mln51: Ct average = 27.65 
 
According to equation 1, the expression ratio of Dap3 relative to Mln51 is: 
 
R = 2(27.65)  / 2(23.26) 
R = 20.96 
 
According to equation 2, the expression ratio calculated from the same figures is: 
 
Re = (1+0.93) (27.65)  / (1+0.89) (23.26) 
Re = 29.18    
    
, where 93% and 89% are the efficiencies for Mln51 and Dap3, respectively.  
 
The above example shows that relatively small differences in primer efficiency can 
have a substantial effect on the calculated expression ratio. Therefore all calculations of 
expression ratio were carried out using equation 2. The final expression data are 
summarized in Table 3.1. 
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Table 3.1 Summary of relative expression ratios, obtained by using efficiency corrected model. * 
Data analysis for NS cells and astrocytes was carried out by M. Sjoeberg 
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Table 3.2 Standard deviations obtained from at least three independent qRT-PCR measurements. * 
Data analysis for NS cells and astrocytes was carried out by Dr. M. Sjoeberg. 
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3.3 Expression profile of a two megabase gene-dense region  
Expression levels of the sixty-eight genes from the 2 Mb gene-dense region on 
mouse chromosome 3 were determined by examining their transcript levels in different 
mouse tissues and cell types. The data are summarised in Figure 3.4 and Table 3.1. 
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Figure 3.4 Expression levels of 68 genes within a two megabase region (x-axis) relative to the 
housekeeping gene Mln51 (y-axis). Ubiquitously expressed and tissue-restricted genes are highlighted in 
grey and light green, respectively. Three tissue-restricted genes, which are situated in between highly 
expressing genes, are highlighted in red. Standard deviations were obtained from at least three 
independent qRT-PCRs. (* The expression levels for these genes exceed the scale of the graph and the 
full details can be found in Table 3.1. M. Sjoeberg carried out the expression analysis for neural stem 
cells (NS) and astrocytes). 
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The expression profiling of the 2 Mb gene-dense region provided valuable 
information about the transcript levels of target genes in different mouse tissues. The 
data confirm that genes with similar expression profiles (ubiquitous and tissue-restricted 
genes) are clustered within same genomic region. Several examples of tissue-restricted 
genes, situated in between highly expressed genes have also been demonstrated. These 
results provide the basis for understanding the epigenetic profiles, which will be 
discussed in Chapters 4-6.  
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Table 3.3 The expression profiles and tissue specificity of 68 analysed genes, which are ordered 
according to their genomic position. Genes are coloured according to the biological pathway they are 
implicated in; haematopoiesis (blue), transcription (green), neural development (red), mitochondrial 
genes (bright green), ammonium metabolism (pink), signal transduction (purple), osteogenesis (orange) 
and housekeeping functions (grey). 
 124 
 
3.3.1 Clusters of tissue-specific genes 
In the following figure, the target two megabases region was split in two regions 
((A) and (B)) of one megabase each. The expression profile for sixty-eight genes is 
shown for the embryonic stem cells only. Clusters of ubiquitously expressed and tissue-
restricted genes are underlined with red and green bars, respectively.  
 
Figure 3.5 Expression levels of the sixty-eight genes in the 2Mb region, relative to Mln51 in ES cells. 
The two megabase region was split in two regions of one megabase, (A) and (B). Ubiquitously expressed 
and tissue-restricted genes are underlined with red and green bars, respectively. Tissue-restricted genes, 
Rhbg, Sema4a, Syt11 and Rusc1, which are surrounded with highly expressed genes, are underlined with 
dotted green line. Different gene clusters are underlined with grey boxes from 1 to 4. (*The exact values 
of the expression levels of these genes can be found in Table 3.1). 
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Ubiquitously expressed clusters 1 and 2 include genes encoding diverse 
housekeeping functions. Mitochondrial proteins (Msto1, Dap3), chromatin remodelling 
enzyme (Ash1l), CDC-like kinase (Clk2), membrane protein (Scamp3), lysosomal 
enzyme (Gba) and metaxin (Mtx1) are some of them. Clustering of tissue-specific genes 
can be classified into three groups; 1) genes belonging to the same gene family (Fcrls 
and Ephrins), 2) genes which code for proteins that participate in same biological 
processes (nestin, brevican, hapln2) and 3) genes with biologically unrelated functions 
(Pklr and Hcn3) (Table 3.4).   
 
 
Table 3.4 Clusters of tissue-restricted genes can be classified into three groups. Genes who 
participate in biologically unrelated or related processes, and genes belonging to same gene families.   
 
Crabp2, Nestin, Brevican and Hapln2 cluster 
Crabp2 (cellular retinoic acid binding protein II), Nes (nestin), Bcan (brevican) 
and Hapln2 (hyaluronan and proteoglycan link protein 2) are four tissue-restricted 
genes, which cover a genomic region of 78 kb (cluster 4, Figure 3.5). Crabp2 transcripts 
were detected only in ES cells and at low levels in brain, Bcan and Hapln2 were 
exclusively found in brain, whereas the highest levels of Nes transcripts were seen in 
neural stem cells (low levels were also detected in ES cells, kidney, lung and muscle). 
Crabp2 encodes a cellular retinoic acid binding protein II. Crabp2 is the only 
gene out of sixty-eight which were analyzed, that has shown ES cell specific 
transcription only. It has been suggested that Crabp2 plays an important role in the 
binding of retinoic acid (Jamison et al., 1994). Two models have been put forward to 
elucidate the function of CRABP proteins; firstly, that the CRABP proteins bind and 
hereby reduce levels of RA, in preventing RA-induced differentiation, and secondly, 
that CRABPs help RA to shuttle from cytoplasm into nucleus where RA can interact 
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with RA receptors (RARs) and induce gene activation (Lane et al., 2008). The fact that 
Lane and colleagues did not detect Crabp2 transcripts in ES cells using Northern 
blotting, suggests that the transcripts that I have measured could have been caused by 
permissive transcription. 
Bcan and Hapln2 are located in close physical proximity to each other. Hapln2 
belongs to Hyaluronan (HA) and proteoglycan binding link protein (HAPLN) family. It 
includes four members Hapln1-4 and they belong to the proteins, which link HA and 
proteoglycans. HA is found in variable amounts in many connective tissues, where it is 
usually bound by large aggregating chondroitin sulfate proteoglycans (CSPGs), such as 
versican and aggrecan, or within the extracelullar matrix (ECM) of the brain and 
central nervous system (CNS), where it is most often bound by the smaller aggregating 
CSPGs, such as brevican or neurocan (Spicer et al., 2003). The exclusive detection of 
Bcan and Hapln2 transcripts in brain correlates very well with their biological function.   
The presence of an additional neural specific gene, nestin, situated within the 
same cluster, reinforces the idea that this could be a neural-specific locus. Nestin 
encodes an intermediate filament protein involved in the formation of cytoskeleton at 
the early stages of neural development. Nevertheless, the presence of nestin in other 
mouse tissues has been reported and its uniqueness regarding the exclusive involvement 
in neural development becomes questionable (reviewed in (Gilyarov, 2008)). This is in 
concordance with our data since we also observed nestin transcripts in kidney, lung and 
muscle tissues, albeit at very low levels. However, whether these are full transcripts and 
whether they give rise to functional nestin protein remains unclear.  
 
Pklr and Hcn3 cluster 
Pklr (pyruvate kinase) and Hcn3 (hyperpolarization-activated cyclic nucleotide-
gated potassium channel 3) (cluster 3, Figure 3.5) are two tissue restricted genes, 
surrounded with two highly expressed ubiquitous genes, Fdps and Clk2. Pklr and Hcn3 
occupy a region of approximately 25 kb, are convergently transcribed and their poly(A) 
regions are separated with only 1kb intergenic sequence. Pklr, whose transcripts were 
predominantly identified in liver and kidney, is involved in the conversion of 
phosphoenolpuruvate into pyruvate. Hcn3, whose transcripts are detected only in brain, 
encodes a cation channel involved in the generation of rhythmic activity in cardiac and 
neuronal cells. Clearly, these two tissue-restricted genes have very diverse biological 
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roles and in spite of their close proximity, retain their different expression profiles. This 
suggests that Pklr and Hcn3 undergo tight gene specific regulation that can occur on the 
level of chromatin and additionally may involve lineage-specific activators and//or 
repressors. The epigenetic profile of these two genes will be discussed in Chapter 4.3. 
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3.3.2 Tissue-specific genes are embedded in clusters of housekeeping genes 
Rhbg, Sema4a, Syt11 and Rusc1 are four tissue-specific genes, which were 
found to lie within clusters of ubiquitously genes (see Figure 3.6). Their expression 
levels and genomic distances to the nearby genes are shown in the following figure. 
 
Figure 3.6 qRT-PCR data are shown for tissue-restricted genes Rhbg (A), Sema4a (B), Syt11 (C) 
and Rusc1 (D) and their neighbouring genes. In the boxes below the graphs, the physical distances and 
length of intergenic regions are shown in kilobases. Y-axis represents the expression levels relative to 
Mln51.  
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Highest Rhbg (rhesus blood group-associated B glycoprotein) transcripts were 
detected in liver and kidney, which correlated well with previously published data 
(Chambrey et al., 2006). Sema4a (semaphorin-4A), which is involved in T cell 
differentiation (Kumanogoh et al., 2002) and regulation of endothelial cell migration 
during vascular morphogenesis (Toyofuku et al., 2007), showed highest levels of 
transcription in liver and kidney (low levels were also measured in other tissues). The 
highest transcript levels of Syt11 (synaptotagmin 11) were detected in brain. This gene 
belongs to the synaptotagmin family, which encodes proteins involved in the neuronal 
development. Rusc1 (RUN and SH3 domain containing 1) encodes a signalling adapter 
protein involved in neurotrophine-dependent neurite outgrowth (MacDonald et al., 
2004). Its role in neuronal differentiation correlates well with the detection of Rusc1 
transcripts exclusively in brain tissue. 
What is interesting about these tissue-restricted genes is their proximity to the 
surrounding housekeeping genes. One such case is Rusc1, whose 5’ end is situated only 
8.5 kb away from the promoter of Fdps, a flanking gene expressed at very high levels in 
all tested tissues. The regulation of these independent transcriptional units during 
development must be crucial for the establishment and propagation of their distinct 
fates. The epigenetic profile of these genes will be discussed in Chapter 4 and 5. 
 
3.4 Summary 
The results presented in this section describe the successful design and 
amplification of the qRT-PCR primers for the expression analysis of the sixty-eight 
genes situated within target 2 Mb region. This analysis has demonstrated that tissue-
specific genes are situated in gene clusters. Some of these clusters include genes 
belonging to the same gene family such as Fcrls and Ephrins, whereas others include 
genes participating in the establishment and maintenance of the same cell type, such as 
“neural-specific” cluster. Additionally, I have demonstrated that isolated tissue-
restricted genes can be found embedded within the clusters of ubiquitously expressed 
genes, such as Rusc1 and Syt11.  
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4 Pattern of histone modifications across a gene-dense region 
on mouse chromosome 3  
 
4.1 Introduction 
A major aim of this project was to carry out a detailed analysis of the epigenetic 
profile of tissue-restricted and ubiquitous genes in pluripotent and differentiated cells 
and to correlate this information with the expression profiles of these genes. Most of the 
analysis was focused on a 2 Mb region of mouse chromosome 3, which was selected for 
the study because of its high gene density (the region contains a total of 68 known 
genes). The region was also chosen because the arrangement of genes with widely 
divergent cell-type specificities, closely juxtaposed and interspersed with one another, 
was expected to provide valuable information about the organisation and epigenetic 
marking of chromatin domains during lineage commitment and cell differentiation. A 
detailed analysis of the transcription profiles of the genes in this region in ES cells, NS 
cells, astrocytes and B cells can be found in Chapter 4 and 5. In order to analyse the 
epigenetic profile of the target region in these cell-types, chromatin 
immunoprecipitation (ChIP) analysis was followed by hybridisation of the ChIP DNA 
to microarrays covering the 2 Mb region (ChIP-on-chip).  
 
4.2 Overview of ChIP-on-chip  
ChIP is a powerful tool for investigating the in vivo distribution of histone 
modifications across defined genomic regions. When it is combined with microarray 
analysis (ChIP-on-chip) it becomes possible to analyse much larger regions, which can 
extend to entire genomes. During ChIP experiments, native chromatin is either obtained 
by digestion of cell nuclei with MNase (N-ChIP) to obtain unfixed chromatin, or is 
cross-linked by the addition of formaldehyde to growing cells, followed by DNA 
sonication (X-ChIP) (see Appendix, Figure A1).  Histone proteins, which are tightly 
bound to the DNA, can be analysed by either X-ChIP or N-ChIP. N-ChIP may give a 
higher resolution for this type of analysis but also suffers from potential problems with 
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nucleosome displacement and sliding during the chromatin preparation. Non-histone 
proteins, such as transcription factors and Pol II can only be analysed by X-ChIP since 
they are not retained on DNA in the absence of fixation. Nevertheless, the disadvantage 
of X-ChIP is that cross-linking can generate a non-specific protein binding. The X-ChIP 
method was used for most of the analysis described in this project. The N-ChIP was 
used for ChIP experiments carried out on NS cells and astrocytes, which was done in 
collaboration with Dr. Elena Cattaneo. 
Before carrying out the microarray analysis, the efficiency of the ChIP was 
estimated by qRT-PCR analysis (Material and Methods, section 2.7.3). ChIP DNA 
samples were tested with a set of primers covering the promoter regions of expressed 
and repressed genes. Appropriate negative controls (IgG and no antibody) were also 
used during ChIP experiments in order to verify the specificity of antibodies used for 
the immunoprecipitation (see Material and Methods, Figure 1.5). 
The small amount of DNA obtained from ChIP experiments made it necessary to 
carry out an amplification step before hybridisation to the microarray. During this 
project, I tested four different amplification techniques. These were whole genome 
amplification (WGA), ligation-mediated PCR (LM-PCR), in vitro transcription (IVT) 
and Klenow amplification. Real-time PCR analysis of the amplified DNA and 
comparison with the signal obtained for non-amplified material was used to check 
whether amplification affected the representation of different sequences in the amplified 
product. The analysis showed that the WGA and Klenow techniques gave the lowest 
amplification bias (Figure 4.1). The WGA protocol was chosen because it was much 
more efficient and the reactions could be performed on as little as 5ng of DNA.  
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Figure 4.1 RT-PCR analysis was used to test different methods for amplifying ChIP DNA. The 
enrichments obtained with the WGA and klenow amplified samples gave the most similar results to the 
values for the non-amplified ChIP DNA.  
 
Following amplification and quantitative analysis of WGA amplified products 
by RT-PCR, the samples were labelled with Cy3-dNTPs (Input) and Cy5-dNTPs (IP’ed 
DNA). The labelling was carried out using Klenow exonuclease. The labelling 
efficiency was estimated by measuring the number of picomols of dye per 1µl of DNA. 
Hybridisation of the DNA samples onto Agilent microarrays and immediate data 
processing was carried out as described in Material and Methods, section 2.9.9. 
Visualisation of all ChIP-on-chip data was carried out using SignalMap (software by 
Nimblegen). Validation of ChIP-on-chip results was carried out as described in Material 
and Methods, section 2.7.5. The set of real-time PCR primers, covering the genomic 
regions, which gave either high or low log2ratio values, were designed. The qRT-PCR 
analysis was carried out on the same ChIP DNA samples, which were used for the 
microarray experiments (Figure 4.2).  
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Figure 4.2 Validation of ChIP-on-chip data was carried out by qRT-PCR analysis using a range of 
real-time primers. A) The ChIP-on-chip data for H3K4me3 in ES cells are visualised in SignalMap and 
the set of primers (in red), covering depleted and enriched regions were designed and used for the 
validation of these results by qRT-PCR. Genes are represented in with green boxes. B) Comparison of 
Chip-chip log2ratios to the values obtained with qRT-PCR. The values for enrichments obtained by qRT-
PCR were transformed into log2 scale.  
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4.3 Tissue-restricted genes can be differentially marked in ES cells 
The analysis was mainly focused on a two megabase target region of mouse 
chromosome 3 that contains 68 genes with differential tissue-specificities. The 
expression analysis described in chapter 3 demonstrated that 25 of these genes have 
tissue-restricted expression. Of these, 12 are completely inactive in ES cells and the 
remaining 13 showed either low or very low transcript levels in ES cells. It is important 
to emphasize that it is not known whether the low transcript levels observed at these 
genes represent functional transcripts or whether they arise from read-through 
transcription from inter- or intragenic promoters, which are known to be widespread in 
ES cells (Guenther et al., 2007; Efroni et al., 2008).  
ChIP-on-chip analysis was carried out on ES cells, B cells, NS cells and 
astrocytes. During this analysis, the distribution of Pol II and the histone H3 
modifications K4me1, K4me2, K4me3, K27me3, K9me2 and K9ac was measured. In 
addition to the gene-dense region on mouse chromosome 3, two gene-poor regions of 1 
Mb and 0.8 Mb from mouse chromosomes 13 and 11 were included in the analysis. The 
1 Mb region on chromosome 13 spans 500 kb upstream and downstream from the Sox4 
gene and contains only one additional gene (Cdkal1). The 0.8 Mb chromosome 11 
sequence contains four related genes, which encode subunits of the GABAA receptors.  
 
4.3.1 The 2 Mb gene-dense region contains multiple bivalent and 
monovalent histone modification domains in ES cells 
Examples of the histone modification profiles for histone H3K9ac, H3K27me3, 
H3K4me1, H3K4me2 and H3K4me3 are shown in Figure 4.3. The full data set can be 
found in Appendix, Figures A2-A6. An initial inspection of the enrichment profiles for 
these modifications across the 2 Mb region reveals several striking features. The most 
obvious is the variation in both the size and distribution of the histone modification 
domains in different parts of the region and in the combinations of modifications that 
were observed. The second feature is the presence of sharp transitions between different 
types of modification across very short distances.  
The bivalent and monovalent histone modification domains were associated with 
discrete genomic regions. The large continuous, bivalent domains (underlined in red, 
Figure 4.3 A) showed high enrichments for all analyzed active histone modifications 
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and for H3K27me3. These domains extended across sequences between 70 and 112 kb 
long and they included both coding and non-coding regions. Most of these domains 
were associated with clusters and single tissue-restricted genes, whose transcripts could 
not be detected by qRT-PCR analysis in ES cells (underlined in red, Figure 4.3 B). 
Crabp2 and nestin are two neural specific genes, which were also transcribed in ES 
cells. These genes will be discussed in more details in the following section. 
Additionally, monovalent histone modification domains were detected across 
large genomic regions. A large region of enrichments for the repressive H3K27me3 
mark covered two B cells specific genes, Fcrl1 and Fcrl5 (see section 4.3.3). Several 
large monovalent regions associated with enrichment for active histone modifications 
and depletion for the repressive H3K27me3 were also detected (underlined in blue, 
Figure 4.3 A and B). These active monovalent domains were linked with the clusters of 
ubiquitously expressed housekeeping genes such as Hdgf, Mrpl24 and Isg20l2 (Figure 
4.3). The remarkable feature of the histone modification profiles is the sharp transitions 
within these different domains, which seems to be closely related to the transcriptional 
status of the affected genes. 
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Figure 4.3 Large genomic regions containing bivalent and monovalent histone modifications were 
observed in the 2 Mb gene-dense region. A) The largest bivalent domains covered genomic sequences 
112 kb, 95 kb and 70 kb in length  (underlined in red), whereas monovalent (underlined in blue) regions 
enriched for the active histone modifications occupied shorter regions. The presence of distinct domains 
correlates well with the expression profiles obtained by qRT-PCR analysis, which is shown in panel B.  
 
A close-up view of some of these genes that are located in bivalent and 
monovalent domains is shown in Figure 4.4. Insrr and Ntrk are two tissue-restricted 
genes that are silent in ES cells. The two genes are located within a 112 kb long bivalent 
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domain (Figure 4.4 A). The levels of H3K27me3 modification appear to be significantly 
higher than H3K4me3, although it is necessary to be cautious when directly comparing 
ChIP values obtained with different antibodies. RNA Pol II was present at the 
background levels across both Ntrk and Insrr. Since I have used a Pol II antibody that 
recognizes large domain of the enzyme, I cannot conclude whether both elongating and 
intiating form or only one of them was present across this genomic region. 
Surprisingly several of the housekeeping genes, which were located within the 
active monovalent domains were associated with tightly localised peaks of enrichments 
for H3K27me3. One such example is Hdgf. The coding region was associated with the 
enrichment for H3K4me3 and Pol II across the gene, but also has peaks of H3K27me3 
at the promoter (Figure 4.4 C). Hdgf encodes a nuclear protein that has a DNA binding 
capability and is involved in the transcriptional repression (Yang et al., 2007).  
Another type of pattern is observed at Iqgap3, which is transcribed at low levels 
in ES cells but is not significantly enriched for any of the analysed histone 
modifications. However, low but continuous levels of Pol II are detected across the 
entire coding region (Figure 4.4 B). The transcripts of this gene were detected at very 
low levels in ES cells and it is questionable whether the measured transcripts give rise 
to fully processed mRNA transcripts. IQGAP3 belongs to a group of proteins that are 
implicated in the establishment of cytoskeletal architecture and intracellular contacts in 
various cells so it is possible that we detected real transcripts (Wang et al., 2007). Hdgf 
and Mrpl24 are two closely situated and highly expressed housekeeping genes. The 
histone modification profile across these two genes showed high enrichments for 
H3K4me3 together with continuous enrichment for Pol II across the intra- and 
intergenic regions. The profiles of histone modifications and Pol II described above 
demonstrate the enormous diversity of histone modification among genes that have 
similar expression patterns. 
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Figure 4.4 Close-up view of two tissue-restricted genes, Ntrk and Insrr and a group of housekeeping 
genes. (A) Ntrk and Insrr are situated in one of the large bivalent domains and are highly enriched for 
H3K27me3 and have lower levels of H3K4me3. (B) and (C) Ubiquitously expressed genes Iqgap3, 
Mef2d, Prcc, Hdgf and Mrpl24 have diverse epigenetic profiles. Iqgap3 that is transcribed at low levels in 
ES cells, is associated with low enrichments of Pol II and no H3K4me3. The promoter region of Mef2d is 
bivalent, while the coding region retains H3K4me3 and Pol II. Highly expressed Hdgf and Mrpl24 are 
enriched for H3K4me3 and Pol II across the entire coding regions and the intergenic sequence that 
separates them. (Red bars across K27me3 track represent probes, which have log2ratio values exceeding 
the y-scale). 
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4.3.2 The epigenetic profile of a cluster of neural-specific genes   
Crabp2, nestin (nes), brevican (bcan) and hapln2 are four tissue-restricted genes 
that are expressed in neural cells and are involved in brain and CNS development (see 
Chapter 3 for their expression profiles). The analysis of histone modifications across 
these genes demonstrated that all four genes are situated within a continuous 95 kb 
bivalent domain in ES cells (Figure 4.5). The canonical bivalent structure was observed, 
with enrichment for H3K27me3 co-existing with enrichments for H3K4me1, H3K4me3 
and Pol II. A close-up view of Crabp2 and nestin is shown in the Appendix, Figure A7. 
 
 
Figure 4.5 Epigenetic profile of Crabp2, Nestin, Bcan and Hapln2 in ES cells. In ES cells, the intra- 
and intergenic regions of all four genes are covered by continuous bivalent histone modification domain. 
H3K27me3 is found at higher levels than H3K4me1 and H3K4me3, while Pol II is present across most of 
the genes at low levels. Crabp2 and nestin transcripts were detected at low levels in ES cells (interrupted 
arrow), while bcan and hapln2 were repressed (double-crossed line). 
 
Transcripts of the Crabp2 gene were detected at low levels in ES cells (Figure 
4.6). However, Lane et al showed that Crabp2 mRNA could not be detected by 
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Northern blotting in ES cells (Lane et al., 2008). The authors have additionally shown 
that the expression of Crabp2, which encodes a retinoic acid binding protein is 
increased upon removal of LIF and by treatment with retinol. This suggests that 
CRABP2 expression is required for retinol-induced differentiation of ES cells into 
neural progenitors. The inability to detect processed Crabp2 mRNA by Northern 
blotting suggests that the transcripts observed in this study are unprocessed and may be 
initiated from intergenic promoters. The results presented here show that the presence of 
a bivalent domain does not prevent substantial levels of intergenic transcription from 
occurring. A similar histone modification and Pol II binding profile was observed across 
the nestin gene, suggesting that nestin is also transcribed permissively in ES cells. 
However, neighboring Bcan and Hapln2 genes did not show any evidence of 
transcription. It is unclear why these closely linked genes behave differently in ES cells.  
 
 
Figure 4.6 Transcript levels of Crabp2, nestin, bcan and hapln2 measured in ES cells. The transcript 
levels were measured, relative to housekeeping gene Mln51. 
 
4.3.3 Lymphocyte specific genes situated within the 2 Mb gene-dense region 
have distinct epigenetic profile 
As described in Chapter 3, many (twelve out of 25) of the tissue-restricted genes 
situated within a 2 Mb gene-dense region were not transcribed in ES cells. The majority 
of these genes were located within large bivalent domains (i.e. Insrr, Ntrk, see Figure 
4.4 A). However, 3 of the 12 tissue-restricted genes (Fcrl1, Fcrl5 and Sh2d2a) were 
associated with the enrichment for H3K27me3 in ES cells. Interestingly, all three genes 
are transcribed specifically in lymphocytes. 
Fcrl1 and Fcrl5 are two relatively large genes (15.6 and 31.7 kb, respectively), 
which are separated by a distance of 43.6 kb (Figure 4.7). The two genes are located at 
one end of a large Fc-receptor like gene cluster.  
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Figure 4.7 Genomic organization of Fc-like receptor cluster on mouse chromosome 3. The section of 
the cluster that is located within the part of 2 Mb region is highlighted in grey and it includes Fcrl1, Fcrl5 
and Etv3.  
 
The transcriptional analysis described in Chapter 3, confirmed that Fcrl1 and 
Fcrl5 are specifically expressed in B cells and are repressed in ES cells. The analysis of 
the histone modification profiles in ES cells showed a large domain of enrichment for 
H3K27me3 covering both genes and the 43.6 kb intergenic region (Figure 4.8 A). These 
results were also confirmed using the Peak Detection application from SignalMap, 
which have shown the presence of probes enriched for H3K27me3 (see Figure 4.9). 
Peak detection is an application that permits one to identify the significant, peaking 
regions and to distinguish them from the background levels of a specific histone 
modification or TF. Methylation of histone H3K4 is largely absent from the region, with 
exception of a localised peak in the intergenic region (see below). The repressive, 
monovalent domain of H3K27 methylation extends until it reaches the housekeeping 
gene, Etv3, where a sudden drop in H3K27me3 mark is observed. In B cells, where the 
genes are active, H3K27 methylation is lost and the entire region (of approximately 150 
kb) becomes highly enriched for active histone modifications (H3K4 methylation and 
H3K9 acetylation) and for RNA Pol II (Figure 4.8 B). 
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Figure 4.8 The epigenetic profile across two B cell specific genes, Fcrl1 and Fcrl5, and ubiquitous 
Etv3 gene in ES cells (A) and B cells (B). Low levels of H3K27me3 modification repress the 
transcription of these two genes in ES cells, while the housekeeping gene Etv3 is clearly enriched for 
H3K4me3 and Pol II and is associated with clear drop in H3K27me3 mark. In B cells, both coding and 
intergenic regions become highly enriched for all active histone modifications and Pol II, and occupy a 
region of approximately 150 kb. 
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The generation of localised regions of active histone modifications (ETCMs) in 
ES cells by binding of pioneer factors has been proposed as a mechanism that would 
prime tissue-specific enhancers and promoters for expression at later stages of 
differentiation (Szutorisz et al., 2005; Szutorisz et al., 2005a; Xu et al., 2007). The 
tightly localised peak of histone H3K4 methylation in the intergenic region between 
Fcrl1 and Fcrl5 is a candidate for such a region. This was obtained using the approach 
where we merged peaks obtained by Peak Detection application from SignalMap, for 
different combination of modifications, representing sites being enriched for 
H3K27me3, H3K9ac, H3K4me1, H3K4me2, H3K4me3 and Pol II (Figure 4.9).  
Nevertheless, the intergenic region A-1 did not show high sequence conservation 
amongst mammals, which suggests that this element could have specie-specific role 
(see Appendix Figure A8). 
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Figure 4.9 The localised genomic site, associated with the enrichment for active histone 
modifications and Pol II is identified in the intergenic region between Fcrl1 and Fcrl5 genes. A) 
Using Peak Detection application the intergenic peak was detected within this genomic sequence 
(highlighted with grey bar). Close-up view is shown in figure B), where the positions of the primers, used 
for validation by qRT-PCR (A1, A2) are shown as red horizontal lines.
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In order to investigate whether GTFs were bound to these sites, qRT-PCR 
analysis was carried out on DNA samples obtained from IPs for TBP and TAF5 in ES 
cells. Both primer sets (A-1 and A-2) gave high enrichments of TBP and TAF5 (Figure 
4.10). The promoters of the repressed Fcrl1 and Fcrl5 genes showed only very low 
enrichment for TBP and TAF5. Functional analysis to determine whether this region has 
enhancer activity in B cells would be one way of testing whether it has the 
characteristics of an ETCM. 
 
 
 
Figure 4.10 The region containing the intergenic peaks is bound by TBP and TAF5 in ES cells. 
qRT-PCR analysis was carried out on DNA samples obtained by ChIP using antibodies specific for TBP 
and TAF5. Intergenic regions A-1 and A-2 were associated with enrichment in TBP and TAF5 whereas 
silent genes Fcrl1 and Fcrl5 showed background binding levels of these two TFs.  
 
The transcripts of the Sh2d2a (SRC-homology-2 domain protein 2A) gene also 
known as T cell-specific adaptor protein (TSAd) were exclusively found in B cells (T 
cells were not included in this study). Others have reported that Sh2d2a is involved in T 
cell antigen receptor-induced cytokine synthesis in T lymphocytes (Spurkland et al., 
1998). Analysis of the pattern of histone modifications across the Sh2d2a gene in ES 
cells showed that the gene was enriched for the H3K27me3 modification but not for 
H3K4 methylation. More detailed inspection showed that the H3K27me3 mark extends 
from a large bivalent domain. The Sh2d2a gene seems to be situated in a transitional 
region, between the bivalent domain and an active monovalent domain of H3K4 
methylation, which is associated with a cluster of housekeeping genes (see next Section 
and Figure 4.11).  
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4.3.4 Cell type-specific genes located close to ubiquitously expressed 
genes often show enrichment for Pol II in ES cells 
Several tissue-restricted genes in the 2 Mb region showed unusual patterns of 
histone modifications in ES cells. Two such genes, Crabp2 and Sh2d2a were introduced 
in the previous sections. These tissue-restricted genes are situated on opposite sides of a 
cluster of housekeeping genes. According to the data obtained from the transcriptional 
analysis (Chapter 3), Crabp2 is transcribed at low levels in ES cells. Detailed analysis 
of the transcriptional status of Crabp2 has shown that processed Crabp2 mRNA is not 
present in ES cells. These results suggest that the transcripts that we have measured 
were most probably products of read-through transcription.  
Crabp2 is situated in a large bivalent domain, which is also associated with high 
levels of Pol II (Figure 4.11 A and Figure 4.12). Interestingly, this gene is situated just 
downstream from a large monovalent domain, which is highly enriched for active 
histone modifications (H3K4 methylation) and Pol II. This monovalent domain covers 
four highly and ubiquitously expressed, housekeeping genes (Mrpl24, Isg20l2, Prcc and 
Hdgf). The promoters of Prcc and Hdgf showed low enrichments of H3K27me3, 
thereby “interrupting” the monovalent domain. Crabp2 is located 8 kb downstream 
from the poly(A) site of the Isg20l2 gene. The region downstream from Crabp2 
contains three neural-specific genes, which are embedded in a large bivalent domain.  
On the other side of the active monovalent domains, the 3’ end of the 
lymphocyte-specific gene Sh2d2a is located only 3.2 kb from the 3’ end of the 
ubiquitous Prcc gene (Figure 4.11 B). Sh2d2a is expressed in T lymphocytes and is 
involved in T cell antigen receptor-induced cytokine synthesis (Spurkland et al., 1998). 
Sh2d2a transcripts were not detected in ES cells. The region immediately upstream also 
marks the beginning of a bivalent domain, which contains the Insrr and Ntrk genes. 
Although both of these genes are located on the boundaries between a single 
active monovalent domain and two flanking bivalent domains, there are significant 
differences in the histone modification profiles of the two genes. In the case of Crabp2, 
there is a very clear shift in the profile of H3K27me3 whereas the domain of H3K4 
methylation extends from the active monovalent region into the Crabp2 gene. 
Interestingly, it is H3K4 mono-methylation that forms a continuous domain between the 
monovalent and bivalent regions. Pol II binding also seems to extend from the Isg20l2 
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gene into Crabp2 coding region. The Sh2d2a gene is monovalent for H3K27 and does 
not show significant enrichment for any of the methylated forms of H3K4. Only low 
levels of Pol II binding were observed and this was restricted to the 3’ end of the 
Sh2d2a transcription unit (Figure 4.12). These results suggest that the transition 
between housekeeping and tissue-restricted genes is managed quite differently for 
different genes. Another factor that could affect these transitions is the orientation of the 
genes. In contrast to the convergent transcriptional orientations of the Sh2d2a and Prcc 
genes, the Crabp2 and Isg20l2 genes have the same orientations, which will result in 
read-through transcription from Isg20l2 into the Crabp2 promoter. 
 
 
Figure 4.11 Transitions between active monovalent and repressive bivalent domains. Active genes 
are represented by purple horizontal bars and tissue-restricted genes by orange bars. Prcc, Hdgf, Mrpl24 
and Isg20l2 (purple bars) are four housekeeping genes located within the monovalent, active domain, 
enriched for AcK9, K4me1, K4me2, K4me3 and Pol II, and depleted for K27me3. Tissue-specific genes  
(yellow bars) in the surrounding domains are associated with the enrichements for active histone 
modifications and repressive mark, K27me3.  
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Figure 4.12 Close-up view of Sh2d2a and Crabp2, two tissue-restricted genes situated at the 
transition region between two distinct histone modification domains. Silent Sh2d2a gene is associated 
with low enrichement for K27me3 modification across its 5’ end. Crabp2, whose low-level transcripts 
were detected in ES cells, was associated with active histone marks and  high levels of repressive mark, 
K27me3. 
 
The Rusc1 and Hcn3 genes are also examples of genes that are transcribed at 
low levels in ES cells. Rusc1 is a tissue-restricted gene involved in neurotrophic 
signalling, which is expressed in brain (MacDonald et al., 2004). The interesting feature 
of this gene is that it is situated within a cluster of ubiquitously expressed genes (Figure 
4.13 A). Ash1l  ((absent, small, or homeotic)-like (Droshopila)) encodes a KMTase, a 
chromatin remodelling protein, whereas Fdps (farnesyl diphosphate synthetase) is 
involved in cholesterol synthesis (Reilly et al., 2002). 
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Figure 4.13 Genomic organization around the tissue-restricted genes, Rusc1, Hcn3 and Pklr. Rusc1 
(A) and Hcn3 (B) are transcribed at very low levels in ES cells, whereas Pklr is transcriptionally inactive. 
The distances are indicated between the genes with interrupted lines, while the arrows represent the 
direction of transcription.  
 
The ChIP-on-chip analysis has demonstrated that there is a sudden shift from the 
active, monovalent region (across Fdps) into a bivalent chromatin structure (Rusc1) 
(Figure 4.14). Additionally, Pol II binding seems to be persistent across the coding 
region of Rusc1, with the highest enrichment observed at the promoter. As with Crabp2 
and Isg20l2, Rusc1 had the same transcriptional orientation as the upstream 
housekeeping gene. This raises the possibility that the permissive transcription of Rusc1 
in ES cells is due to its close proximity to the housekeeping gene and that 
transcriptional read-through occurs from Fdps into Rusc1. 
Another gene that supports this model is Hcn3. It belongs to a group of genes 
coding for hyperpolarization-activated channels. It is expressed in heart and sensory 
ganglions (Wells et al., 2007; Zhou et al., 2007), while we detected its transcripts in 
brain and at very low levels in ES cells. 4.9 kilobases upstream from Hcn3 is located 
ubiquitously expressed Clk2 promoter and only 1 kb downstream of Hcn3 is situated 
divergently transcribed, tissue-restricted, Pklr gene (Figure 4.13 B). Pklr encodes the 
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enzyme involved in the conversion of phosphoenolpuruvate into pyruvate and is 
expressed in liver and kidney, while being silent in ES cells.  
The epigenetic profiling showed that Hcn3 and Pklr are situated within a 
bivalent chromatin domain associated with low levels of Pol II (Figure 4.14). The silent 
Pklr gene has very similar epigenetic profile to Hcn3 although its transcripts were not 
detected in ES cells. These data suggest that low level Hcn3 transcription in ES cells, 
could be due to its close proximity to a ubiquitous Clk2 promoter. 
 
Figure 4.14 Histone modification profile across the tissue-restricted genes, Rusc1, Pklr and Hcn3 
and the neighbouring housekeeping genes, Fdps and Clk2. Hcn3 and Rusc1 are two tissue-restriced 
genes whose low-level transcripts were detected in ES cells (interrupted arrow). These two genes are 
situated very closely to the active genes Fdps and Clk2. Low levels of active histone modifications 
together with Pol II seem to extend from Fdps and Clk2 into Rusc1 and Clk2 , respectively. The tissue-
resticted gene, Pklr that is located futher away from the active genes is silent. 
 
4.4 Summary  
• Multiple bivalent and monovalent domains are associated with discrete genomic 
regions in ES cells. The large, continuous, bivalent domains are mostly 
associated with the clusters of tissue-restricted genes, while the domains of 
active monovalent histone modifications contain clusters of ubiquitously 
 151 
expressed genes. Repressive, monovalent regions of H3K27me3 enrichment are 
found at three lymphocyte specific genes within the 2 Mb target region. 
Transitions between these domains are often characterized by sharply defined 
changes in the histone modification profiles. 
• Several genes located at transition regions between the bivalent and monovalent 
domains have unusual and variable epigenetic and transcriptional profiles, 
which may depend on the precise orientation and position of the gene.  
• Tissue-restricted genes situated close to ubiquitously expressed genes often 
show association with large domains of enrichments for Pol II in ES cells. The 
mechanism for this “spillover” is unclear, but some of it could be due to read-
through transcription from the active gene. Alternatively, the proximity of the 
active gene could generate a chromatin structure that facilitates Pol II binding 
and permissive transcription.  
• A tightly localised region of active histone modifications was identified in the 
intergenic region between two B cell specific genes, Fcrl1 and Fcrl5. This 
region is bound by Pol II, TBP and TAF5, and has some of the characteristics 
of an ETCM. 
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5 Bivalent marks are widespread in mature B cells  
 
5.1 Introduction 
The initial studies that described the co-existence of H3K27me3 and H3K4me3 
histone modifications suggested that these bivalent marks are an exclusive characteristic 
of ES cells. According to this model, the presence of both active and repressive histone 
modifications helps to keep genes in “poised” state while in ES cells, and prepares them 
for rapid activation or repression upon differentiation and cell commitment (Bernstein et 
al., 2006). However, more recent studies demonstrated that bivalent domains are also 
present at some genes in MEFs and human T cells (Roh et al., 2006). The data that I 
present in this chapter show that bivalent domains of methylated histone H3K27 and 
H3K4 are present at many genes in B cells, mirroring the profile observed in ES cells to 
a very high extent. Bivalent domains were also detected in NS cells and astrocytes, but 
in the majority of cases, these regions occupied more localised genomic regions. 
 
5.2 Incidence of bivalency at tissue-restricted genes in B cells 
The expression profiles of the genes in the 2 Mb target region in ES and B cells 
are shown in Figure 1.1. Most of the genes that are repressed in ES cells remain silent in 
B cells as these genes are specific for other lineages. The 2 Mb region that was analyzed 
in this study contains three genes that are specifically expressed in B cells (Fcrl1, Fcrl5 
and Sh2d2a).  
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Figure 5.1 Expression profiles of the 68 genes situated within the 2Mb target region in ES cells and 
B cells. The two megabase region was split in two regions of one megabase. Grey and green bars 
represent expression in ES cells and B cells respectively. Fcrl1, Fcrl5 and Sh2d2a are specifically 
expressed in B cells (underlined in red).  
 
The analysis of the patterns of histone H3K27me3 and H3K4me3 between 
pluripotent ES cells and differentiated B cells showed that silent tissue-specific genes 
have strikingly similar profiles of the two modifications in these two very different cell 
types. The majority of the tissue-restricted genes retained the same epigenetic profile as 
the one observed in ES cells. An example of this can be seen with two tissue-restricted 
genes, Ntrk and Insrr (Figure 5.2). Ntrk (also known as trkA) encodes the nerve growth 
factor receptor, while Insrr encodes the insulin receptor-related receptor. Several studies 
have indicated that as well as being physically near to each other in the genome, Ntrk 
and Insrr are coexpressed in both the peripheral nervous system and the CNS  
(Reinhardt et al., 1994; Tsuji et al., 1996). In addition, the expression of these two genes 
has been observed in kidney (Kurachi et al., 1992), pancreas (Kanaka-Gantenbein et al., 
1995) and thymus (Hannestad et al., 1997). However, the transcriptional analysis 
carried out during this project did not detect transcripts from either gene in any of the 
analyzed tissues. This could be because the analysis was carried out on RNA that was 
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isolated from whole organs, which might not be sufficiently sensitive to detect 
expression in a subset of cells.   
The analysis of histone modification patterns across Ntrk and Insrr in ES cells 
and B cells showed that this genomic region has a remarkably similar profile in these 
two very distinct cell types. The active histone modification H3K4me3 was present 
across both genes, although at much higher levels across the promoter region and 
coding sequences of Insrr (Figure 5.2). The same pattern was detected with H3K4me1 
and H3K4me2 (data not shown). Enrichment for Pol II was detected across neither Ntrk 
nor Insrr. The repressive histone modification H3K27me3 was present at very high 
levels across the Insrr gene and a slightly lower level across the Ntrk gene.  Thus the 
bivalent domain appears to be divided into two regions, a region of high H3K4me3 and 
high H3K27me3 that spans the Insrr gene and a region that has considerable lower 
levels of H3K4me3 across the Ntrk gene. The entire bivalent domain covered a region 
of around 98 kb. Peak detection analysis confirmed the presence of the bivalent 
chromatin state across both genes in ES cells and B cells. Interestingly, the repressive 
H3K27me3 mark extended well beyond the Ntrk/Insrr bivalent domain to cover a larger 
genomic region. More localized peaks of active histone modifications were found 
within this region, creating several short bivalent domains (see Appendix, Figure A9). 
Another well established repressive mark, H3K9me2 was also analyzed. Only 
background levels of this modification were detected in both ES and B cells.  
Analysis of neural stem (NS) cells and astrocytes showed a quite different 
pattern. The large domain of H3K27me3 was also present across both genes in these 
cells, but enrichment for H3K4me1, H3K4me2 and H3K4me3 was much more 
localized, creating short bivalent domains of 1-2 kb on the gene promoters and within 
the Insrr gene (data shown only for NS cells).  
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Figure 5.2 The epigenetic profile across two inactive tissue-restricted genes, Ntrk and Insrr, in ES 
cells, B cells and NS cells. A very similar pattern of histone modifications is observed in pluripotent ES 
cells and differentiated B cells. K4me3 modification co-exists with repressive K27me3, with highest 
levels detected across 5’end of Insrr gene. K9me2 is depleted across both genes. In NS cells, the bivalent 
domains are confined to more localised regions.  
 
 The epigenetic analysis of the genomic region that contains the cluster of 
neural-specific genes, Crabp2, nestin, bcan and hapln2 showed that this region also 
retains an epigenetic profile in B cells that is strikingly similar to the one observed in 
ES cells. High levels of H3K4me1, H3K4me3 and H3K27me3 are found within the 
coding regions and also across the intergenic regions. None of the four genes are 
transcribed in B cells, and low level transcription across Crabp2 and nestin was 
measured by RT-PCR in ES cells (Chapter 3, Section 4.3.2). Within this region, some 
interesting differences were observed in the patterns of H3K27me3 and H3K4me3. 
Whereas, H3K27me3 covered the entire region including the intergenic sequences, 
H3K4me3 was more localised to the genes and their immediate flanking sequences. The 
differences in level and distribution of the different modifications suggest that 
generation of these modification profiles involves the action of multiple sequence-
specific factors and co-factors that are likely to show subtle variations between cell 
types.  
In NS cells and astrocytes, nestin and bcan retain only active histone 
modifications at their 5’ ends, while Crabp2 and hapln2 remain associated with very 
low level enrichments of H3K27me3 and H3K4 methylation (data not shown). This 
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epigenetic profile correlated well with the transcriptional state of the genes (see 
Appendix, Figure A10).  
 
 
Figure 5.3 A cluster of four neural specific genes remains associated with a large bivalent domain in 
B cells. The cluster encompassing Crabp2, nestin, bcan and hapln2 is enriched for H3K4me1, H3K4me3 
and H3K27me3, in ES cells (upper panel) and B cells (lower panel). Very low level transcription of 
Crabp2, and nestin was observed in ES cells (chapter 3, section 4.3.2), whereas in B cells, none of the 
genes produced measurable transcripts.  
 
In order to extend the observations made on the 2 Mb region, the epigenetic 
profiles of additional tissue-restricted genes (Sox3, Dlx1/Dlx2 and Msx1/2) located on 
different chromosomes were also examined. The Sox3 gene, which is not expressed in 
ES cells and B cells, showed very similar epigenetic profiles for H3K27me3 and 
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H3K4me3 in these two cell types. The bivalent domain generated by the two 
modifications occupies a region of approximately 14kb. Several interesting differences 
were observed in the profile of H3K4me1 and H3K9ac. In ES cells, the pattern of 
enrichment for both of these modifications closely follows the enrichment profile for 
H3K4me3 whereas in B cells, H3K4me1 and H3K9ac both occupy a smaller region that 
is more closely localized to the Sox3 gene and it’s immediate flanking sequences. 
(Figure 5.4). In NS cells and astrocytes where Sox3 is active (Brunelli et al, 2003), the 
repressive H3K27me3 modification was greatly reduced, although some enrichment 
was still observed in the region upstream from the gene in astrocytes. The active histone 
modifications H3K4me1, H3K4me2 and H3K4me3 remain associated with the 
promoter and coding sequences, which is consistent with the expression of Sox3 in 
these cells. Interestingly, a small drop within a region of 200bp, corresponding to a 
genomic sequence occupied by a mononucleosome was detected at the 5’ end of Sox3. 
It is not clear whether this is caused by the difference in the probe sensitivity or the 
nucleosome depletion across the promoter of Sox3.  
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Figure 5.4 The epigenetic profile across the Sox3 gene in four different cell types. In ES cells and B 
cells, both coding and surrounding sequences are enriched for H3K4me3 and H3K27me3. In NS cells and 
astrocytes, H3K27me3 is greatly reduced and active histone modifications are retained, which is 
consistent with the active transcriptional state of Sox3 in these cells. (Because of lower amounts of 
chromatin obtained from astrocytes, only two modifications were analysed in this cell type, K4me2 and 
K27me3).  
 159 
 
Similar profiles were also observed in ES cells and B cells across the distal-less 
homeobox 1 (Dlx1) and 2 (Dlx2) genes, which are involved in the formation of 
GABAergic neurons (Bendall et al., 2000). A large bivalent domain (occupying a region 
of around 30kb), associated with  enrichment for H3K4me1, H3K4me3 and high levels 
of H3K27me3 spanned the closely linked Dlx1 and Dlx2 genes in ES cells and B cells 
(Figure 5.5). The bivalent chromatin structure extended into the 3’ end of the silent 
Metapl1 (methionine aminopeptidase-like 1) gene (expression data retrieved from 
(Mikkelsen et al., 2007). The active histone modification, H3K9ac was present at much 
lower levels in both ES cells and B cells, when compared to the other active marks. It is 
not clear whether this is caused by lower affinity of the H3K9ac antibody for its epitope 
(leading to globally lower enrichments) or whether this mark is present at lower levels, 
in the bivalent regions. In NS cells and astrocytes, where low level transcription of Dlx1 
and Dlx2 has been detected (Mikkelsen et al., 2007), the large domain of H3K27me3 is 
replaced by more localized intergenic peaks located downstream of Dlx1 and upstream 
of Dlx2. The active H3K4me1, H3K4me2 and H3K4me3 histone modifications remain 
associated with 5’ ends and coding regions of both genes and do not overlap with 
H3K27me3 peaks.  
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Figure 5.5 The epigenetic profile across the Dlx1/Dlx2 genes and the neighbouring Metapl1 gene, in 
ES cells, B cells, NS cells and astrocytes. The profile of histone modifications is very similar in ES and 
B cells, with a large bivalent domain associated with the coding regions of Dlx1 and Dlx2, and extending 
into the surrounding intergenic sequences. In NS cells and astrocytes, where the Dlx genes are expressed 
at low levels (interrupted arrow), the large domain of H3K27me3 is lost and only active histone 
modifications remain associated with the 5’ end and the coding regions.   
 
Two additional homeobox genes were included in the analysis, Msx1 and Msx2  
(homeobox msh-like 1 and 2), which are located on different chromosomes. Msx1 and 
Msx2 are also implicated in the early stages of neural development (Robert et al., 1989) 
but both genes have been shown to be transcriptionally inactive in ES cells and NS cells 
(Mikkelsen et al., 2007). The genes showed a slightly different pattern of histone 
modifications from Dlx1 and Dlx2. The epigenetic analysis demonstrated that the 
coding and surrounding regions of both Msx1 and Msx2 are associated with high 
enrichment for H3K27me3 in all analysed cell types (data are shown only for Msx1) 
(Figure 5.6). In all cell types that were examined enrichment of H3K4me2 were 
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associated with more localised sites, located immediately upstream and downstream of 
the Msx1 TSS. The profile of other active histone modifications was very similar to the 
one shown for H3K4me2. A close-up view of the Msx1 gene together with the pattern 
of H3K4me3 modification across this genomic region is shown in the Appendix, Figure 
A11. A small reduction in all of the analysed modifications was clearly visible across 
the Msx1 promoter, occupying a region of approximately 1 kb. The reason for this drop 
in levels is unclear.  If it were due to nucleosome loss across the promoter region, then it 
would be an unusual type of depletion because of the relatively large size of the 
depleted region and the fact that it is observed in all cell types, irrespective of 
expression status. Analysis with an antibody that recognises the C-terminus of histone 
H3 would be required to confirm this. The Msx2 promoter was not associated with this 
feature and both the 5’ end and the coding region were highly enriched for H3K27me3 
and active histone modifications.  
 
 
Figure 5.6 The epigenetic profile of H3K27me3 and H3K4me2 modifications across Msx1 gene in 
four different cell types. The repressive histone modification H3K27me3 is present across a large 
continuous region, whereas the enrichment for H3K4me2 is localised to regions close to the 5’ end of the 
gene. 
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5.2.1 Some genes acquire bivalent marks in B cells  
As described in the previous section, bivalent marks do not necessarily resolve 
upon cell differentiation and are clearly widespread in at least one differentiated cell-
type. Data obtained in this study has also shown that bivalent marks, which are absent 
on some genes in ES cells, can be acquired in more committed cell types. Thbs3 
(thrombospondin 3) is a tissue-restricted gene, which illustrates this phenomenon. The 
transcription start site (TSS) of the Thbs3 gene is situated only 1302bp away from the 
TSS of the ubiquitously expressed Mtx1 gene and is located in a region that contains a 
number of ubiquitously expressed genes.  Low-level transcription is detected by RT-
PCR across the Thbs3 gene in ES cells and this correlates with the presence of a 
continuous domain of Pol II binding across the promoter and the body of the gene. Low 
levels of active histone modifications (H3K9ac, H3K4me1, H3K4me2, H3K4me3) and 
Pol II were found across the 5’ end and the coding region (Figure 5.7 A) and 
H3K27me3 and H3K9me2 were largely absent. Thbs3 transcripts were not detected in 
mature B cells and the gene was enriched for H3K27me3 and H3K4me3 across the 
promoter and the body of the gene (Figure 5.7 B). There was also enrichment for 
H3K9ac and H3K4me1, and a localised peak of enrichment for H3K4me2 at the 
promoter region, Pol II was largely absent from the gene. The absence of H3K9me2 
also indicated that Thbs3 is not repressed in a “classical” manner through the formation 
of a heterochromatic chromatin structure, but rather through the presence of a bivalent 
domain. A similar acquisition of a large bivalent domain was also observed at the 
lamina and Rab25 genes in B cells (Figure 5.8). 
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Figure 5.7 Bivalent regions can be acquired during cell differentiation. The histone H3 modification 
profiles across the ubiquitous Mtx1 and tissue-restricted Thbs3 genes are shown for ES cells (A) and B 
cells (B). Although tissue-restricted, Thbs3 is transcribed at low levels in ES cells. In B cells, the gene is 
repressed and this is accompanied with the observation that its promoter and coding region become 
enriched for H3K27me3 and H3K4me3.  
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Figure 5.8 The histone modification pattern across Lmna and Rab25 genes, in ES and B cells. Both 
lmna and Rab25 are transcribed in ES cells, which correlates well with the presence of K4me1 and 
K4me3 (upper panel). In B cells, where both genes are transcriptionally inactive, the coding and 
intergenic sequences acquire large amounts of the H3K27me3 modification in B cells, while retaining 
H3K4me1 and H3K4me3 (lower panel). 
 
5.2.2 Bioinformatic analysis confirms that the bivalent probes are 
widespread in B cells 
The microarray data was subjected to additional bioinformatic analysis (with 
assistance from Dr. Marion Leleu) to compare the frequency of bivalent domains in 
pluripotent ES cells, multipotent NS cells and fully differentiated B cells. The 
distribution of at least two active histone modifications and H3K27me3 (considered as 
bivalent mark) was examined. Out of the total number of microarray probes that were 
analyzed 16% were defined as bivalent in ES cells, 23% in B cells and 14% in NS cells  
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(Figure 5.9). These data provide the surprising observation that the number of bivalent 
probes increases in cells belonging to lymphoid lineage.  
 
 
Figure 5.9 Venn graphs summarizing the presence of different histone modifications in ES cells, B 
cells and NS cells. The level of the three analyzed groups is similar in ES cells and NS cells, where 
probes detecting bivalent signals constituted 16% and 14% of the total number of probes respectively. B 
cells showed higher number (23%) of probes associated with bivalent modifications than ES cells and NS 
cells.  
 
Further analysis was carried out in order to examine whether the presence of 
bivalent probes was preferentially located at specific types of genomic site (eg. gene-
dense versus gene-poor regions). There was no obvious variation in the number of 
bivalent marks for most of the regions that were studied (Figure 5.10). However, the 
probes situated along mouse chromosome 11, showed a significantly higher number of 
bivalent probes in NS cells (64%), than what was observed in ES (29%) and B (5%) 
cells. Surprisingly, this bivalent region on chromosome 11 included four genes coding 
for the subunits of GABAA receptor, which are expressed in GABAergic neurons. The 
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epigenetic profiles of these and additional neurotransmitter receptor (NTR) encoding 
genes will be described in chapter 6. 
 
 
Figure 5.10 Distribution of bivalent marks across specific regions of chromosome 13, 3 and 11 in 
ES, B and NS cells. The y-axis represents the percentage of bivalent probes relative to the total number 
of probes that has been analysed on each specific chromosome. In the table below, the percentage of 
bivalent probes is summarized. ES cells and B cells, showed similar distribution of bivalent probes across 
chromosome 13 and 3, whereas there is fewer bivalent probes in B cells (5%) across chromosome 11. The 
bivalent regions were associated with fewer probes in NS cells, across chromosomes 13 and 3 (8% and 
28%, respectively), relative to ES and NS cells. On the contrary, NS cells showed a strikingly high 
number of bivalent probes (64%) across chromosome 11. 
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5.3 Silenced genes located in gene-poor regions and their 
surrounding sequences are enriched for H3K9me2 in ES cells 
The majority of repressed genes located within the 2Mb gene-dense region on 
chromosome 3 were enriched for histone H3K27me3 but not for H3K9me2 (Chapter 4, 
section 4.3.1). However, when silent genes situated in gene-poor regions were analysed, 
some interesting differences were observed in the histone modification profiles. The 
Gabra1 and Gabrb2 genes are located within a gene cluster occupying a region of 0.8 
Mb that contains only four genes (Chapter 6). The distance between the Sox4 gene and 
the closest neighbouring genes is 371.6 kb in the 5’ direction and 799.1 kb in the 3’ 
direction. The silent promoters of these genes showed localised bivalent peaks of 
enrichment for H3K4me3 and H3K27me3 in ES cells (Figure 5.11). Regions of Pol II 
binding were also present at the promoters. The Sox4 gene had some additional regions 
of H3K4me3 that were not bivalent. The large regions of H3K27me3 that were found in 
the gene-dense region were absent from the gene-poor regions. Instead, the remaining 
intra- and intergenic regions in these regions seemed to be associated with low, but 
continuous stretches of H3K9me2. Short regions that were depleted of H3K9me2 were 
also observed, which corresponded closely with the sequences that were enriched for 
bivalent chromatin modifications. These results suggest that the presence of H3K9me2 
might be a feature of gene-poor regions in ES cells and that this could lead to these 
regions adopting a more condensed heterochromatic chromatin structure.  
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Figure 5.11 Gene-poor regions are enriched for H3K9me2 in ES cells. The silent promoters of 
Gabra1, Gabrb2 and Sox4 genes, situated in gene-poor regions, showed localised bivalent peaks of 
enrichment for H3K4me3 and H3K27me3 in ES cells. The bivalent histone modification across Gabra1 
and Gabrb2 genes was localised around the 5’ end of the genes, whereas the rest of the genes was 
depleted for analysed histone modifications.  The entire coding sequence of Sox4 had bivalent chromatin 
structure and also several bivlanet peaks were detected downstream of the gene. The remaining intra- and 
intergenic sequences in these regions seemed to be associated with low, but continuous stretches of 
H3K9me2 modification. 
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5.4 Summary 
The results described in this chapter show that: 
• The epigenetic profile is very similar between pluripotent ES cells and 
committed B cells 
• A high proportion of tissue-restricted genes that are bivalent in ES cells, retain 
bivalent chromatin modifications in B cells  
• Several genes which were associated with the active histone modifications in ES 
cells acquire bivalency in B cells and this correlates well with gene silencing  
• Low but continuous enrichment for the repressive histone H3K9me2 
modification is found within and around genes that are located in gene-poor 
regions.  
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6 Epigenetic marking of neurotransmitter receptor genes 
during stem cell commitment in neural stem cells 
 
6.1 Introduction  
Neurotransmitters play a key role in synaptic communication between neurons 
and they do so by binding to neurotransmitter receptors (NTRs). Besides their role in 
intercellular communication in the brain, neurotransmitters are also implicated in the 
processes occurring at the early stages of neural development, during which NS cells 
differentiate into mature neurons (Doetsch et al., 1999). The major excitatory and 
inhibitory neurotransmitters are GABA, serotonin, dopamine, gluatamate, glycine and 
nicotin acetylcholine (Nguyen et al., 2001).  
The GABA neurotransmitter is bound by several classes of GABA receptors 
with the GABAA receptor being the most common one (Backus et al., 1993).  The 
GABAA receptor subunits exhibit different patterns of temporal and spatial expression 
in the developing brain. For examples, the α2, α3 and β3 subunits are predominantly 
expressed in prenatal brain regions, while α1 and β2 are most prominent during 
postnatal development (Laurie et al., 1992). In adult brain, the α1β2γ2 combination is 
widely expressed and represents the largest population of GABAA receptors (Laurie et 
al., 1992). In contrast, most other subunits are rarely expressed or have a unique 
distribution in specific subsets of neurons. One such example is α6, which is 
exclusively expressed in cerebellar granule cells (Wisden et al., 1992). Genes coding for 
GABAA receptor subunits are usually found in clusters and it has been suggested that 
such an arrangement may facilitate clustered gene regulation.  
ChIP-on-chip analysis was used to determine the histone modification profiles of 
four genes (Gabra1, Gabra6, Gabrg2, Gabrb2) that are located in a single cluster, 
which encodes the most abundant subunits of the GABAA receptor. Three of these 
subunits (β2, α1 and γ2) are widely expressed in the brain whereas the α6 subunit is 
restricted to the cerebellum. A qRT-PCR analysis (carried  out by Dr. M. Sjoberg) 
showed that none of the four genes are expressed in either ES cells or embryonic NS 
cells (data not shown).  The profiles of H3K27me3, H3K4 methylation, H3K9 
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acetylation and Pol II binding were analyzed across these genes (the profiles for the 
H3K4me1, H3K4me3 and K27me3 are shown in Figure 6.1 and a close-up view of all 
studied histone modifications and Pol II is represented in Figure 6.2). 
 
 
Figure 6.1 The profile of H3K4me1, H3K4me3 and H3K27me3 across the cluster containing four 
Gabra genes in ES cells. The peaking probes (blue bars) are only detected across the 5’ promoters of 
Gabra1, Gabrb2, whereas Gabra6 is depleted of any peaks. The peaks are not detected across the Gabrg2 
promoter, but when the profile of Gabra1 is visualised in a close-up view, it is clear that it is enriched for 
all active marks and H3K27me3 (see Figure 6.2). The peaks were determined using Peak Detection 
function of SignalMap (by Nimblegen). 
 
 
The analysis showed that in ES cells, active modifications (H3K9Ac, H3K4me1, 
H3K4me2, H3K4me3) and the repressive H3K27me3 modification were absent from 
most of the locus, but were present as localised peaks at the promoters of the Gabrg2, 
Gabra1 and Gabrb2 genes (Figure 6.2). The promoters of these genes were also 
associated with low levels of Pol II. The Gabra6 gene, which codes for GABAA 
receptor subunit alpha 6, showed distinct pattern of histone modifications in ES cells, 
when compared to the other genes in the cluster. The Gabra6 promoter was devoid of 
H3K4me3 and  of all of the other active histone modifications that were analysed but 
did show some enrichment for H3K27me3. A narrow peak of bivalent modifications 
was also detected within the Gabra6 coding region whose function remains unclear. 
The difference in modification profiles could be related to the fact that Gabra6 
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expression is restricted to cerebellar granule cells whereas the other three genes are 
expressed throughout the nervous system. 
 
 
Figure 6.2 The epigenetic profile across four genes coding for the subunits of GABAA receptor in 
ES cells. The promoter regions of Gabrg2, Gabra1 and Gabrb2 show localised bivalent peaks of 
H3K27me3 and all of the active modifications that were analysed (highlighted with vertical grey bars). 
The promoter region of Gabra6 seems to be devoid of any modifications, although there is an intragenic 
peak of bivalent modifications.  
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6.2 Genes coding for NTRs are marked in different fashion in 
committed cell types 
As described above, the transcriptional analysis showed that the four genes 
situated within GABAA cluster are transcriptionally inactive in embryonic NS cells and 
astrocytes (personal communication from Dr. M. Sjoberg).  I carried out an analysis of a 
series of histone modifications in NS cells and astrocytes, in order to examine the 
epigenetic profile of this gene cluster in these cell types. The analysis was also carried 
out on fully differentiated B cells where the NTR genes are permanently silenced. The 
NS cells were derived from ES cells cultured in the presence of either fibroblast growth 
factor 2 (FGF-2) alone or together with epidermal growth factor (EGF), as described in 
(Conti et al., 2005) (carried out in collaboration with Dr. Elena Cattaneo, University of 
Milan). These cells expressed the neural marker nestin and upon stimulation with BMP4 
further differentiated towards astrocytes. The same study showed that these cells were 
competent for differentiation into neurons and were immunopositive for GABA (E. 
Cattaneo, personal communication).  
 
6.2.1 The major mouse GABAA receptor locus acquires a large bivalent 
domain in neural stem cells and astrocytes 
In NS cells and astrocytes, the region containing the Gabrg2, Gabra1, Gabrb2 
and Gabra6 genes showed an unusual epigenetic profile (Figure 6.3). Enrichment for 
H3K4me1, H3K4me2, H3K4me3 and H3K27me3 was detected across a large genomic 
region of approximately 0.8 Mb, extending across inter- and intragenic sequences. The 
same bivalent pattern was observed in astrocytes, suggesting that this epigenetic pattern 
is not exclusive to early neural precursors. The peaking regions were also confirmed 
using the Peak detection function of SignalMap software (from Nimblegen) (Figure 
6.4).  
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Figure 6.3 The epigenetic profile of the GABAA cluster in NS cells and astrocytes. A large bivalent 
domain covers the entire 0.8Mb region in both NS cells (upper panel) and astrocytes (lowest panel). The 
coding and intergenic sequences are enriched for active histone modifications K4me1, K4me2 and 
K4me3 as well as repressive K27me3 modification. Close-up views of the Gabrg2 and Gabra1 genes in 
NS cells are shown in middle panel. 
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Figure 6.4 Peak detection analysis of the histone modification profiles across the Gabrg2-Gabra1-
Gabra6-Gabrb2 locus. The peaking probes are represented as blue bars. In ES cells, the peaking regions 
of H3K4me1 and H3K4me3 are confined to the promoter regions of Gabra genes, whereas in NS cells, 
the peaks are localised across the entire 0.8Mb region. The density of H3K27me3 peaks also increases 
dramatically in NS cells. Peaks were detected using the Peak detection function of SignalMap (see 
Materials and Methods, Section 2.11 for details). 
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6.2.2 The bivalent domain at the major GABAA receptor locus extends 
across a distance of 1.3 Mb in neural stem cells 
The initial analysis of the GABAA cluster was carried out on a region of 0.8 Mb 
which covered the four Gabra genes in the cluster. To investigate how far the bivalent 
domain extended, the analysis was extended to a larger region that included additional 
flanking sequences. The aim was to extend the analysis to the first upstream and 
downstream genes that bordered the GABAA cluster. Inspection of the surrounding 
sequences showed that the GABAA cluster is situated in a relatively gene-poor region 
and that the nearest genes are located 1155kb upstream of Gabrg2 and 518 kb 
downstream of Gabrb2. In order to analyze this region, a new microarray design was 
generated that covered a genomic sequence of 3 Mb.   
As shown in Figure 6.5, the targeted 3 Mb region was associated  with little 
enrichment for H3K27me3 and H3K4me3 in ES cells. Clear enrichments for H3K4me3 
were observed at two clusters of genes, situated at each end of the analysed region  The 
5’ cluster contains four housekeeping genes and is completely depleted for H3K27me3 
in both cell types. Of the genes in the 3’ cluster, Pttg1 is a housekeeping gene, Slu7 
exhibits complex patterns of expression in human and mouse tissues and the remaining 
two genes (C1qtnf2 and Ccnjl) are uncharacterised. In ES cells and NS cells, Pttg1 and 
Slu7 are enriched for H3K4me3 and depleted for H3K27me3, whereas C1qtnf2 and 
Ccnjl are bivalent in ES cells and depleted for H3K27me3 in NS cells (Figure 6.5). The 
Peak Detection analysis shown in Figure 6.6 indicates that the bivalent domain that 
covers the GABAA cluster extends across a region of around 1.3 Mb. The region of 
H3K27me3 extends considerably further and is only interrupted by the 5’ housekeeping 
cluster.  
Together, these data demonstrate that the genomic sequence around the four 
Gabra genes is marked by an exceptionally large, bivalent domain in NS cells and 
astrocytes. Further analysis of complexes such as the PcG and trx complex will be 
necessary to provide insights into the mechanisms that are responsible for the 
organization, establishment and maintenance of this large bivalent domain. 
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Figure 6.5 ChIP-on-chip analysis of a 3Mb region that includes four genes coding for GABAA 
receptor subunits. A high level of enrichment for H3K27me3 and H3K4me3 is observed in NS cells and 
occupies a region of approximately 1.3Mb. Close-up views of the gene clusters that flank the region are 
shown in panels B and C (tissue-restricted genes are represented in red, housekeeping genes in green and 
uncharacterized genes are in black). (The red dashed line indicates the 0.8 Mb region that was initially 
analysed). Housekeeping genes Pttg1 and Slu7 are enriched for K4me3 in ES and NS cells. C1qtnf2 and 
Ccnjl have bivalent histone modifications in ES cells and are depleted for K27me3 in NS cells. 
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Figure 6.6 Peak Detection analysis confirms the presence of a large bivalent domain across the 
Gabra gene cluster in NS cells. In ES cells, the promoter regions of Gabra1, Gabrg2 and Gabrb2 genes 
are enriched for K4me3 and K27me3. Majority of the housekeeping genes at the 3’ and 5’ ends of 
analysed 3Mb region are highly enriched for K4me3. Few of them are also associated with K27me3 
modification (Ccng1 and C1qtnf2) (see Figure 6.5). In NS cells, these histone modifications occupy entire 
Gabra locus and extends into surrounding sequences. The region associated with the bivalent histone 
modifications in NS cells (1.3 Mb) is represented by red dashed line above the K4me3_NS track. Peaks 
were analysed using Peak Detection function of SignalMap (Nimblegen) (see Materials and Methods, 
section 2.11). 
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6.2.3 Bivalent histone modifications are localised at the promoters of NTR 
genes in B cells  
In order to examine the epigenetic profile of the Gabra genes in a non-neural 
lineage where they are permanently silenced, I carried out the ChIP-on-chip analysis on 
chromatin from fully differentiated activated B cells. Analysis of the histone 
modifications across the Gabra genes in B cells demonstrated that bivalent peaks of 
H3K27me3 and H3K4me3/H3K4me2/H3K4me1 are present at the promoter regions of 
Gabra1, Gabrb2 and Gabrg2 genes, similar to the profile that was observed in ES cells 
(Figure 6.7). Strikingly, the Gabra6 gene was devoid of any enrichment, which is also 
the profile that was observed in ES cells.  
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Figure 6.7 The epigenetic profile of the GABAA cluster in B cells. Four genes situated in GABAA 
cluster encode subunits of GABAA receptor that are expressed in cells beloning to the neural lineage. In B 
cells, this gene cluster is permanently silenced. The Gabra1, Gabrb2 and to a lesser extent the Gabrg2 
promoters were enriched for the H3K4me1, H3K4me2, H3K4me3 and H3K27me3 in B cells. The rest of 
the coding sequences were depleted for any histone modification, whereas Pol II was presenet at 
background levels. The promoter region of Gabra6 gene did not show any enrichment for these 
modifications.  
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6.3 Other NTR encoding genes have diverse epigenetic profiles in ES and 
NS cells 
 The histone modification profiles of the Drd1a (dopamine receptor D1A) and 
Htr3a and Htr3b (5-hydroxytryptamine receptor subunit 3A and 3B) genes were also 
analysed in ES cells and NS cells. Expression analysis carried out by Mikkelsen and 
colleagues (Mikkelsen et al., 2007) showed that Htr3b and Drd1a  are not expressed in 
ES cells and remain silent in NS cells.  
In ES cells the Drd1a was highly enriched for both H3K27me3 and H3K4me3 
generating a bivalent domain that extends across the promoter and coding region 
(Figure 6.8). The region of H3K4me3 enrichment extends into the neighbouring Sfxn1 
(sideroflexin1) gene, which is a ubiquitously expressed, mitochondrial gene. A change 
in the pattern of expression is observed in NS cells with the enrichment for H3K4me3 
and H3K27me3 present as tightly localised peaks at the promoter region of the gene. 
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Figure 6.8 The epigenetic profile across Drd1a gene, in ES cells and NS cells. Drd1a gene is silent in 
both ES and NS cells. In ES cells, the Drd1a was enriched for both K4me3 and K27me3 histone 
modifications that were extending into the surrounding up- and downstream regions. In NS cells, K4me3 
and K27me3 were detected as tightly localised peaks at the promoter region of Drd1a. Neighbouring 
ubiquitously expressed Sfxn1 gene was enriched for K4me3 in both cell types.  
 
The Htr3a and Htr3b genes encode subunits of the serotonin (5-
hydroxytryptamine) receptor. The 5-HT3 complex is a ligand-gated ion channel that 
mediates fast synaptic neurotransmission within brain and peripheral nervous system 
(PNS) (Nguyen et al., 2001). Htr3b is inactive in both ES and NS cells, while Htr3a is 
activated in NS cells (Mikkelsen et al., 2007). The analysis of histone modification 
profiles across this locus in ES cells showed that the promoter regions of Htr3a and 
Htr3b are weakly enriched for all active marks (H3K9Ac, H3K4me1, H3K4me2, 
H3K4me3 and Pol II). A large domain of enrichment for H3K27me3 extended across 
the entire inter- and intragenic regions occupying a region of approximately 165 kb 
(Figure 6.9). In NS cells Htr3a loses the H3K27me3 mark and retains methylation of 
H3K4, which is consistent with its expression in this cell type (Figure 6.10). Several 
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new bivalent sites appear within the body of Htr3a and downstream of its 3’ end in NS 
cells. The role of these marks is not clear. The promoter of the Htr3b gene, which is 
inactive in NS cells, remains bivalent in NS cells. Two new bivalent regions appear in 
the coding region as a result of localised H3K4 methylation along with a single 
monovalent H3K4 methylation mark immediately downstream from the gene.  
These results demonstrate that the genes that code for NTRs have very diverse 
epigenetic profiles in ES cells and NS cells. The Gabra genes have bivalent domains 
that are tightly localised to the promoters in ES cells and then acquire a very large 1.3 
Mb domain in NS cells.  The Drd1a gene is embedded in a bivalent region in ES cells 
and this then changes to much more localised bivalent marks in ES cells. The Htr3b 
gene is marked by a large H3K27me3 domain and localised bivalent marks in ES cells. 
In NS cells, H3K27me3 becomes localised and the gene is again marked by discrete 
bivalent domains. Nothing is known about the mechanisms that give rise to these 
complex patterns but it must be assumed that they result from the action of multiple 
sequence-specific factors that interact with the genes in ES cells and during 
commitment to the neural lineage. 
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Figure 6.9 The profile of histone modifications across the serotonin receptor subunits 3A (Htr3a) 
and 3B (Htr3b) in ES cells.  Htr3a and Htr3b genes are inactive in ES cells.  The promoters of both 
genes are enriched for K9Ac, K4me1, K4me2, K4me3 and K27me3 histone modifications. Besides 
promoter sequences, repressive K27me3 mark extends into coding sequences as well as intergenic region, 
which is separating Htr3a and Htr3b genes. 
 185 
 
Figure 6.10 The profile of histone modifications across the serotonin receptor subunits 3A (Htr3a) 
and 3B (Htr3b) in NS cells. Htr3a is actively transcribed in NS cells, whereas Htr3b remains inactive. 
The transcriptional state of Htr3a correlates well with the presence of K4me1, K4me2 and K4me3 at its 
promoter region. Htr3b on the other hand retains K27me3 together with active histone modifications, 
rendering a bivalent histone modification pattern to this gene. These bivalent marks are tightly localised 
to  the 5’ end of the gene as well as within its coding sequence. 
 
6.4 Summary  
 
The results described in this chapter demonstrate that the genes situated in the 
major GABAA neurotransmitter gene locus acquire an unusual epigenetic profile 
in neural stem cells; 
• In ES cells, the promoters of tissue-restricted Gabra genes are associated with 
bivalent histone modifications 
• In embryonic NS cells and astrocytes, the locus becomes highly enriched for 
both active and repressive marks to give a bivalent domain of 1.3 Mb, which is 
the largest bivalent domain that has been described so far.  
• The promoter regions of three of the Gabra genes were also marked by bivalent 
modifications in fully differentiated B cells with the locus showing a histone 
modification profile that is strikingly similar to the one observed in ES cells.  
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7 Discussion 
 
7.1 Overview 
ES cells are pluripotent cells that can self-renew and differentiate into all 
somatic lineages in the presence of specific signals. The process of ES cell 
differentiation towards more committed progenitors requires tissue-specific patterns of 
gene expression to be established and maintained throughout the life of an organism. 
Many recent studies have focused on transcriptional and epigenetic mechanisms that are 
involved in the regulation of tissue-specific genes, and several models have been put 
forward. The first model that was considered was the global accessibility model 
(Kimura et al., 2004; Lee et al., 2004). However, this model was later contradicted by a 
study that demonstrated that high levels of repressive marks exist in ES cells (Meshorer 
et al., 2006). The localised presence of active marks in ES cells (Szutorisz et al., 2005; 
Anguita et al., 2004)  and the recent identification of bivalent domains  (Bernstein et al., 
2006) suggested that “priming” of tissue-specific genes occurs in ES cells and could be 
important for rapid activation/repression upon cell differentiation. 
Several studies have shown that gene organization within mammalian genomes 
is not random and that co-expressed genes are found within same gene clusters (Caron 
et al., 2001; Versteeg et al., 2003; Purmann et al., 2007). Co-expression of clustered 
genes can be explained by several evolutionary and genetic mechanisms, such as gene 
duplication, mutual use of regulatory elements, bidirectional promoters, common 
chromatin structures and transcriptional read-through (reviewed in (Batada and Hurst, 
2007)). However, there are also many genomic regions which are gene-dense and where 
tissue-restricted genes are situated close to highly expressed housekeeping genes. In 
spite of the fact that they are located in close proximity to each other, tissue-restricted 
genes are able to maintain their independent regulation and expression patterns, which 
are essential for cellular identity.   
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7.2 Monovalent and bivalent histone modification domains co-exist in 
close proximity to one another within a 2 Mb gene-dense region 
The major ChIP-on-chip studies that have been carried out on ES cells to date 
have mainly been whole genome studies that generate very large datasets, which are 
then used to detect statistical correlations between groups of genes. While this approach 
has proved to be very valuable, by its very nature, it looks for similarities rather than 
differences between genes. The strategy that was followed in this study was to carry out 
a very detailed analysis of a relatively short region of the mouse genome with the aim of 
detecting epigenetic features that might have been overlooked in large-scale genome-
wide studies. The results of the study revealed an extremely complex pattern of 
modifications, with individual genes often having their own distinctive modification 
profile.  
To interpret the results from this type of analysis it is essential to have accurate 
information about the expression pattern of the genes. Rather than relying on 
information from databases, a detailed transcriptional analysis was carried out in order 
to determine the cell-type specificities of each gene in the 2 Mb region. This led to the 
identification of different clusters of tissue-restricted and housekeeping genes within the 
region. Some of the clustered tissue-restricted genes belonged to the same gene family 
(eg. the Fcrl and Ephrin genes). Co-regulated expression of genes duplicated in tandem 
has been described for the Hox and globin loci (reviewed in (Sproul et al., 2005)) and it 
is possible that the paralogous Fcrl and Ephrin genes were kept together during 
evolution in order to be co-regulated. 
Additionally, some of the tissue-specific clusters located within the 2 Mb region 
included genes that are not part of the same families but are involved in related 
biological processes (eg. the neural-specific cluster). Other regions contained genes that 
are located close to one another but have different expression patterns and biologically 
unrelated functions (eg. Pklr and Hcn3).  In another type of arrangement tissue-
restricted genes are located as single genes situated between highly expressed 
housekeeping genes (Rusc1 and Syt11).  
Within the gene-dense region, domains of histone modifications showed several 
different types of organisation. For example, large domains of fairly continuous 
enrichment for H3K27me3 (in the range of 40-160kb) were observed across clusters of 
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silent genes. Within these domains of H3K27me3, shorter regions of H3K4 mono-, di- 
and tri-methylation generated discrete bivalent domains. Some of these bivalent 
domains were localised to the 5’ ends of genes, whereas others covered one or more 
genes (Chapter 4, Figure 4.4). In another type of arrangement, the domains of H3K4 
methylation corresponded fairly closely to the regions that were enriched for 
H3K27me3 (Chapter 4, Figure 4.5). 
While the bivalent domains were associated with silent, tissue-restricted genes, 
monovalent domains of active histone modifications were found at groups of 
housekeeping genes. Many of the housekeeping genes showed high levels of 
enrichment for mono-, di- and tri-methylation of H3K4 and binding of Pol II across 
entire inter- and intragenic regions (eg. Hdgf and Mrpl24, Chapter 4, Figure 4.3a and 
4.4c). These regions were depleted for H3K27me3.  
Relatively few domains were observed that were enriched for H3K27me3 
without any accompanying H3K4 methylation. This correlates well with other studies, 
which have shown that the H3K27me3 mark alone rarely occurs in ES cells (Pan et al., 
2007; Zhao et al., 2007). The monovalent H3K27me3 domains that we detected were 
associated with three lymphocyte-specific genes, Fcrl1, Fcrl5 and Sh2d2a. However, 
the sample size is too small to reach any conclusions as to whether there is a specific 
association with lymphocyte-specific genes. Another type of monovalent repressive 
domain showed enrichment for H3K9me2. This type of domain was not detected in the 
2 Mb gene-dense region, but was observed at inter- and intragenic sequences in gene-
poor regions (see Chapter 5 Figure 5.11). Our results also confirmed the negative 
correlation between the two repressive marks, H3K27me3 and H3K9me2 (Regha et al., 
2007; Bernsten et al., 2006). 
 
7.3 Sharp transitions are observed between domains that contain 
different types of histone modification 
An interesting feature of these closely juxtaposed chromatin domains is that they 
undergo clear and sharp transitions that mirror the different transcriptional states of the 
genes situated within the respective domains. Figure 4.3 in Chapter 4 provides a 
particularly good illustration of this phenomenon. Several transitions can be seen, where 
the changes in enrichment and depletion of H3K27me3 are very clear. For example, the 
neural specific cluster containing the Crabp2, nestin, Bcan and Hapln2 genes are 
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flanked on either side by ubiquitously expressed genes and shows sharp transition from 
a bivalent domain to regions on both sides that are depleted for H3K27me3. The nature 
of the mechanisms that define these boundaries remains unclear.  
Binding of RNA Pol II was observed at varying levels on all four of the neural-
specific genes and low levels of transcripts were also detected in ES cells. A recent 
study on the Crabp2 gene has shown that its mature mRNA could not be detected by 
northern blotting of mouse ES cell RNA (Lane et al., 2008). This implies that  the 
transcripts that were observed were not correctly initiated and are likely to be a product 
of permissive transcription. It is possible that the physical position and proximity of the 
neural cluster to ubiquitously expressed genes and active modifications makes the 
region more permissive for non-specific transcriptional initiation. A similar effect could 
also explain the low level Rusc1 transcripts, which is situated 8.5 kb downstream of a 
housekeeping promoter. Permissive transcription has been described previously in ES 
cells and is believed to play an important role in generating the plasticity of these cells 
(Szutorisz et al., 2005; Efroni et al., 2008). 
 Another interesting question is how unrelated genes (such as Pklr and Hcn3) are 
regulated within a same gene cluster. Pklr (liver pyruvate kinase) and the brain-specific 
Hcn3 gene are convergently transcribed from the promoters situated ~25 kb apart and 
their poly(A) ends are separated by an intergenic region of only 1 kb. The analysis of 
the epigenetic profiles showed that both genes have a bivalent histone modification 
profile in ES cells (Chapter 4, Figure 4.15). The only distinction between these two 
tissue-specific genes was that Hcn3, which is situated close to the promoter of the 
ubiquitous Clk2 gene, appears to be undergoing permissive transcription in ES cells, 
whereas Pklr is repressed. These data showed that not all tissue-restricted genes are 
subject to transcriptional read-through in ES cells, and that the distance between a 
tissue-restricted gene and nearby housekeeping gene promoters may be important for 
determining the incidence of permissive transcription. Nevertheless, it is still not clear 
how closely juxtaposed genes retain differential profile of expression and what are the 
additional factors and/or boundaries that define individual transcriptional units. One 
approach for the future experimental work could be the examination of binding sites of 
lineage specific factors across the 2Mb region.  
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7.4 Mature B cells and ES cells have strikingly similar bivalent 
histone modification profiles at repressed genes  
The initial discovery of bivalent histone modifications suggested that co-existing 
active and repressive histone modifications were a unique characteristic of ES cells. 
Even though several recent studies have reported the presence of bivalency in more 
committed cells (Roh et al., 2006; Pan et al., 2006; Mikkelsen et al., 2007), the model 
proposing that bivalent domains play a key role in determining ES cell pluripotency is 
still widely accepted (for a recent review, see (Pietersen and van Lohuizen, 2008)).  
The epigenetic profiling carried out on fully committed B cells has shown that 
these cells have a profile of H3K27me3 and H3K4 methylation which is surprisingly 
similar to the one detected in pluripotent ES cells. This trend was not only observed 
within the 2 Mb gene-dense region, but it was also seen across genes that are situated on 
other chromosomes, such as Msx1, Msx2, Dlx1 and Dlx2. The main 2 Mb gene-dense 
target region, was associated with relatively large monovalent and bivalent domains, 
and it correlated well with the transcriptional state of the analyzed genes. Lymphocyte-
specific genes, such as Fcrl1 and Fcrl5, which are inactive in ES cells, acquired the 
active histone modification and Pol II, leading to gene activation. The observation that 
the transcripts of tissue-restricted genes, which showed low level transcription in ES 
cells (such as Crabp2, Rusc1 and Hcn3), could not be detected in B cells, confirmed the 
phenomenon of  “permissive” transcription in ES cells (Efroni et al., 2008). Further 
analysis of the epigenetic marks and GTFs are necessary in order to gain insight into the 
mechanisms causing this ES cell-specific state.   
 A further observation, which reinforced the conclusion that bivalency is not an 
ES cell-specific mark, is the appearance of bivalent domains in B cells across genomic 
regions that are not bivalent in ES cells. Thrombospodin3 (thbs3) is a tissue-restricted 
gene, which shows low level transcription in ES cells and is inactive in B cells. The 
transcriptional state of Thbs3 was consistent with its epigenetic profile (Chapter 5, 
Figure 5.7). In ES cells, the Thbs3 promoter and its coding region were enriched with 
active histone modifications and Pol II and showed little enrichment for H3K27me3. In 
B cells, where Thbs3 undergoes long-term silencing, Pol II was largely absent and 
H3K27me3, H3K4me1, H3K4me2 and H3K4me3 enrichment were detected across the 
entire coding region of the gene, generating a typical bivalent domain.  
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The striking similarity of the epigenetic profiles between pluripotent ES cells 
and fully differentiated and committed B cells needs to be verified on a genome-wide 
level, since the results described in this study suggest that these two cells have very 
similar epigenetic profile. It is currently believed that upon lineage commitment, the 
bivalent marks resolve into either active or repressed chromatin state that is associated 
with loss of pluripotency. At present, it is still very little known about the signals that 
regulate PcG-recruitment and clearance from a given locus. Recent studies suggested 
the role of non-coding RNA in recruitment of PcG and trx protein to their targets (Rinn 
et al., 2007; Sanchez-Elsner et al., 2006). A recent study that demonstrated that the Eed 
-/- ES cells retain their pluripotency, additionally suggesting that PRC2 is not necessary 
for the maintenance of the pluripotent state in ES cells (Chamberlain et al., 2008). The 
authors suggest that positive regulation of pluripotent factors is sufficient for mediating 
stem cells pluripotency. 
Nevertheless, our data raises new questions, such as what is the role of 
polycomb proteins in a lineage-committed cell types. The results described here also 
showed that terminally silent genes (such as above described thbs3 gene) can acquire 
bivalent chromatin state, suggesting that this epigenetic mark may be involved in long-
term silencing. 
There is also a substantial body of evidence indicating that mature B cells show 
an unusual degree of plasticity compared with other differentiated cell types. 
Conditional knockout of the Pax5 gene in B cells allows the cells to dedifferentiate to 
uncommitted progenitors (Cobaleda et al., 2007). Ectopic expression of C/EBPalpha is 
also sufficient to induce trans-differentiation of B cells into macrophages (Xie et al., 
2004). A recent study has also provided evidence suggesting that generation of induced 
pluripotent stem (iPS) cells by expression of Oct4, Sox2, Klf4 and c-Myc occurs at an 
unusually high frequency in B cells following knockdown of Pax5 or ectopic expression 
of C/EBPalpha (Hanna et al., 2008). It is possible that the widespread prevalence of 
bivalent domains in B cells contributes to this plasticity. 
 192 
 
7.5 A very large bivalent domain is acquired at the major GABAA 
receptor subunit locus in NS cells and astrocytes 
Neurotransmitter receptors (NTRs) are bound by neurotransmitters such as 
GABA, glycine, dopamine, glutamate, nicotinic acetylcholine and serotonin (Nguyen et 
al., 2001). Neurotransmitters participate in synaptic communication between neurons 
and are also implicated in the processes occurring at the early stages of neural 
development. In order to examine how the genes that code for NTRs are regulated, the 
histone modification profiles of several of these genes was analyzed in ES cells, NS 
cells and neural progenitors.  
In ES cells, the majority of the NTR genes are bivalently marked. The GABA 
receptor subunit genes, Gabrg2, Gabra1 and Gabrb2, have localized bivalent marks at 
the promoter regions, while the dopamine receptor gene Drd1a is bivalently marked 
across its entire coding region. Gabra6 was the only GABAA subunit encoding gene 
that was analyzed that was devoid of any marks in ES cells (see Chapter 6 Figure 6.1.). 
This observation might be related to the fact that the Gabra6 gene is specifically 
expressed in the cerebellum, whereas the other genes in the locus are expressed 
throughout the adult brain.  
A striking observation that was made in this study was the large size of the 
bivalent domain that covers the major GABAA receptor locus and surrounding regions 
in NS cells.  Further analysis using a microarrays covering larger genomic region 
demonstrated that this domain occupied a genomic sequence of approximately 1.3 Mb, 
which is the largest bivalent domain that has been described so far. It is interesting to 
note that the domain of H3K27 methylation was larger than the domain of H3K4 
methylation. The region of H3K27 methylation extended on one side right to the nearest 
cluster of ubiquitously expressed genes, whereas the region of H3K4 methylation 
stopped well short of this. This finding raises interesting questions about the 
mechanisms that lead to the formation of bivalent domains. The large size of the domain 
strongly suggests a spreading mechanism. However, if this is the case, the extent of the 
spreading is clearly different for the two types of modification.  Further studies are 
necessary in order to investigate whether subunits of the PcG complexes are associated 
with these regions and what establishes this domain in NS cells. Another possibility is 
that non-coding RNAs could be involved in generating the domain. A non-coding RNA 
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have been shown to be involved in generating a 40 kb domain of PcG binding and 
H3K27 methylation across the human hoxD locus (Rinn et al., 2007). 
 Another interesting question is why the GABAA receptor locus acquires such a 
large bivalent domain in NS cells and what role this domain plays in its regulation. The 
Drd1a gene, which encodes a dopamine receptor, is also silent in ES cells, but only has 
a localized bivalent peak at the promoter in NS cells. Further studies will be required to 
address this question. ChIP-on-chip analysis carried out on GABAergic neurons (where 
the four Gabra genes are transcriptionally active) would also make it possible to see 
how this tissue-specific and gene-poor region behave upon gene activation. 
 
7.6 Conclusions  
The results described in this thesis emphasise the value of a detailed analysis of 
histone modification profiles that takes into account of the differences as well as the 
similarities between genes. An intensive analysis of a 2 Mb gene-dense region of the 
mouse genome demonstrated the complexity of the histone modification patterns of 
mammalian genes and suggests that genome-wide studies may oversimplify the 
epigenetic mechanisms that are responsible for ES cell pluripotency and cell 
specification. It was shown that distinct patterns of monovalent and bivalent histone 
modifications associate with different transcriptional units. Permissive transcription was 
observed in ES cells but was found mainly at genes that are situated close to 
ubiquitously expressed housekeeping genes. This suggests that proximity to a nearby 
housekeeping promoter may play a role in making tissue-restricted genes susceptible to 
permissive transcription in ES cells. However, the fact that this phenomenon is not 
observed in B cells for genes that have the same transcriptional and epigenetic profiles 
as in ES cells, suggests that additional and as yet unidentified levels of regulation 
distinguish ES cells from B cells. The observation that a very large bivalent domain is 
acquired at a major NTR locus in NS cells adds a new level of complexity to the 
regulation of these genes.  
 A major finding of this study was the observation that bivalent histone 
modifications are widespread in B cells and that they show a very similar pattern to the 
one observed in ES cells. These data raise questions about the model that proposes 
bivalency is responsible for stem cell pluripotency and raises new questions regarding 
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the epigenetic mechanisms that distinguish pluripotent stem cells from fully 
differentiated cells.  
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 Appendix 
 
 
Figure A1. The size of chromatin fragments was verified on Agarose gels. Sonicated (lane 2) and 
MNase digested (lane 4) chromatin was verified on 1% Agarose gels (lanes 1 and 3 are DNA ladder).  
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Figure A2. The epigenetic profile of all analyzed histone modifications and Pol II in ES cells, across 
a part of the target 2Mb region (section 1). The ChIP-on-chip data are shown for the sequence 
spanning genomic region from 87.489.300-87.999.381 on mouse chromosome 3 (mm7). 
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Figure A3. The epigenetic profile of all analyzed histone modifications and Pol II in ES cells, across 
a part of the target 2Mb region (section 2). The ChIP-on-chip data are shown for the sequence 
spanning genomic region from 87.972.716-88.442.431 on mouse chromosome 3 (mm7). 
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Figure A4. The epigenetic profile of all analyzed histone modifications and Pol II in ES cells, across 
a part of the target 2Mb region (section 3). The ChIP-on-chip data are shown for the sequence 
spanning genomic region from 88.438.824-88.933.962 on mouse chromosome 3 (mm7). 
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Figure A5. The epigenetic profile of all analyzed histone modifications and Pol II in ES cells, across 
a part of the target 2Mb region (section 4). The ChIP-on-chip data is shown for the sequence spanning 
genomic region from 88.910.985-89.406.050 on mouse chromosome 3 (mm7). 
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Figure A6. The epigenetic profile of all analyzed histone modifications and Pol II in ES cells, across 
a part of the target 2Mb region (section 5). The ChIP-on-chip data are shown for the sequence 
spanning genomic region from 89.393.048-89.575.611 on mouse chromosome 3 (mm7). 
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Figure A7. Close-up view of the histone modification profile and Pol II across Crabp2 and nestin in 
ES cells. In ES cells, low levels of transcripts of both genes are detected (interrupted arrow), which is 
surprising considering the amount of repressive H3K27me3 modification, which is present across the 
coding (and intergenic) regions. All analysed active marks together with Pol II seem to coexist with 
repressive mark.  
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Figure A8. Sequence conservation of Regions A1 and A2 (from UCSC browser). Intergenic 
sequences A-1  (A) and A-2 (B) were blasted against known mammalian genomes in the UCSC browser.  
The conservation level amongst mammals is shown in dark blue track. The level of homology between 
murine sequences and other organisms is shown in black tracks. The intergenic region A-1 shows very 
little homology when compared to other mammals and only rat’s synthenic region shows relatively high 
homology. The intergenic region A-2 shows high level of sequence similiarity amongst mammals.  
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Figure A9. Peak detection across Insrr and Ntrk locus. The analysis confirmed that this region is 
associated with bivalent histone modifications in B cells. The bivalent histone modification pattern is 
shown where K4me1, K4me2, K4me3 and Pol II co-exist with high levels of K27me3. Blue bars 
represent peaking regions identified by SignalMap (by Nimblegen). 
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Figure A10. The expression profile of a neural-specific cluster in four different cell types. Low 
transcipt levels of Crabp2 gene were detected in ES cells, nestin transcripts were detected at low leveles 
in ES cells, NS cells and astrocytes. Bcan showed very low level transciption in NS cells and astrocytes. 
 
 
Figure A11. Close-up view of histone modification profile across the Msx1 gene. The active marks, 
H3K4me2 and H3K4me3 seem to be associated with the sequences right upstream and downstream of 
Msx1 transcription start site (TSS), whereas a dip in both modifications, in all cell types is detected at the 
TSS itself.  
 
 
 
 
